,Tweet content,date,symbol,increase
0,"GE Short Sales
See Here ---&gt; https://t.co/4X2zHu7qPs

$GE $REGN $AAP #pennystocks$REGN double bottom waiting for mean reversion  bounce
#healthcare $ALDR $MNKD $GILD https://t.co/eXYAvjv7j8RT @DayTradeWarrior: WIN a FREE Warrior PRO Bundle! | To enter #RT &amp; Sign up here: https://t.co/wqoC4WK6I6 | $BUFF $AMGN $FCEL $REGN $LUV h‚Ä¶$REGN .... falling on Patent loss. https://t.co/yQmiCpY46LBiogen's Newer Problems; Their Relevance To The Biotech Sector https://t.co/8FX0qpX1zJ $ABBV $AMGN $GILD $IBB $IONS $MRK $REGN $RHHBY $SNYBiogen's Newer Problems; Their Relevance To The Biotech Sector https://t.co/wE7qXBQpSH $ABBV $AMGN $GILD $IBB $IONS $MRK $REGN $RHHBY $SNYBiogen's Newer Problems; Their Relevance To The Biotech Sector https://t.co/ZjHUYBTlxq $ABBV $AMGN $GILD $IBB $IONS $MRK $REGN $RHHBY $SNY$REGN | Regeneron Pharmaceuticals, Inc. is down 33% since we reported $1,977,198 of insider selling on ... - https://t.co/zl0hApTVu4$REGN's Dublin Site Critical for Future Growth https://t.co/LVaPFs3znl by @BioSpace#RegeneronPharmaceuticals Regeneron's Dublin Site Critical for Firm's R&amp;D and Growth  . Read more: https://t.co/2kmLE2Lp7f $REGN#RegeneronPharmaceuticals Regeneron's Dublin Site Critical for Firm's R&amp;D and Growth  . Read more: https://t.co/IjwEtJNigk $REGNFirst Week of November 18th Options Trading For Regeneron Pharmaceuticals  $REGN  #stockoptions https://t.co/FbOMqpaoB8$REGN:US  Dublin base critical for US drug company Regeneron #REGENERON PHARMACEUT  https://t.co/gzMQD9p9rJ #NASDAQCanaccord Genuity Cuts Price Target on Regeneron $REGN as Uncertainties Weigh on Stock https://t.co/4FVLFgpfSL$REGN:

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Issued With ‚Ä¶:

https://t.co/zpXPz83f8O$REGN:

Analysts At Canaccord Genuity Reiterated Regeneron ‚Ä¶:

https://t.co/RcAl1R8jqtRT @Taarriqq: Nice bounce off ystrdays post  &gt; Macd curling up $GILD + 2.5$ $REGN $WMT https://t.co/3pLhLRzDwDGAM Holding AG Buys 291 Shares of Regeneron Pharmaceuticals Inc $REGN https://t.co/oAxcohNXLp$REGN:US  Dublin base critical for US drug company Regeneron #REGENERON PHARMACEUT  https://t.co/SiWFf7JhJG #SP500Nice bounce off ystrdays post  &gt; Macd curling up $GILD + 2.5$ $REGN $WMT https://t.co/3pLhLRzDwD#RegeneronPharmaceuticals Regeneron, Bayer to jointly develop novel combination therapy for... Read more: https://t.co/2oSwIoST84 $REGN#RegeneronPharmaceuticals Regeneron, Bayer to jointly develop novel combination therapy for... Read more: https://t.co/jjAdrv3bLV $REGN$REGN:

Under Analyst‚Äôs Radar: Regeneron Pharmaceuticals Inc (NASDAQ ‚Ä¶:

https://t.co/TI7C6EFOD7I upgrade $REGN to moderate buy  - #Growth #Speculation #bullish #RSI #MACD #ADX #buyCallOption https://t.co/tYJ81A9zaeMarch 28 Analyst Upgrades &amp; Downgrades $FUL $NBR $FINL $KMX $XONE $PTLA $FANG $CF $FB $PVH $REGN $BIIB &amp; more.. https://t.co/K4QuqEtBhKWatch List: $TSLA $VRX $REGN $NUGT $AMZN $CMGCanaccord Genuity Reiterates a Hold Rating on Regeneron $REGN https://t.co/8aM9n7Ge9hREGN 52Wk Low
See Here ---&gt; https://t.co/fXkZiWAo58

$REGN $XLV $MCO #stockmarketRegeneron Pharmaceuticals Inc $REGN Stock Rating Reaffirmed by Canaccord Genuity https://t.co/Yu3mBpMtCNRegeneron Pharmaceuticals Inc $REGN Rating Reiterated by Piper Jaffray https://t.co/oZeFLqe1rrRegeneron Pharmaceuticals Inc $REGN Price Target Cut to $444.00 by Analysts at Jefferies Group https://t.co/XOzA2DsFMGREGN 1,040,355 Stock Charts $REGN Regeneron Pharmaceuticals Inc. (NASDAQ) Last Updated: 03/28/2016 02:50:46 RE https://t.co/Fhqtz6XoNcSawtooth Asset Management Inc. Acquires 3,547 Shares of Regeneron Pharmaceuticals Inc $REGN https://t.co/DlPB4FsWJ6$REGN:

Regeneron Pharmaceuticals (REGN) Short Interest Disclosure:

https://t.co/vA6bVSmMqmRegeneron Pharmaceuticals Inc $REGN Receives ‚ÄúSell‚Äù Rating from Chardan Capital https://t.co/Y2eYh5P4YX$REGN:

Large Outflow of Money Witnessed in Regeneron Pharmaceuticals:

https://t.co/vxJtgqxdU8RT @theflynews: Judge puts off decision on possible ban of Praluent. What that means for $AMGN $REGN and $SNY: https://t.co/NLQSvVXnrJ",2016-03-28,REGN,1
1,"Our Picks Are Seeing Incredible Gains! Get Exclusive Early Access To Our New Alerts: https://t.co/dWbN7JMySK $CSIQ $LLEN $REGNThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $CSIQ $LLEN $REGNOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $CSIQ $LLEN $REGNOur Picks Are Seeing Incredible Gains! Get Exclusive Early Access To Our New Alerts: https://t.co/dWbN7JMySK $ALXN $PCAR $REGNZNGA Stock Forum
See Here ---&gt; https://t.co/oFuwYWC1fG

$ZNGA $REGN $GVSI #nasdaqHPQ E.P.S.
See Here ---&gt; https://t.co/ZOXPC4Zo1M

$HPQ $REGN $YGE #share#Biotech: Valuations Have Changed, Fundamentals Have Not $IBB $GILD $BIIB $CELG $REGN #mybluechips #stocks
https://t.co/eLCQhpU46G$REGN target under 320. Chart looks ready to break lower as do various other bio's. $IBB $XBI (Long april puts) https://t.co/FBRAs2Y2xXThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $ALXN $PCAR $REGNOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $ALXN $PCAR $REGNRegeneron Pharmaceuticals Inc $REGN Price Target Cut to $444.00 https://t.co/T2g89gEjqUNEW POST: Listen to the Message  https://t.co/fPJOhqccMO $CMG $FB $NFLX $REGN $UVXY$SNY $REGN:

Sanofi SA (ADR)(NYSE:SNY), Regeneron (REGN) post remarkable ‚Ä¶:

https://t.co/msyl98xwbXRegeneron Pharmaceuticals‚Äô $REGN Hold Rating Reiterated at Piper Jaffray https://t.co/7rdxYao5TYRegeneron Pharmaceuticals Inc $REGN Price Target Cut to $444.00 https://t.co/ZHcgjM5k2aIf $IBB can get it's shit together, $IONS will have a nice day. A lot depends on $REGN and $GILD.$CSAX #1 MMJ Security. 35 cent. OTCQB. $1m monthly revs. 7m float https://t.co/7D29lJtlEy 

#stocks $LFL $GAI $REGN
https://t.co/u9vxRshXFT$regn price target reduced by canaccord today. Pt still above today's price at $450. I remain long#RegeneronPharmaceuticals Bayer Regeneron sign $130m pact to develop eye therapy. Read more: https://t.co/nYXGqluKeZ $REGN#RegeneronPharmaceuticals 
          Bayer and Regeneron to develop combination therapy to ... Read more: https://t.co/2LRx3gx3tX $REGN#RegeneronPharmaceuticals Bayer Regeneron sign $130m pact to develop eye therapy. Read more: https://t.co/0KLlxb7sn9 $REGN#RegeneronPharmaceuticals 
          Bayer and Regeneron to develop combination therapy to ... Read more: https://t.co/uJmIxrZssL $REGNPopular: $AAPL, $GLBL, $TROV, $AMBA, $XIV, $REGN, $WYNN, $SNY, $GOLD, $FCX, $GSKRT @regeneron: $REGN and @Bayer to develop novel combination therapy for eye diseases https://t.co/6sfXdHowEO$REGN:

New SEC Filing for REGN: Form 8-K (No. 0001104659-16-108062):

https://t.co/rktJ18MpAJ$REGN New SEC Document(s) for Regeneron Pharmaceuticals, Inc.
From our Stock News Alerts App$IBB headed to 200 area , as many #biotech stocks still have declines ahead $BIB $REGN $BIIB $JAZZ $KITE $BLUE $JUNO $CELG $ICPT $PCRXInvestment Analysts' Recent Ratings Changes for #RegeneronPharmaceuticals (). Read more: https://t.co/Guzq9MmXF8 $REGNInvestment Analysts' Recent Ratings Changes for #RegeneronPharmaceuticals (). Read more: https://t.co/rjQ3lvXW8T $REGNInvestment Analysts‚Äô Recent Ratings Changes for Regeneron Pharmaceuticals $REGN https://t.co/giW9DUmu5gREGN Quotes
See Here ---&gt; https://t.co/2VilgpRO1X

$REGN $KS $EEQ #stockmarketOur Picks Are Seeing Incredible Gains! Get Exclusive Early Access To Our New Alerts: https://t.co/dWbN7JMySK $CSIQ $LLEN $REGNThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $CSIQ $LLEN $REGNOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $CSIQ $LLEN $REGN",2016-03-29,REGN,0
2,"Over 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $ALXN $PCAR $REGN$REGN short setup https://t.co/R351MHyLheHRB % Change
See Here ---&gt; https://t.co/kDvK0qWfvb

$HRB $REGN $AHGP #investingRT SeekingAlpha: Regeneron Is Good Value But At A Lower Price https://t.co/FGrWdTbgkY $REGNRegeneron Is Good Value But At A Lower Price https://t.co/DztJ8YXOWt $REGNRegeneron Is Good Value But At A Lower Price https://t.co/gk3c90CrJR $REGNWednesday Sector Laggards: Utilities, Healthcare $CNP $NRG $XLU $MYL $REGN #stocks https://t.co/QZfyykKWwt$REGN presenting entry opportunity on unsubstantiated fears initiated by unknown ""analyst"" $IBB $SPY $SPX $SNY@NorthmanTrader I want to grab some $REGN on the dip. How low can it go? Bad move? I am already in $AMGN. ThanksJBEM is bak 2 sendng out comprehensive DD.Goin bak 2 his roots:  https://t.co/hBrHFNeVvm $REGL $REGN $REI $REIS $REK $RELL $RELV $RELXRegeneron and Bayer to develop combo therapy for eye diseases https://t.co/CuMeg0T03V $REGN, $BAYRY
#biotechRT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR‚Ä¶RT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR‚Ä¶RT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR‚Ä¶RT @WrigleyTom: Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR‚Ä¶Qtr Cleaning, nLod
$IBB $GILD $OPHT $CBPO $BMRN
$NLNK $INCY $SAGE $DVAX $VRX
$ZIOP $ALXN $AMGN $CELG $CLVS
$XON $REGN $ALDR $ALNY $BIIBRT @regeneron: For National #DoctorsDay, $REGN celebrates the perseverance of physicians in their commitment to patient care. https://t.co/‚Ä¶For National #DoctorsDay, $REGN celebrates the perseverance of physicians in their commitment to patient care. https://t.co/Y4p4bx3gC1RT @barronsonline: 5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK http‚Ä¶RT @barronsonline: 5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK http‚Ä¶RT @barronsonline: 5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK http‚Ä¶RT @barronsonline: 5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK http‚Ä¶5 potential blockbuster drugs https://t.co/obFbpOVmyf $RHHBY $SHPG $AGN $ANAC $PFE $NVS $REGN $AMGN $GILD $BMY $MRK https://t.co/VUA3sMo2spNorinchukin Bank The Cuts Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/2RGXaY9cMFToronto Dominion Bank Cuts Stake in #RegeneronPharmaceuticals Inc (). Read more: https://t.co/l4RKwdaj1h $REGNToronto Dominion Bank Cuts Stake in #RegeneronPharmaceuticals Inc (). Read more: https://t.co/iRtOUl4ZCd $REGNCanaccord Genuity Reaffirms Hold Rating for Regeneron Pharmaceuticals Inc $REGN https://t.co/C0jb5N9tRsAmeritas Investment Partners Inc. Has $1,721,000 Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/DZkzxoVESfAmeritas Investment Partners Inc. Has $1,721,000 Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/XcMyPaXo5HToronto Dominion Bank Cuts Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/yQH7muMfc6Philadelphia Trust Co. Maintains Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/RO67GEMGg1KKD Open
See Here ---&gt; https://t.co/ltc5eEmdvr

$KKD $PG $REGN #stockOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $CSIQ $LLEN $REGNThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $ALXN $PCAR $REGNOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $ALXN $PCAR $REGN$REGN:

How Analysts Feel About Regeneron Pharmaceuticals Inc ‚Ä¶:

https://t.co/YKaEhmC6Uf$REGN Current Report Filing (8-k)‚Ä¶ https://t.co/9Zeo35Rw3nREGN Last Price
See Here ---&gt; https://t.co/E13wO8wg3q

$REGN $BSTC $MSTR #share",2016-03-30,REGN,1
3,"Over 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $ALXN $PCAR $REGNRT @regeneron: For National #DoctorsDay, $REGN celebrates the perseverance of physicians in their commitment to patient care. https://t.co/‚Ä¶Regeneron Pharmaceuticals's hold rating reiterated at Canaccord Genuity. $450.00 PT. https://t.co/uYlV9hl3fn $REGN #REGNRegeneron Pharmaceuticals Inc $REGN Earns ‚ÄúHold‚Äù Rating from Canaccord Genuity https://t.co/uB6HUsKltpRegeneron Pharmaceuticals's hold rating reiterated at Canaccord Genuity. $450.00 PT. https://t.co/b4rP5kXMSY $REGN #REGN@Stephanie_Link some of my favourite CEOs 
$UA $TSLA $CRM $SNA $NFLX $SBUX $TMUS $FB $DPZ $HAIN $DIS $RH $JPM $AMZN $WFC $REGN $MCD $MA $HON$JNJ ditches fulranumab &amp; $AMGN deal. @ByJonGardner story about this troubled drug class from a year ago https://t.co/YDlY4Irouq $PFE $REGNNew insights on T cell bispecifics and how we can improve on blinatumomab https://t.co/x1uGX5AaZZ $amgn $rhhby $mgnx $regn$PEN Breaking through trendline on chart - Hot IPO in mid 15 volume recently
$MDVN $GNCA $VRTX $ENDP $REGN $IBB https://t.co/M1FHbfnnjZ$IBB $.SPX $VRTX $REGN $ALXN $BIIB $CELG $GILD $AMGN:

Can biotech recover from big slide?:

https://t.co/uP5kvz4wVFRT @Benzinga: Worst Stocks Of The First Quarter $ENDP $ESV $REGN $WMB $VRTX https://t.co/27qfTE9honWorst Stocks Of The First Quarter $ENDP $ESV $REGN $WMB $VRTX https://t.co/27qfTE9hon$REGN:

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) 52-week High ‚Ä¶:

https://t.co/CDDaPO5Gu6Yesterday We Made $94,000 In Just One Trade More Info Here https://t.co/ZMvOsK1CVa .. $CSIQ $LLEN $REGN$REGN gearing up to move higher here#RegeneronPharmaceuticals Inc Stake Raised by Liberty Mutual Group Asset Management Inc. Read more: https://t.co/zhFKAlWiuF $REGN#RegeneronPharmaceuticals Inc Stake Raised by Liberty Mutual Group Asset Management Inc. Read more: https://t.co/8oLui5hOI0 $REGN#RegeneronPharmaceuticals Inc Stake Raised by Mutual of America Capital Management LLC. Read more: https://t.co/4OWC6jwwTs $REGN#RegeneronPharmaceuticals Inc Stake Raised by Mutual of America Capital Management LLC. Read more: https://t.co/ilkOsLv2qZ $REGN@breakpointrades @MikeF_trading nice call, I'm following this one too. think long is the higher probability, but we'll see $REGNFinancial Counselors Inc. Boosts Position in #RegeneronPharmaceuticals Inc (). Read more: https://t.co/qZPjmBgq8Y $REGNFinancial Counselors Inc. Boosts Position in #RegeneronPharmaceuticals Inc (). Read more: https://t.co/MhFCnkUUc4 $REGNRT @breakpointrades: $REGN trade idea, could either way, a short if loses support or long if it finds support, react don't predict https://‚Ä¶Yesterday We Made $94,000 In Just One Trade More Info Here https://t.co/ZMvOsK1CVa .. $ALXN $PCAR $REGNRT @breakpointrades: $REGN trade idea, could either way, a short if loses support or long if it finds support, react don't predict https://‚Ä¶$REGN trade idea, could either way, a short if loses support or long if it finds support, react don't predict https://t.co/B3vR0lbhrERegeneron Pharmaceuticals Inc $REGN Stake Raised by Liberty Mutual Group Asset Management Inc. https://t.co/PBivQnvfFdRegeneron Pharmaceuticals Inc $REGN Stake Raised by Liberty Mutual Group Asset Management Inc. https://t.co/BzroQaS1dCadded $REGN 360$REGN | Regeneron Pharmaceuticals, Inc. is down 34% since we reported $1,977,198 of insider selling on ... - https://t.co/7t86m7X5MIRT @portefeuillefun: Bought 10 $REGN at $362. New #zzporte position. #biospring repositioning :) @zzlangerhansBought 10 $REGN at $362. New #zzporte position. #biospring repositioning :) @zzlangerhansRT @GraycellAdvisor: Biotechs Poised to Move Higher. https://t.co/o4GPqRRwcp $espr $mdvn $trvn $juno $kite $nbix $blue $itek $gild $incy $r‚Ä¶Biotechs Poised to Move Higher. https://t.co/o4GPqRRwcp $espr $mdvn $trvn $juno $kite $nbix $blue $itek $gild $incy $regn $vrtx $celg $regnRegeneron Pharmaceuticals Inc $REGN Stake Raised by Commonwealth of Pennsylvania Public School Empls Retrmt SYS https://t.co/BVu7BwSdvVRegeneron Pharmaceuticals Inc $REGN Stake Raised by Mutual of America Capital Management LLC https://t.co/jkEC66oS3sFinancial Counselors Inc. Boosts Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/C8Jiykzt8wOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8QMnm $CSIQ $LLEN $REGNThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sgRRp $ALXN $PCAR $REGNOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8QMnm $ALXN $PCAR $REGNRT @regeneron: For National #DoctorsDay, $REGN celebrates the perseverance of physicians in their commitment to patient care. https://t.co/‚Ä¶Premium Alerts Ranked #1 For Gains 2834% Last Week At https://t.co/ewcYkLb72h .. $HBAN $REGN $BBGIRegeneron Pharmaceuticals Inc $REGN PT Lowered to $444.00 at Jefferies Group https://t.co/GygTZztoQHYears ago I bought Regeneron  $REGN around $5 before it took off. It went to around $600 a share. $GERN could do that if all plays out good!REGN News
See Here ---&gt; https://t.co/v8WmQXwf2r

$REGN $MTW $DRD #nasdaqThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $CSIQ $LLEN $REGNBuying Biotech stocks for Long term here will be rewarding. Many stocks are off by 50%. I like $regn and $gildOver 1,466% Gains On Our Top Stock Picks Lately! See Our Big New Pick Early: https://t.co/4FeNl8zbvO $CSIQ $LLEN $REGNIs The Biotech ETF IBB Forming A Double Bottom Pattern? https://t.co/aLuvEmhNLw $AMGN $BIIB $CELG $GILD $REGN $IBBThree Penny Stock Picks More Than QUADRUPLED In Value! More Big Things On The Way: https://t.co/fctN9sytfZ $ALXN $PCAR $REGN",2016-03-31,REGN,1
4,"CYDY running, FLKS is just starting: https://t.co/lwSyWTxOEB $REGL $REGN $REI $REIS $REK $RELL $RELV $RELX$REGN So funny, up $45, then down 25 cents. LOLOLOL. Look this is going Up. End of story.$REGN: Analyst action by Leerink Swann on Regeneron Pharmaceuticals: https://t.co/XlkvO7mgsG https://t.co/1TWn6NMG9jTWTR 52Wk Low
See Here ---&gt; https://t.co/P2lged9pCK

$TWTR $REGN $MAN #financeRT @regeneron: #ICYMI @NYGovCuomo recognized $REGN‚Äôs contributions to NY‚Äôs biomedical industry https://t.co/FQPMBJVteY https://t.co/0rZ2Pmd‚Ä¶For 8ema cross 21ema stocks 
$GRPN
$SKYS
$MDT
$EXEL
$SC
$SNY
$RTN
$HOLX
$HZNP
$BIIB
$ALXN
$REGN
$KITE
Nice cross$REGN | Regeneron Pharmaceuticals, Inc. is down 26% since we reported $1,977,198 of insider selling on ... - https://t.co/LlvDnFBkOb$IBB has 190 holdings; top 10 = 57.83% weight; basically you are saying $AMGN $GILD $REGN $BIIB $CELG $ILMN $MYL $ALXN $VRTX $INCYRT @MiamiTrader7: @IconicTrading Dont listen to the crowd mentality about no.volume day ect ect. A+ setups for points 6 for 6 $REGN$EW$TREE‚Ä¶@TheHunter5515 @SheffStation $REGN news looks bad for $IMNP. Both inhibit eotaxin-1 but $REGN also inhibits eotaxin-3, more important@Lyset831 @kn0ckem0ut I want to do $REGN weeklys. Options.$REGN - BUY Signal at 405.25 on Apr 01, 16 By https://t.co/6PpjiKmc9G, Trading Robot#Stockstowatch #Stockmarket #trading #trade #investing@Lyset831 oh $REGN lol, I only have 40! From what I've seen, I know @kn0ckem0ut has a couple thousand though.@go2sleepjj @kn0ckem0ut any thoughts about $regn?@go2sleepjj should have bought more, Only have a small stake in this 31300 stocks, are you still in $regn? Sold friday bought today again$REGN New SEC Document(s) for Regeneron Pharmaceuticals, Inc.
From our Stock News Alerts AppRegeneron Pharmaceuticals director just cashed-in 2,000 options  https://t.co/SFlCEOSfWP $REGNRT @regeneron: #ICYMI @NYGovCuomo recognized $REGN‚Äôs contributions to NY‚Äôs biomedical industry https://t.co/FQPMBJVteY https://t.co/0rZ2Pmd‚Ä¶@IconicTrading Dont listen to the crowd mentality about no.volume day ect ect. A+ setups for points 6 for 6 $REGN$EW$TREE$WWE$ACAD$SHPG#ICYMI @NYGovCuomo recognized $REGN‚Äôs contributions to NY‚Äôs biomedical industry https://t.co/FQPMBJVteY https://t.co/0rZ2Pmd8dtNasdaq100 #Stocks Performance $VRTX $TSLA $ALXN $ISRG $CHTR $ADSK $AAPL $BMRN $SYMC $CERN $INCY $REGN $ILMN more@ https://t.co/YdSIjFJqHfCheck. Regeneron Pharmaceuticals Is My Top Pick In The Biotech Space https://t.co/nAh91Ou1T4 $ABBV $AMGN $ESRX $GILD $MRK $SNY $REGNIt's Official: The Good Times Are Over https://t.co/SMnhHtdjUQ $IBB, $XBI, $BIB, $BBH, $FBT, $JNJ, $GSK, $VRX, $REGN, $ALXN, $VRTX, $TEVA3 Biotech Stocks on the Verge of an Overdue Run $AMGN $GILD $REGN - https://t.co/rHvJgfFccm$REGN may be closer to a pain drug blockbuster with $JNJ discontinuing its Phase 3 study
https://t.co/hiOqP1JXnF by @BioSpaceRT @regeneron: We asked, you answered! According to $REGN employees, our best company tradition is Cheesy Hawaiian Shirt Day! https://t.co/‚Ä¶RT @regeneron: Time flies when we‚Äôre having fun &amp; working hard! Ringing the @NASDAQ opening bell to celebrate our 25th year as a public com‚Ä¶RT @FiercePharma: With impressive dupilumab data, Sanofi, Regeneron gear up for potential $5B in sales https://t.co/bOIyFcM22v $SNY $REGN #‚Ä¶RT @NASDAQ: .@Regeneron rings the @Nasdaq Opening Bell in celebration of 25 years as a public company! $REGN #Nasdaq100 üí´ https://t.co/xMGA‚Ä¶With impressive dupilumab data, Sanofi, Regeneron gear up for potential $5B in sales https://t.co/bOIyFcM22v $SNY $REGN #pharma #marketing$REGN: Analyst action by Leerink Swann on Regeneron Pharmaceuticals: https://t.co/XlkvO7mgsG https://t.co/rM4C0Rk4H5With impressive dupilumab data, Sanofi, Regeneron gear up for potential $5B in sales: https://t.co/5XYGFgSt0r $SNY $REGN #pharma #marketingRT @regeneron: Time flies when we‚Äôre having fun &amp; working hard! Ringing the @NASDAQ opening bell to celebrate our 25th year as a public com‚Ä¶REGN 405.00 Regeneron Pharmaceut $REGN added to my watch list. Right now with REGN I am watching the last pric https://t.co/26bJowGONbRT @WrigleyTom: $REGN 405.25
bumps PT $505 ‚ûú $523
stock is Outperform-rated
-Leerink https://t.co/GUig8tO9QX#RegeneronPharmaceuticals Inc Expected to Post FY2017 Earnings of $5.67 Per Share (). Read more: https://t.co/m0TBcXu44k $REGN#RegeneronPharmaceuticals Inc Expected to Post FY2017 Earnings of $5.67 Per Share (). Read more: https://t.co/kphfmUQAnN $REGN$REGN going to $412IBB Is About To Break Out With Significant Upside Potential https://t.co/qj59jVdFzI $AMGN $BIIB $CELG $GILD $MDVN $MRK $REGN $SNY $RHHBYIBB Is About To Break Out With Significant Upside Potential https://t.co/q1uyzabZUK $AMGN $BIIB $CELG $GILD $MDVN $MRK $REGN $SNY $RHHBYIBB Is About To Break Out With Significant Upside Potential https://t.co/fWieiAKyIr $AMGN $BIIB $CELG $GILD $MDVN $MRK $REGN $SNY $RHHBY$REGN chart to substantiate comment just posted. https://t.co/ZK8HxBdBBe$REGN Still holding 1/3 of original pre-pop position; bought 1/3 back on a.m. pullback. Working overbought off &amp; acting as could go higher.$REGN ""...released the long-awaited results of its SOLO 1 and 2 results for...#Dupilumab
https://t.co/jYw0G5Yd1S    @AlexanderPoulosBetter Buy: #RegeneronPharmaceuticals, Inc. vs. Amgen. Read more: https://t.co/qQKulTHTFm $REGNBetter Buy: #RegeneronPharmaceuticals, Inc. vs. Amgen. Read more: https://t.co/cP692FZ2cu $REGNIn $REGN May 20 $500c @ .85 excellent risk to reward ER 5/5Johnson &amp; Johnson's Phase 3 Cancellation: Why It Matters https://t.co/2gr7eofqpM $AMGN $LLY $PFE $REGN $SNY $SPY $JNJ3 Biotech Stocks on the Verge of an Overdue Run $AMGN $GILD $REGN - https://t.co/Io60dl1i8h$IBB doing well today even into this weakness.. #biotech stocks pushed up well since last week 
$JAZZ $AMGN $BIIB $CELG $REGN $ALXN etc.$REGN $IBB $XBI Still holding firm, watch closing price depending on $IBB close https://t.co/4BUO82vMYsRT @agrudadvisors: Regeneron Pharmaceuticals surges 12.43% to $405.25 after releasing positive trial results of experimental drug IL-4 and‚Ä¶I like the $REGN chart. Reminds me of the $AMZN selloff. I believe it heads back up to the $500 level.RT @regeneron: Time flies when we‚Äôre having fun &amp; working hard! Ringing the @NASDAQ opening bell to celebrate our 25th year as a public com‚Ä¶RT @NASDAQ: .@Regeneron rings the @Nasdaq Opening Bell in celebration of 25 years as a public company! $REGN #Nasdaq100 üí´ https://t.co/xMGA‚Ä¶RT @NASDAQ: Watch @Regeneron ring the @Nasdaq Opening Bell in celebration of 25 years as a public company! $REGN #Nasdaq100 https://t.co/WS‚Ä¶Looks good on $IBB recovery $REGN https://t.co/AOCOZQXuZ9$REGN chart: Looks good on $IBB recovery. https://t.co/JtDtZMJFo5Big implied vol drops: $UVXY -21.5%, $VRX -8.5%, $BBRY -6.1%, $VALE -3.8%, $REGN -3.5%, $XLF -2.1%, $EFA -1.9%Top 5 HC -13% YTD vs -20.65% $IBB.  Last 21 days +4.65 outperf.  Watching $GILD $CELG $MDVN $BIIB $REGN on HC recov https://t.co/XTg1WMNtAlRT @regeneron: Time flies when we‚Äôre having fun &amp; working hard! Ringing the @NASDAQ opening bell to celebrate our 25th year as a public com‚Ä¶$IBB very important test for #biotech right now!

$AMGN $GILD $CELG
$BIIB $REGN https://t.co/x8SZ3DWqIgCanaccord Genuity Reiterates Hold Rating for #RegeneronPharmaceuticals Inc (). Read more: https://t.co/ukVH7tE3FW $REGNCanaccord Genuity Reiterates Hold Rating for #RegeneronPharmaceuticals Inc (). Read more: https://t.co/VObJoZgYpY $REGNRT @IndvTrader: Commented on Biotech Will Blast Past Its 2015 Highs https://t.co/qTbt7iDOrv $GILD $LABU $REGN $IBBPricey #PCSK9 Inhibitors Require Careful Patient Selection $AMGN $REGN $ESPR's bempedoic acid could b priced at 1/5  https://t.co/iELNsQcurOCommented on Biotech Will Blast Past Its 2015 Highs https://t.co/qTbt7iDOrv $GILD $LABU $REGN $IBBTrending #Biotech topics include $REGN, $CBLI, #Rumalaya #stocks #invest See more https://t.co/EpbbdqDEG1$JNJ's Ph 3 cancellation is looking good for $REGN &amp; its chronic pain #drug https://t.co/2jHRLMyvFB by @SeekingAlpha https://t.co/dDm2jXwwAART @asclepiacap: Insights Into Statin Intolerance Roundtable from Clinical Cardiology

$ESPR $AMGN $SNY $REGN $MRK 

https://t.co/1RdeXttC01#RegeneronPharmaceuticals Injectable eczema drug dupilumab meets primary endpoints in two p... Read more: https://t.co/HqLZCncrGC $REGN#RegeneronPharmaceuticals Injectable eczema drug dupilumab meets primary endpoints in two p... Read more: https://t.co/roT05A0zYt $REGN#RegeneronPharmaceuticals Regeneron's Potential Blockbuster Sidelines PCSK9 Lawsuit Against... Read more: https://t.co/s3LCAwj3Qd $REGN#RegeneronPharmaceuticals Regeneron's Potential Blockbuster Sidelines PCSK9 Lawsuit Against... Read more: https://t.co/wE8WJZBW8T $REGN$REGN:

Analysts At Leerink Swann Indicated Regeneron Pharmaceuticals ‚Ä¶:

https://t.co/AGoQraRGrsRT @NASDAQ: Watch @Regeneron ring the @Nasdaq Opening Bell in celebration of 25 years as a public company! $REGN #Nasdaq100 https://t.co/WS‚Ä¶Added $scty 25 calls $ibb 275 $regn 620 bios back in action fang stocks need some rest $nflx $amzn $googl $fb staying out from it for now$REGN:

Sell, Buy or Hold Stocks?? Regeneron Pharmaceuticals, Inc ‚Ä¶:

https://t.co/UiSP1shW9d@PFOLIOALERT PREDICTED WINNERS APR 4 $ZFGN $JAZZ $AMGN  $OHRP $INCY $HKMPY $AMPH $NVO $ACAD $BMRN $REGN $CASI $FOLD $RGLS $INO
 ALPHACHAOSRT @NASDAQ: Watch @Regeneron ring the @Nasdaq Opening Bell in celebration of 25 years as a public company! $REGN #Nasdaq100 https://t.co/WS‚Ä¶Insights Into Statin Intolerance Roundtable from Clinical Cardiology

$ESPR $AMGN $SNY $REGN $MRK 

https://t.co/1RdeXttC01RT @NASDAQ: .@Regeneron rings the @Nasdaq Opening Bell in celebration of 25 years as a public company! $REGN #Nasdaq100 üí´ https://t.co/xMGA‚Ä¶Watch @Regeneron ring the @Nasdaq Opening Bell in celebration of 25 years as a public company! $REGN #Nasdaq100 https://t.co/WSv1jn2IrRBiotech Will Blast Past Its 2015 Highs https://t.co/Fc5J0ZYueJ $GILD $LABU $REGN $IBB$REGN:

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) and Sanofi ‚Ä¶:

https://t.co/3rHigTJ0GfRT @NASDAQ: .@Regeneron rings the @Nasdaq Opening Bell in celebration of 25 years as a public company! $REGN #Nasdaq100 üí´ https://t.co/xMGA‚Ä¶$REGNRT @NASDAQ: .@Regeneron rings the @Nasdaq Opening Bell in celebration of 25 years as a public company! $REGN #Nasdaq100 üí´ https://t.co/xMGA‚Ä¶.@Regeneron rings the @Nasdaq Opening Bell in celebration of 25 years as a public company! $REGN #Nasdaq100 üí´ https://t.co/PvmIcDOYBK.@Regeneron rings the @Nasdaq Opening Bell in celebration of 25 years as a public company! $REGN #Nasdaq100 üí´ https://t.co/xMGAenP33N#RegeneronPharmaceuticals Mitsubishi UFJ Kokusai Asset Management CO. LTD. Has $28,486,000 ... Read more: https://t.co/HeHV9rIvGy $REGN#RegeneronPharmaceuticals Mitsubishi UFJ Kokusai Asset Management CO. LTD. Has $28,486,000 ... Read more: https://t.co/XdgsCWckmt $REGNWe calculated 63-day Expected Return of $REGN for you: -23.78% https://t.co/SwUMTR2sdFUnusual call buying: $DXJ 10x average volume, $REGN 6x, $BBRY 4x, $JWN 4x, $IBB 3x, $FXI 2x, $TSLA 2x, $VRX 2x#RegeneronPharmaceuticals Inc Price Target Raised to $523.00. Read more: https://t.co/1IciSwuY6k $REGN#RegeneronPharmaceuticals Inc Price Target Raised to $523.00. Read more: https://t.co/sIdzXOhNCu $REGNRT @regeneron: Time flies when we‚Äôre having fun &amp; working hard! Ringing the @NASDAQ opening bell to celebrate our 25th year as a public com‚Ä¶RT @regeneron: Time flies when we‚Äôre having fun &amp; working hard! Ringing the @NASDAQ opening bell to celebrate our 25th year as a public com‚Ä¶RT SeekingAlpha: Biotech Will Blast Past Its 2015 Highs https://t.co/DuqrMD9waQ $GILD $LABU $REGN $IBBBiotech Will Blast Past Its 2015 Highs https://t.co/ZsXgWxc7sq $GILD, $LABU, $REGN, $IBBBiotech Will Blast Past Its 2015 Highs https://t.co/MMLIklpO5V $GILD $LABU $REGN $IBBBiotech Will Blast Past Its 2015 Highs https://t.co/i6mKyHRMIm $GILD $LABU $REGN $IBBBiotech Will Blast Past Its 2015 Highs https://t.co/069kUvbBNB $GILD $LABU $REGN $IBBTime flies when we‚Äôre having fun &amp; working hard! Ringing the @NASDAQ opening bell to celebrate our 25th year as a public company $REGNRT @regeneron: We asked, you answered! According to $REGN employees, our best company tradition is Cheesy Hawaiian Shirt Day! https://t.co/‚Ä¶$REGN $HOT $UAL options have the largest change in price. Free options screener. https://t.co/EiI9Sxvl29Regeneron Pharmaceuticals Inc Expected to Post FY2017 Earnings of $5.67 Per Share $REGN https://t.co/iiloV1bMuhRegeneron Pharmaceuticals Inc $REGN Price Target Raised to $523.00 https://t.co/H1nt0jBn1v#RegeneronPharmaceuticals Inc Price Target Raised to $523.00. Read more: https://t.co/c223Bov7Ne $REGN#RegeneronPharmaceuticals Inc Price Target Raised to $523.00. Read more: https://t.co/aBUltNXUhQ $REGNRegeneron Pharmaceuticals Inc $REGN Price Target Raised to $523.00 https://t.co/sBwJBkp3V3Watch List $REGN $TSLA $NUGT $VRX $MDVN $GWPHRT @WrigleyTom: $REGN 405.25
bumps PT $505 ‚ûú $523
stock is Outperform-rated
-Leerink https://t.co/GUig8tO9QXWe asked, you answered! According to $REGN employees, our best company tradition is Cheesy Hawaiian Shirt Day! https://t.co/CT8fRJ6o2S$REGN 405.25
bumps PT $505 ‚ûú $523
stock is Outperform-rated
-Leerink https://t.co/GUig8tO9QXRegeneron Pharmaceuticals's PT raised by Leerink Swann to $523.00. outperform rating. https://t.co/8GdoKXmomn $REGN #REGN$REGN maintains Outperform rating at Leerink Swann- PT raise $523 from $5054/4 Daily Scan - $REGN $GILD $INO $CRMD $TERP $TSLA $SKYS $GNCA - https://t.co/KbRFEaBW7dRT SeekingAlpha: Johnson &amp; Johnson's Phase 3 Cancellation: Why It Matters https://t.co/lmYo8Tcd7t $AMGN $LLY $PFE $REGN $SNY $SPY $JNJRegeneron Pharmaceuticals's PT raised by Leerink Swann to $523.00. outperform rating. https://t.co/IW1cgWcoUm $REGN #REGNJohnson &amp; Johnson's Phase 3 Cancellation: Why It Matters https://t.co/FjsitwPVES $AMGN $LLY $PFE $REGN $SNY $SPY $JNJ$REGN $AMC:

Top Wall Street Stories: Regeneron Pharmaceuticals, Inc. (NASDAQ ‚Ä¶:

https://t.co/CGQVT6qllW$REGN:

Take a look at Analysts Tips: Regeneron Pharmaceuticals, Inc ‚Ä¶:

https://t.co/2Qf9k4JMAc#RegeneronPharmaceuticals Inc. Surged On Phase 3 Study Results . Read more: https://t.co/3PljCukzpu $REGN#RegeneronPharmaceuticals Inc. Surged On Phase 3 Study Results . Read more: https://t.co/71JWBXfAjN $REGNRT @MarketCurrents: Pfizer's PCSK9 inhibitor bococizumab successful in late-stage cholesterol study https://t.co/5fhIZB4Mub $PFE $AMGN $REG‚Ä¶RT @fwpharma: Sanofi, Regeneron's dupilumab hits main goals in two late-stage atopic dermatitis studies https://t.co/64rtgHDlM0 $SNY $REGN$TSLA $AAPL $REGN looking nice for today#RegeneronPharmaceuticals Inc Shares Sold by Deere &amp; Co. Read more: https://t.co/XisGAIPQZG $REGN#RegeneronPharmaceuticals Inc Shares Sold by Deere &amp; Co. Read more: https://t.co/oV51TBPRt7 $REGNPremarket Biotech Digest: $REGN Surges, $ARRY Setback, $ACAD Insider Buying https://t.co/mCSg1q7yRyDai Ichi Life Insurance CO. LTD. Sells 294 Shares of Regeneron Pharmaceuticals Inc $REGN https://t.co/yH4W4xqULzMitsubishi UFJ Kokusai Asset Management CO. LTD. Has $28,486,000 Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/xwybLep31FMitsubishi UFJ Kokusai Asset Management CO. LTD. Has $28,486,000 Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/6mbMwJ1LMWWeekly S&amp;P500 #Stocks Performance $RCL $REGN $TRIP $CCL $ATVI $HOG $ALXN $MNK $CSC $RHI $DLTR $UHS $AMAT  more@ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Performance $REGN $TRIP $ATVI $ILMN $ALXN $DLTR $AMAT $LBTYA $CERN $INCY $VIP  more@ https://t.co/YdSIjFJqHfRegeneron Pharmaceuticals surges 12.43% to $405.25 after releasing positive trial results of experimental drug IL-4 and IL-13 $REGN #HEALTHRegeneron Pharmaceuticals Inc $REGN Shares Sold by Deere &amp; Co. https://t.co/0K8eGxk8AAWe calculated 21-day Expected Return of $REGN for you: 0.5% https://t.co/SwUMTR2sdFlx21 made $10,989 profit on $REGN - What an amazing trade!! https://t.co/w97YP31S40 $SVBL $EVOK $SRG.R $AMDA $HEARRegeneron‚Äôs Blockbuster Dreams Get Brighter - WSJ $REGN https://t.co/WY7VeixZZMRegeneron Pharmaceuticals Inc $REGN Given Hold Rating at Credit Suisse https://t.co/26tgK5TuvvRegeneron Pharmaceuticals Inc $REGN Given Hold Rating at Credit Suisse https://t.co/7Z61RYNJleRegeneron Pharmaceuticals gains 12.43% to $405.25 on Friday : Among top 10 gainers on S&amp;P500. $REGN #stockmarket #pharma #healthcare #NASDAQ$REGN - BUY Signal at 405.25 on Apr 01, 16 By https://t.co/6PpjiKmc9G, Trading Robot#Stockstowatch #Stockmarket #trading #trade #investing$REGN Triangle breakout from 3 different start pts + close over 50sma, levels: 420, 437, then 447 Fib $ibb $XBI https://t.co/4TusTFmg7S2/ #biotechnology #equities #health #healthcare #investing $REGN #regeneronpharmaceuticals #regeneronpharmaceuticalsincUnicorn Bay rating for $REGN is 2.57 out of 5. https://t.co/ztJMzVmErJjust did a scan daily CD entry breaks, wow $REGN what the heck happened there?
https://t.co/P91zDQVMY1Live Day Trade Area https://t.co/YQAnFmMbrx $DWTI $REGN $TERP $TSLA $VXX $BBRY $HOT $MAR $SUNE $UWTI $XIV $DE $CAT $GM $F $STX $HLT $MRO $JDRegeneron Pharmaceuticals, Inc.  Reiterated Rating by Robert W. Baird (Ranked 17th) to Buy $REGN #REGN https://t.co/6KTXk3W2QEBio stocks back in action $icpt $regn $ibb $isrg will be getting them today after the first 15 mins to see if there is day 2 on themRegeneron Pharmaceuticals, Inc.  Reiterated Rating by Piper Jaffray (Ranked 60th) to Hold $REGN #REGN https://t.co/6KTXk3W2QERegeneron Pharmaceuticals, Inc.  Reiterated Rating by Roth Capital (Ranked 79th) to Buy $REGN #REGN https://t.co/6KTXk3W2QERT @schaeffers: Regeneron's option volume soared to an annual high today https://t.co/cS0PZxXmPM $REGN$REGN Getting this under $400 will be tough, $413, $459 Not bad targets given resistance levels --- can deliver nice returns",2016-04-04,REGN,0
5,"REGN Stock Forum
See Here ---&gt; https://t.co/Qyb2m8GkrH

$REGN $CERN $FN #pennystocksNAP Last Trade
See Here ---&gt; https://t.co/j4OeFxzDsn

$NAP $AXON $REGN #invest$BIIB With Ceo putting near 90 mill in direct stock purchase last yr 
 $Regn Recent action these bio look set for movesGreat segment on @MadMoneyOnCNBC tonight with @Fibonacciqueen charting the Biotechs. I particular liked the $REGN chart. Thanks Carolyn.Scan EOD...
$CORT
$GRPN
$INVT
$ODP
$TRTC
$SEED
$STXS
$VVUS
$CYDY
$RTK
$MRVL
$TSLA
$RKUS
$ICPT
$CHMT
$REGN
$PVHO
$CAS
$DRWIFY2017 EPS Estimates for Regeneron Pharmaceuticals Inc $REGN Decreased by Analyst https://t.co/gEdPzf6roO$REGN https://t.co/o7QFX20QYaRegeneron Pharmaceuticals Inc Is THE Biotech Stock to Buy! $REGN - https://t.co/ttAkTpxB6URT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶RT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶#Evolocumab Cuts Cholesterol for #Statin Intolerant‚Äîbut #JAMA Says Cost Too High $AMGN $SNY $REGN https://t.co/ccQ2OaLA1n via @ajmc_journalNew Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https://t.co/aEVMYkWYpjRegeneron: Leerink sees 30% upside https://t.co/nE41Eftsr4 $REGNSold remaining leg of $REGN into the close for gain of 40.24/sh or 11.08%; entry 4/1.Nasdaq100 #Stocks Performance $TSLA $VRTX $GILD $EBAY $CELG $ALXN $NFLX $BIIB $NTAP $LLTC $FAST $REGN $ADP  more@ https://t.co/YdSIjFJqHf$REGN 20160415 =&gt; 20160520 25 spreads trade. ~$1 MM notional value.Started $REGN 405Two Stocks That May be Better Picks than Regeneron $REGN https://t.co/2X8BbQ3zAa https://t.co/GkUI3ho9Cj$REGN  Regeneron and MedImmune Enter Into Licensing Agreement for the Development of Antibody Drug Conjugates... https://t.co/bOYMkPBq8J@RedDogT3 Couple more days, $REGN could have a nice shelf.RT @VailshireCap: Sectors: Long biotech. Long gold/silver. Short refiners. -- https://t.co/iClE4419yP 
$IBB $GILD $REGN $CELG $BMY $RGLD $G‚Ä¶Forget #RegeneronPharmaceuticals, Inc.: These 2 Stocks Are Better Buys. Read more: https://t.co/4t77dMTi4g $REGN#RegeneronPharmaceuticals 2 Stocks that are Better Buys than Regeneron  . Read more: https://t.co/noX5sluivi $REGNHow To Find Stocks That Outperform The $SPY 10:1 - $XPO $FIT $VRX $GRPN $REGN $FEYE $AAPL &amp; more https://t.co/LzlOD9ZXBm via @salphatrendingSectors: Long biotech. Long gold/silver. Short refiners. -- https://t.co/iClE4419yP 
$IBB $GILD $REGN $CELG $BMY $RGLD $GSV $MUX $TSO#RegeneronPharmaceuticals MedImmune, Regeneron Launch Cancer Collaboration. Read more: https://t.co/pFdzA8ya1J $REGN$REGN close above 410 could resume friday run  https://t.co/eWPd17ztbh via https://t.co/11Wpw9y7t1RT @FiercePharma: With impressive dupilumab data, Sanofi, Regeneron gear up for potential $5B in sales https://t.co/bOIyFcM22v $SNY $REGN #‚Ä¶$REGN Notice, when our app like something, its like a brick wall. ""You Cant Touch This"" - MC HammerS&amp;P500 #Stocks Performance $VRTX $NEM $GILD $OKE $DO $CNX $MCHP $APA $RTN $MRO $ESV $XYL $PFE $BA $REGN  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Performance $VRTX $GILD $INCY $REGN $BIIB $TXN $LLTC $ALXN $EBAY $CELG $MNST $NFLX $FB  more@ https://t.co/YdSIjFJqHfRT @BreakoutStocks: A Biotech Breakout? https://t.co/fA97Kf4Vsh $IBB $XBI $AMGN $REGN$REGN: Analyst action by Roth Capital on Regeneron Pharmaceuticals: https://t.co/EjXLXXi293 https://t.co/HVFUBfNkP6RT @regeneron: $REGN and @MedImmune enter licensing agreement to develop antibody drug conjugates to treat #cancer https://t.co/4ofrsXIBFkRegeneron Pharmaceuticals‚Äô $REGN ‚ÄúHold‚Äù Rating Reiterated at Canaccord Genuity https://t.co/RiUV2usINwRegeneron Pharmaceuticals‚Äô $REGN ‚ÄúHold‚Äù Rating Reiterated at Canaccord Genuity https://t.co/OtsvczrPN1MYEC Ask Size
See Here ---&gt; https://t.co/DyJJqBfos1

$MYEC $SHOP $REGN #stocksRegeneron Is THE Biotech Stock to Buy! $REGN - https://t.co/ttAkTpxB6UCYDY running, FLKS is just starting: https://t.co/lwSyWTxOEB $RCPI $RCPT $REGN $RELISH.BO $RENE.L $REPH $RGBP $RGENRegeneron: Leerink sees 30% upside https://t.co/kOKK48GV0S $REGNRT @regeneron: $REGN and @MedImmune enter licensing agreement to develop antibody drug conjugates to treat #cancer https://t.co/4ofrsXIBFk$SNY $REGN:

Why Analysts See $5 Billion Revenue Potential For Sanofi SA (ADR ‚Ä¶:

https://t.co/BikQ3wPSfKA peek into this patient's life is an indicator of $REGN's breakthrough potential! https://t.co/LHad0tjhHQ by @matthewherperA Biotech Breakout? $IBB $XBI $AMGN $REGN https://t.co/S6DviHMrfm https://t.co/T4L3ZfvWUc https://t.co/tli9FCHdT7RT @regeneron: $REGN and @MedImmune enter licensing agreement to develop antibody drug conjugates to treat #cancer https://t.co/4ofrsXIBFkTrending #Biotech topics include $AMGN, $REGN, #Norvasc #stocks #invest See more https://t.co/EpbbdqDEG1RT @BreakoutStocks: A Biotech Breakout? https://t.co/fA97Kf4Vsh $IBB $XBI $AMGN $REGNA Biotech Breakout? https://t.co/fA97Kf4Vsh $IBB $XBI $AMGN $REGNRegeneron Stock Is THE Biotech to Buy! $REGN https://t.co/teLYXTtAfbRegeneron Pharmaceuticals Inc $REGN Rating Reiterated by Credit Suisse https://t.co/5s0bJjzhi1#RegeneronPharmaceuticals Inc Shares Bought by Principal Financial Group Inc. Read more: https://t.co/rxnZWw2dUC $REGN#RegeneronPharmaceuticals Inc Rating Reiterated by Credit Suisse. Read more: https://t.co/4KqM1ylw2Q $REGN$REGN and @MedImmune enter licensing agreement to develop antibody drug conjugates to treat #cancer https://t.co/4ofrsXIBFk$REGN Can't break that $412$REGN looking like could bust another move higher today. Still holding last leg of original position.$REGN Daily flagging for next leg up, 410 Fib resis to get over $ibb $XBI $QQQ https://t.co/yVdtt4ETCU$REGN ‚¨ÜÔ∏èRegeneron Pharmaceuticals Inc $REGN Shares Bought by Principal Financial Group Inc. https://t.co/WhPCrmynD6Regeneron Pharmaceuticals Inc $REGN Shares Bought by Principal Financial Group Inc. https://t.co/RHeEZawX14$REGN can be ready to move higherRegeneron Pharmaceuticals Inc $REGN Given New $523.00 Price Target at Leerink Swann https://t.co/XYYfncTScLRegeneron Pharmaceuticals Inc $REGN Given New $523.00 Price Target at Leerink Swann https://t.co/SJded57a6PRegeneron Pharmaceuticals Inc $REGN Given New $523.00 Price Target at Leerink Swann https://t.co/LjzwKKVFcGRT @pjraitt: $AGN  $ICPT  $REGN  Should be a great day. Funny, two rooms now offering chart reviews and now live trading. Iconic again chan‚Ä¶Robust efficacy &amp; safety in phase 3 trials for #atopicdermatitis / #eczema with dupilumab reported by $REGN &amp; $SNY https://t.co/k1u7shH0YG$REGN: Analyst action by Roth Capital on Regeneron Pharmaceuticals: https://t.co/EjXLXXi293 https://t.co/1l1V9XGf5aRT @hybridfund: Watch List: $TSLA $VRX $AGN $NUGT $REGN $ALXN $BLUEAnalysts Weigh in on Regeneron Pharmaceuticals Inc (REGN) and NVIDIA Corporation (NVDA) $NVDA $REGN https://t.co/5EmVobPYD2Notable PreM Movers: (Up) $NUGT $JNUG $MPC $TWTR (Down) $AGN $REGN $GBX $TS $RBSWatch List: $TSLA $VRX $AGN $NUGT $REGN $ALXN $BLUE$AGN  $ICPT  $REGN  Should be a great day. Funny, two rooms now offering chart reviews and now live trading. Iconic again changing the gameRT @FiercePharma: With impressive dupilumab data, Sanofi, Regeneron gear up for potential $5B in sales https://t.co/bOIyFcM22v $SNY $REGN #‚Ä¶Weekly S&amp;P500 #Stocks Performance $EW $SWN $REGN $ALXN $RCL $ZTS $CCL $MNK $BSX $ATVI $ISRG $HOG $TSS  more@ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Performance $REGN $ALXN $ILMN $INCY $TSLA $BMRN $ATVI $ISRG $CERN $LBTYA $AAPL  more@ https://t.co/YdSIjFJqHfRoth Capital Reiterates a Buy Rating on Regeneron $REGN https://t.co/yeUhXz4I9O$REGN:

Shares of Regeneron Pharmaceuticals (NASDAQ:REGN) Sees ‚Ä¶:

https://t.co/AmB5cdxpz9REGN Chart
See Here ---&gt; https://t.co/G4OYocvVeJ

$REGN $SHRK $TEAM #investing$REGN:

Ruling stocks in today‚Äôs market: Regeneron Pharmaceuticals, Inc ‚Ä¶:

https://t.co/ml4quQMD81#RegeneronPharmaceuticals Regeneron, Sanofi Up, Eczema Drug Tops Phase III Studies. Read more: https://t.co/d87evEdol6 $REGNRT @DiegoDomiguez10: Still on my radar this week $TSLA $AAPL  $SCTY $REGN $IBB $RLYP $GEQUSWING MACHINE WARNED SUBSCRIBERS TODAY OF A ""VOLUME SPIKE MARK"" IN $ADN $TSLA $REGN and more https://t.co/l4vowwCNUCRT @regeneron: #ICYMI @NYGovCuomo recognized $REGN‚Äôs contributions to NY‚Äôs biomedical industry https://t.co/FQPMBJVteY https://t.co/0rZ2Pmd‚Ä¶RT @MiamiTrader7: @IconicTrading Dont listen to the crowd mentality about no.volume day ect ect. A+ setups for points 6 for 6 $REGN$EW$TREE‚Ä¶Still on my radar this week $TSLA $AAPL  $SCTY $REGN $IBB $RLYP $GEQU#trading #stocks #investing #daytrader 
$REGN - Intraday Resistance Zone $411.00
https://t.co/Gc7cqTVXf4 https://t.co/o9cJGzL62H$REGN $HOT $UAL options have the largest change in price. Free options screener. https://t.co/EiI9Sxvl29RT @FiercePharma: With impressive dupilumab data, Sanofi, Regeneron gear up for potential $5B in sales https://t.co/bOIyFcM22v $SNY $REGN #‚Ä¶LR $REGN updating our revenue forecast for dupilumab based positive Phase III SOLO data, and we are increasing our REGN price target to $5231st request $REGN .Nice double bottom. Potential res at previous breakdown area. Use #MNM to request the next chart https://t.co/p2BRUMBqkH$PJP 2
$RARE 2
$REGN 2
$ALNY 2
$SC 2
$ALKS 2
$SGMO 2
$TTPH 2
$AGIO 2
$VNDA 2
$VRTU 2
$ADMS 2
$XENT 2
$KITE 2RT @NASDAQ: Watch @Regeneron ring the @Nasdaq Opening Bell in celebration of 25 years as a public company! $REGN #Nasdaq100 https://t.co/WS‚Ä¶",2016-04-05,REGN,1
6,"$MNTA 1
$IVC 1
$MCK 1
$ITCI 2
$INSM 2
$FSC 2
$REGN 2
$EXEL 2
$RVNC 2
$SAGE 2
$SC 2
$SCTY 2
$CNCE 2
$BLCM 2
$AMRI 2biotech massive moves $regn $biib + 13$ $VRX HAD SOME CALLSCYDY running, FLKS is just starting: https://t.co/lwSyWTxOEB $REGL $REGN $REI $REIS $REK $RELL $RELV $RELXREGN EOD Data
See Here ---&gt; https://t.co/ImFhdwacOX

$REGN $CYNO $MHLD #investS&amp;P500 #Stocks Trend $ALXN $CELG $STZ $REGN $OI $MCK $BIIB $PFE $AMGN $MNK $EBAY $KMX $EW $CAH $ZTS $SEE $MLM  @ https://t.co/RPeaHBHYi0S&amp;P500 #Stocks Performance $BHI $ENDP $VRTX $ALXN $CELG $HAL $STZ $REGN $OI $MCK $HES $MYL $BIIB $APA $PFE more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $INCY $BMRN $ILMN $ALXN $CELG $REGN $BIIB $AMGN $EBAY $TSLA $ISRG $GILD $FOXA $ADP  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $INCY $VRTX $BMRN $ILMN $ALXN $CELG $REGN $MYL $BIIB $AMGN $EBAY $TSLA $AKAM  more@ https://t.co/YdSIjFJqHf$IBB $CELG $REGN $XBI $VRX Making it rain today üí∏Enter Ichimoku https://t.co/4IO025NyVW $WFC $WMB $POT $HZNP $VRTX $DSX $REGN $VRNT $PACB $AVXL $ITCI $FOSL $GASL $IPXL $RIGL   $KLIC $CSTE23:35-&gt;https://t.co/vqaokSKgmf

Also,see:https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/GOUhn7Y5HI$REGN: Analyst action by Roth Capital on Regeneron Pharmaceuticals: https://t.co/EjXLXXi293 https://t.co/amQGxdJMlTAt least my kings did well. $SNY $REGN $AERI $INO...thank gawd I have an IRA =)VCRA Stock Forum
See Here ---&gt; https://t.co/eZGsaQsVxW

$VCRA $OPTT $REGN #tradeideas$REGN if you're short, I'm sorry. üò¨üòÅüò¨üòÅüò¨üòÅ https://t.co/sNxCVyjgGnBig day for #biotechs , 5% pop for the sector , help #nasdaq gain 76 points for the day. $BBH $AMGN $ALXN $REGN $VRTX $JAZZ@wallstjesus ME too JESUS‚Ä¶I locked in profits on $REGN 4/8 420 calls a tad early before the YELLS..oh well high class problemS&amp;P500 #Stocks Trend $VRTX $CELG $REGN $BIIB $OI $ALXN $STZ $PFE $MCK $EBAY $AMGN $EW $KMX $ZTS $CAH $UA $MLM  @ https://t.co/RPeaHBHYi0S&amp;P500 #Stocks Performance $VRTX $BHI $ENDP $HAL $CELG $REGN $BIIB $OI $ALXN $MYL $STZ $PFE $MCK $HES $APA more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $INCY $VRTX $BMRN $CELG $ILMN $REGN $BIIB $ALXN $EBAY $AMGN $TSLA $ISRG $FOXA $GILD  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $INCY $VRTX $BMRN $CELG $ILMN $REGN $BIIB $ALXN $MYL $EBAY $AMGN $TSLA $AKAM  more@ https://t.co/YdSIjG11yNRT @StockTwits: There were some impressive moves in biotech today. This heatmap shows the best and worst: https://t.co/IAOfjppV0h

$IBB $RE‚Ä¶$REGN breaking out today. No position. $PFE lead pharmaceutical rally?$REGN:

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) missed ‚Ä¶:

https://t.co/xC8B6oiueuRT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶Regeneron‚Äôs Stock Reacts to Dupilumab Phase 3 Trials https://t.co/zL3D4J7ZlT $REGN $IMNPRT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶$REGN sentiment rise to: 0.75, change: +0.61, sdr: 1.19, 1H, 3:00 PM, #nasdaq $SPY $NDX$IBB Looking at the strength in leading bio names $CELG $AMGN $GILD $REGN, it doesn't look like this rally is going to run out steam here@JNapodano $REGN set the bar fairly high with their recent results with dupilumabRT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the secto‚Ä¶ https://t.co/spbUBQVbPv$REGN SPECULATION CLOSED IntraDAY LONG from 413.XX at 423.XX for $10 GAIN IntraDAY https://t.co/yKmFxee471RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN‚Ä¶ https://t.co/2TLhE1deMQ https://t.co/unKBV0NM78Trending #Biotech topics include $REGN, $AMGN, #Propecia #stocks #invest See more https://t.co/EpbbdqDEG1RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶Rotation into biotech is happening, especially the long over suppressed names $IBB $SNY $GILD $AMGN $REGN $NK $OPHTRT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @FierceBiotech: Better off buying 30% of a platform  co., share R&amp;D, like $SFY and $REGN. It's easy to kill innovation.  https://t.co/R0‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶RT @StockTwits: Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t‚Ä¶Whoa. Biotech is having a monster day.

$CELG +6%
$BIIB +5%
$REGN +5%
$AMGN +4%

Now look at the sector ETF $IBB: https://t.co/ukIc5C5Q2l$IBB $VRX $REGN such an awesome day!Both $PFE and $AGN are looking for acquisitions. These are 5  candidates  https://t.co/OyU7XgUkU9 $BIIB $VRTX $INCY $CELG $BMRN $REGNEyes wide open now for most peeps. Will be more telling if this move continues next week $IBB $GILD $CELG $AMGN $REGN $BIIB $JAZZ $ILKM $VRXBetter off buying 30% of a platform  co., share R&amp;D, like $SFY and $REGN. It's easy to kill innovation.  https://t.co/blI1Zj6hW7 story fro‚Ä¶RT @FierceBiotech: Better off buying 30% of a platform  co., share R&amp;D, like $SFY and $REGN. It's easy to kill innovation.  https://t.co/R0‚Ä¶Better off buying 30% of a platform  co., share R&amp;D, like $SFY and $REGN. It's easy to kill innovation.  https://t.co/R0Ekvx6zLG.@matthewherper @JohnCFierce @brentlsaunders That would be $IONS. Maybe also $REGN and $ALNY :) $AGN$REGN $424.07 ""Fat Boy""https://t.co/aiUwQgdIEr Breakout, imo, Lol @StayClassy1979 @LadyLeMans @TroxK @SleemStockPicks @boatman07 @ARivera203$REGN 437 and then 446 Fib as next resis $xbi $IBB https://t.co/jThqT6Otu5@Fibonacciqueen Thanks for the segment on @MadMoneyOnCNBC,.  Great call on $IBB, $CELG, $BIIB and $REGN!Poking its head up $REGN https://t.co/a1AB7ajBTz ~ via https://t.co/Kd2qwcsyitBiotech Sector Outlook (video + static charts) - https://t.co/8GlXA7UHZ2 $XBI $IBB $PBE $GILD $AMGN $ABBV $CELG $BIIB $REGNPoking its head up $REGN https://t.co/EE3Q8NBCOs$REGN chart: Poking its head up. https://t.co/oqqG4GXNE6Regeneron Phar., $REGN, is up 5.1% - https://t.co/Kf4DUbqz1mPT $REGN $432.00-$437.00 for a swing play, imoRT @govermentchild: $regn breaking outShlda bought $REGN a month ago üòëI'd have to go back at least a year to find a day where $REGN, $BIIB, $GILD and $CELG have had this kind of sustained strength! $IBB $XBI$regn breaking outthat time you realized the $REGN calls you sold at $20 are now worth $52. #soldtoosoon #patience https://t.co/xzutPuUwTnNot much in the way to 480, me\u2026 $REGN https://t.co/TWt9j28aP8$REGN is breaking above my recent buy notes for subscribers after building a perfect little bull flag. https://t.co/ytw67kNmaWRT @portefeuillefun: Sold those 10 $REGN shares at $411.50. #zzporte @zzlangerhans$UVXY smacked. $REGN there's the rip. $AMZN primed.RT @ACInvestorBlog: $REGN at breakout point. Long over 419 https://t.co/SYAd6WdYFY$REGN $XBI $IBB clear Breakout https://t.co/0B9tbfUCZuJust because it's 420---- $REGN... heheheheLots of bio getting some nice action and move today . Last wk $IBB was building $AGIO $BLUE $ENDP $REGN$REGN Sat still for 2 days while market stabilized just how we predicted. Our app provides emotion free trading. More right than wrong.$REGN $420 calls (4/8) going on! Is AMGN ready to make deal?$REGN at breakout point. Long over 419 https://t.co/SYAd6WdYFY$REGN Here you go- UP!. We know, we share, we mean business trading the market. We have the tools to be successful and really profit.@ACInvestorBlog Can you look at $REGN Chart AC? Lil Breakout, imoCelgene &amp; Regeneron one of the best buys in the market. $CELG $REGN $IBB$REGN BREAK OUT $418 Whoo Hooo! PPS $418.25$REGN keep in mind fed minutes at 2$REGN double bottom B/O https://t.co/qLWnTvDDzq$REGN hot chart. Hot like a potato.Added $REGNClose $REGN https://t.co/Lm1wXa9Wju$REGN chart: Close. https://t.co/CaCvC5liVl$REGN SPECULATION - NEW LONG at 413.XXCIDM Bid Size
See Here ---&gt; https://t.co/IIMcbzNTQz

$CIDM $CORE $REGN #stockRT @portefeuillefun: Sold those 10 $REGN shares at $411.50. #zzporte @zzlangerhansSold those 10 $REGN shares at $411.50. #zzporte @zzlangerhans$ACAD Buying and selling has produced my third biggest gainer! 1. $regn 2. $GENZ Paid $36.73 on 12/15/15 Lots happened since!$REGN $XBI $IBB Pushing over resis https://t.co/E36HtZUTDiThe watchlist is doing well
$SHPG $DB $NVS $TLN $REGN $OLN $EVHC $ADM $FDC $BX https://t.co/0LuUEgvhb9$IBB $CELG $GILD $BIIB $AMGN $REGN MY TOP 10 POSITIONS BIOTECHNOLOGY, $VRTX $ALXN 
(Giant company) , https://t.co/borQWNNOrxCornerstone Capital Management Holdings LLC. Has $9,330,000 Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/ZlZ6T1GZ8v$REGN It wants to make a big move higher but just can't break above $411. Patience on this one. $IBBRT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶RT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶$REGN 1-hr bull flag https://t.co/AghOW0hjNC via https://t.co/11Wpw9y7t1@tgtxdough $BIIB &amp; &amp;GILD are most preferred in large-cap biotech
GILD lost traction from Q1 to Q2, while $REGN experienced an uptick@jimcramer @davidfaber $AGN could pay cash for the best pharma which is $REGN.RT @matthewherper: Regeneron's Eczema Data Look Great. Don't Believe Me? Ask A Patient $REGN $SNY https://t.co/rspVAcia09RT @FiercePharma: With impressive dupilumab data, Sanofi, Regeneron gear up for potential $5B in sales https://t.co/bOIyFcM22v $SNY $REGN #‚Ä¶Watch List: $REGN $CMG $TSLA $AGN $ICPT $VRXTraders Buy Regeneron Pharmaceuticals Inc $REGN on Weakness https://t.co/90RoOiNrQ5Traders Buy Regeneron Pharmaceuticals Inc $REGN on Weakness https://t.co/ePyX2fnNTj@Lblegend33 @PharmaceuticBen @JohnCFierce @brentlsaunders $REGN is ~30% owned by $SNY so not sure it is realistic. $BMY is more possible.RT @regeneron: $REGN and @MedImmune enter licensing agreement to develop antibody drug conjugates to treat #cancer https://t.co/4ofrsXIBFkWeekly S&amp;P500 #Stocks Performance $SHW $PX $EW $ALXN $REGN $ZTS $VRTX $RCL $PFE $BIIB $CCL $GILD $CCE $BSX more@ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Performance $TSLA $ALXN $REGN $VRTX $INCY $BMRN $BIIB $ILMN $GILD $CERN $MDLZ  more@ https://t.co/YdSIjFJqHf@yusschr @NotaBubble @Nicole1515 Heard Cramer put the Kibash on $GILD yesterday. Recommended $CELG, $REGN $BIIB etc &amp; thinks $IBB bottomed.Do you know that #WallStreet price for $REGN is $485.32 https://t.co/DAg0b95jpj$REGN: Analyst action by Roth Capital on Regeneron Pharmaceuticals: https://t.co/EjXLXXi293 https://t.co/lOrKVwJrvP$regn Hourly bull flag resolves at 460 $xbi $IBB https://t.co/sEfXCbxxoV$REGN The $45 pop is holding just as we thought. Wont budge waiting for market to stabilize.Thanks Jim &amp; Carolyn for gr8 fib charts&amp;analysis of $IBB, $BIIB, $REGN, $CELG &amp; $GILD on @MadMoneyOnCNBC tonight. @Fibonacciqueen @jimcramerRT @seeitmarket: New Post -  5 Large Cap Biotech Stocks With Upside https://t.co/1X6jpQSUsX by @OphirGottlieb $GILD $BIIB $AMGN $REGN https‚Ä¶$REGN Fast Stochastic %D crossed above 80 for 04/05 https://t.co/qXZPJqm6AM https://t.co/GXKVaoL3cc",2016-04-06,REGN,0
7,"Nasdaq100 #Stocks Trend $CELG $BMRN $INCY $WYNN $AMGN $SBUX $TSLA $GILD $CHKP $ILMN $REGN $BIIB $ADP $CMCSA  @ https://t.co/YdSIjFJqHf$REGN:

Joseph Goldstein Unloaded 2000 Shares of Regeneron ‚Ä¶:

https://t.co/RH7ctGf45vRT @InsiderWire: JOSEPH GOLDSTEIN L  Sells $672,180 Worth of $REGN Regeneron Pharmaceuticals, Inc. - #Form4 #InsiderTrading - https://t.co/‚Ä¶$REGN New SEC Document(s) for Regeneron Pharmaceuticals, Inc.
From our Stock News Alerts AppRT @pharmalot: Docs won't prescribe new cholesterol meds unless they lower heart risk sufficiently: survey https://t.co/YnaBXeuedV #pharma‚Ä¶JOSEPH GOLDSTEIN L  Sells $672,180 Worth of $REGN Regeneron Pharmaceuticals, Inc. - #Form4 #InsiderTrading - https://t.co/J65cnU8lVI$REGN:

New Insider Transaction on REGN by Director:

https://t.co/ocFa4ZbeuM https://t.co/RAZpgMhiEKRT @regeneron: We asked, you answered! According to $REGN employees, our best company tradition is Cheesy Hawaiian Shirt Day! https://t.co/‚Ä¶RT @DozenStocks: Nasdaq100 #Stocks Trend $BMRN $CELG $WYNN $AMGN $INCY $TSLA $GILD $ILMN $REGN $BIIB $CHKP $ADP $CMCSA $AVGO  @ https://t.c‚Ä¶Nasdaq100 #Stocks Trend $BMRN $CELG $WYNN $AMGN $INCY $TSLA $GILD $ILMN $REGN $BIIB $CHKP $ADP $CMCSA $AVGO  @ https://t.co/YdSIjFJqHfBrown Advisory Inc. Acquires 58 Shares of Regeneron Pharmaceuticals Inc $REGN https://t.co/3uC3yhfEX9RT @TheNakedZebra: $AAPL $ GOOGL $TSLA $REGN $AMZN most of these big down moves happen before earnings - they know what they knowRT @TheNakedZebra: $SPX $TSLA $REGN $AAPL $GOOGL $cmg https://t.co/kLAGsaFNBE$SPX $TSLA $REGN $AAPL $GOOGL $cmg https://t.co/kLAGsaFNBE$AAPL $ GOOGL $TSLA $REGN $AMZN most of these big down moves happen before earnings - they know what they know$regn good support at 354barronsonline: RT barronsstckblog: Is Biotech Back? https://t.co/e75eDmb81W via barronsonline $REGN $VRTX $GILD $ALXN $CELGRT @barronsstckblog: Is Biotech Back? https://t.co/r5L11Nchog via @barronsonline $REGN $VRTX $GILD $ALXN $CELGRT @paynej247: Quick Scan..
$ARTH 
$AAU 
$GSAT 
$HIVE 
$CYDY 
$CANN 
$TRTC 
$LEI 
$KBH 
$REGN 
$ARIA 
$MACK 
$SSRI 
$ICPT 
$TKAI 
$ZFC 
$RL‚Ä¶Quick Scan..
$ARTH 
$AAU 
$GSAT 
$HIVE 
$CYDY 
$CANN 
$TRTC 
$LEI 
$KBH 
$REGN 
$ARIA 
$MACK 
$SSRI 
$ICPT 
$TKAI 
$ZFC 
$RLYP 
$AFOP 
$KTOVDocs won't prescribe new cholesterol meds unless they lower heart risk sufficiently: survey https://t.co/YnaBXeuedV #pharma $AMGN $REGN $SNYIs Biotech Back? https://t.co/r5L11Nchog via @barronsonline $REGN $VRTX $GILD $ALXN $CELGRT @fezziwig2008: The recent CTEP failure https://t.co/2x5BenL7mj should provide $PFE greater incentive to press their $HALO dosing advanta‚Ä¶The recent CTEP failure https://t.co/2x5BenL7mj should provide $PFE greater incentive to press their $HALO dosing advantage over $REGN $AMGNREGN Filings
See Here ---&gt; https://t.co/ruC26uNM7a

$REGN $XONE $DBD #stocksRT SeekingAlpha: Why Are Quality Biotech's Soaring? https://t.co/rXauMlrt4n $AGN $ALXN $BIIB $BMY $CELG $GILD $IBB $MDVN $PFE $REGN$REGN: Analyst action by Roth Capital on Regeneron Pharmaceuticals: https://t.co/EjXLXXi293 https://t.co/HcOSUwr5ttRT @agrudadvisors: Regeneron Pharmaceuticals gains 5.83% to $427.20 on Wednesday : Among top 10 gainers on S&amp;P500.  $REGN #pharma #stocks #‚Ä¶Why Are Quality Biotech's Soaring? https://t.co/rUgLvq0W80 $AGN $ALXN $BIIB $BMY $CELG $GILD $IBB $MDVN $PFE $REGNS&amp;P500 #Stocks Trend $BBBY $CAG $CAH $PFE $DHI $DVA $MHK $MRK $SEE $CELG $REGN $ALLE $STZ $WYNN $NEM $COH $SHW @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $BBBY $CHKP $CELG $REGN $BMRN $TSLA $INCY $WYNN $AMGN $ALXN $SBUX $SPLS $GILD $ILMN  @ https://t.co/YdSIjFJqHfRT @paynej247: Quick Scan... 
$AAU 
$CYDY 
$CANN 
$TRTC
$LEI 
$KBH 
$NEM 
$RIC
$SSRI 
$KTOV 
$LXK 
$HIVE 
$TKAI 
$ZFC 
$AVGR
$REGNSold $REGN to lock profitQuick Scan... 
$AAU 
$CYDY 
$CANN 
$TRTC
$LEI 
$KBH 
$NEM 
$RIC
$SSRI 
$KTOV 
$LXK 
$HIVE 
$TKAI 
$ZFC 
$AVGR
$REGNBank of Montreal Can Increases Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/pmK2Zmft67Bank of Montreal Can Increases Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/BZmrpUNQnGBiotech breakout? Not so fast says @mnkahn. $IBB $XBI $GILD $REGN $BMRN $REGN $NKTR $MYGN https://t.co/vuMwBL2UNx https://t.co/WhuClb9BV3Biotech breakout? Not so fast video 4:00 https://t.co/Ng262It8nK $IBB $XBI $GILD $REGN $BMRN $REGN $NKTR $MYGN @TechnicianApp$regn. Strong this am to upside.  Momentum continues on recent price upgrades. I remain long$REGN Big Boy on the Move Still Green!!!! PPS $433.00Regeneron Pharmaceuticals gains 5.83% to $427.20 on Wednesday : Among top 10 gainers on S&amp;P500.  $REGN #pharma #stocks #healthcare #nyseRT @iviewmarkets: $REGN reached the highest rating since Jan 9th, still weak, but significant imporviement https://t.co/8CvdtAayDB$REGN reached the highest rating since Jan 9th, still weak, but significant imporviement https://t.co/8CvdtAayDBRT @iviewmarkets: $SPY names recently crossing their 50 Day $LLY $MYL $VRTX $ALXN $MU $REGN $MDLZ https://t.co/tJMqFPSfqt$SPY names recently crossing their 50 Day $LLY $MYL $VRTX $ALXN $MU $REGN $MDLZ https://t.co/tJMqFPSfqtDVN E.P.S.
See Here ---&gt; https://t.co/GXSsTwVTez

$DVN $IBTX $REGN #financeAdvantus Capital Management Inc Increases Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/jQ8Bq9XFuXAdvantus Capital Management Inc Increases Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/EpNuvJh3b1RT SeekingAlpha: Government's Gift To The Stock Market - Cramer's Mad Money (4/6/16) https://t.co/ZfQpukzch8 $AGN $PFE $VRX $REGN $CELG $B‚Ä¶RT @regeneron: $REGN goes beyond medicine ‚Äì we‚Äôre advancing #ScienceEducation in our community: https://t.co/4WBjNbGFZV #STEM https://t.co/‚Ä¶$IBB Biotech Will Blast Past Its 2015 Highs https://t.co/ol1NrLaPqz $GILD $LABU $REGN $IBB$REGN goes beyond medicine ‚Äì we‚Äôre advancing #ScienceEducation in our community: https://t.co/4WBjNbGFZV #STEM https://t.co/HmE6upQwVX@PFOLIOALERT PREDICTS WINNERS APRIL 7 $GILD $REGN $ADXS $PTLA
$AMGN $IMMU $MRK $MDVN $CELG $CELG
USING CHAOS THEORY
https://t.co/mUqg3vekddWeekly S&amp;P500 #Stocks Trend $EW $REGN $ALXN $BIIB $CELG $PFE $MNK $ZTS $AMGN $GILD $MLM $EBAY $STZ $ABBV $BMY  @ https://t.co/RPeaHBHYi0Weekly S&amp;P500 #Stocks Performance $EW $REGN $ALXN $VRTX $BIIB $CELG $PFE $MNK $ZTS $AMGN $GILD $HES $MLM  more@ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Trend $INCY $REGN $TSLA $ALXN $BMRN $ILMN $BIIB $CELG $AMGN $GILD $EBAY $ISRG $FOXA  @ https://t.co/YdSIjFJqHfWeekly Nasdaq100 #Stocks Performance $INCY $REGN $TSLA $ALXN $VRTX $BMRN $ILMN $BIIB $CELG $AMGN $GILD  more@ https://t.co/YdSIjFJqHfRT @DiegoDomiguez10: Current WL for Options: Short; $TSLA Long; $AAPL $SCTY $REGN $RLYPCurrent WL for Options: Short; $TSLA Long; $AAPL $SCTY $REGN $RLYP$REGN:

Leerink Swann Maintains Regeneron Pharmaceuticals Inc to ‚Ä¶:

https://t.co/0PQfuirhRvRT @BioBounce: $IBB has 190 holdings; top 10 = 57.83% weight; basically you are saying $AMGN $GILD $REGN $BIIB $CELG $ILMN $MYL $ALXN $VRTX‚Ä¶$REGN:

Roth Capital Maintains Regeneron Pharmaceuticals Inc to Buy with ‚Ä¶:

https://t.co/UtXwbi5ZIV$REGN:

Key Stocks of the Day: Regeneron Pharmaceuticals, Inc. (NASDAQ ‚Ä¶:

https://t.co/Y28E1fC6SkPfizer, Allergan to hunt for deals of their own      https://t.co/ML3IFsWK6n via @WSJ

Y BIOTECHS will be partying on
$BIIB $CELG VRTX $REGNHuge winners in the #Biotech space today - $ANAC $INCY $LABU $IBB $REGN $ILMN $BIIB $ICPT $JAZZRT @go2sleepjj: At least my kings did well. $SNY $REGN $AERI $INO...thank gawd I have an IRA =)NTES Ex-Div Date
See Here ---&gt; https://t.co/m81Kx0byOv

$NTES $TNP $REGN #stocksRT @FierceBiotech: Better off buying 30% of a platform  co., share R&amp;D, like $SFY and $REGN. It's easy to kill innovation.  https://t.co/R0‚Ä¶INT E.P.S.
See Here ---&gt; https://t.co/agScVHO1LG

$INT $WPPGY $REGN #share",2016-04-07,REGN,0
8,"So now it's clear that $REGN has done all these non-MAb-related (mouse) genetics studies w/ orphan/genome editing drug dev in mind.RT @JohnCFierce: UPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an #IPO
$REGN
https://t.co/wWu5ELFHoNRT @JohnCFierce: $125M in cash for Intellia in this $REGN deal. As I said before, Intellia is run by very sharp people
https://t.co/8FOe01B‚Ä¶Gene-Editing Company Intellia Discloses IPO Plan, $REGN Pact
https://t.co/j0kY3IHAdsRT @BentheFidler: CRISPR Developer Intellia Deals With Regeneron, Jumps Into IPO Queue https://t.co/Gr1JvEHxf7 by @alexlash $NTLA $EDIT $RE‚Ä¶$REGN, Intellia Therapeutics Announce Pact to Discover and Develop CRISPR/Cas Therapeutics https://t.co/L1TTESv2GlInvestors Buy Regeneron Pharmaceuticals Inc $REGN on Weakness on Analyst Downgrade https://t.co/VIRGvPnNJY$REGN Intellia Therapeutics announce a  licensing and collaboration agreement to advance Crispr/Cas  gene-editing technology#Gene-Editing Company Intellia Discloses IPO Plan, Regeneron Pact https://t.co/RnPeUueyIf $REGNInvestors Buy Regeneron Pharmaceuticals Inc $REGN on Weakness on Analyst Downgrade https://t.co/n7cXVMmP0dRT @BentheFidler: CRISPR Developer Intellia Deals With Regeneron, Jumps Into IPO Queue https://t.co/Gr1JvEHxf7 by @alexlash $NTLA $EDIT $RE‚Ä¶CRISPR Developer Intellia Deals With Regeneron, Jumps Into IPO Queue https://t.co/Gr1JvEHxf7 by @alexlash $NTLA $EDIT $REGN $ALNYRT @JohnCFierce: UPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an #IPO
$REGN
https://t.co/wWu5ELFHoN$REGN: Regeneron Pharma &amp; Intellia Therapeutics announce a licensing and collaboration agreement to advance... https://t.co/jOTqlRmuzW#RegeneronPharmaceuticals Regeneron, Intellia Partner to Develop CRISPR/Cas Therapeutics. Read more: https://t.co/67QhLC8pUc $REGN#RegeneronPharmaceuticals Regeneron, Intellia Partner to Develop CRISPR/Cas Therapeutics. Read more: https://t.co/JfTbPzVryl $REGNBRIEF-#RegeneronPharmaceuticals, Intellia Therapeutics announce collaboration to discover, ... Read more: https://t.co/SVjxTfSiCP $REGNBRIEF-#RegeneronPharmaceuticals, Intellia Therapeutics announce collaboration to discover, ... Read more: https://t.co/JyuOaqrcZE $REGNRT @JohnCFierce: UPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an #IPO
$REGN
https://t.co/wWu5ELFHoNRT @AndyBiotech: $NTLA @intelliatweets inks $REGN deal and files for $120M #IPO 
https://t.co/yWNOLGK1Km

$EDIT #CRISPR competitor https://‚Ä¶RT @JohnCFierce: UPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an #IPO
$REGN
https://t.co/wWu5ELFHoNRT @JohnCFierce: The Intellia S-1 also includes juicy details about its pact with $NVS as well as $REGN
https://t.co/mqYbqpvBQZRT @AndyBiotech: $NTLA @intelliatweets inks $REGN deal and files for $120M #IPO 
https://t.co/yWNOLGK1Km

$EDIT #CRISPR competitor https://‚Ä¶RT @JohnCFierce: Regeneron commits $125M in quick cash to kickstart a CRISPR/Cas9 deal with Intellia
$REGN
https://t.co/x0OQ5qTgD6RT @JohnCFierce: UPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an #IPO
$REGN
https://t.co/wWu5ELFHoNRT @JohnCFierce: UPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an #IPO
$REGN
https://t.co/wWu5ELFHoNRT @JohnCFierce: The Intellia S-1 also includes juicy details about its pact with $NVS as well as $REGN
https://t.co/mqYbqpvBQZRT @jordixiol: Delivery will be the biggest challenge for Intellia and $REGN. Interesting that they chose LNPs over virusesRT @JohnCFierce: The Intellia S-1 also includes juicy details about its pact with $NVS as well as $REGN
https://t.co/mqYbqpvBQZDelivery will be the biggest challenge for Intellia and $REGN. Interesting that they chose LNPs over virusesRT @JohnCFierce: The Intellia S-1 also includes juicy details about its pact with $NVS as well as $REGN
https://t.co/mqYbqpvBQZThe Intellia S-1 also includes juicy details about its pact with $NVS as well as $REGN
https://t.co/mqYbqpvBQZRT @JohnCFierce: $125M in cash for Intellia in this $REGN deal. As I said before, Intellia is run by very sharp people
https://t.co/8FOe01B‚Ä¶RT @HumbleBioTrader: $REGN, Intellia Therap Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics https://t.co/CYXqrrjChm‚Ä¶RT @JohnCFierce: UPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an #IPO
$REGN
https://t.co/wWu5ELFHoNRT @JohnCFierce: UPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an #IPO
$REGN
https://t.co/wWu5ELFHoNRT @JohnCFierce: UPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an #IPO
$REGN
https://t.co/wWu5ELFHoNRT @bradloncar: $REGN and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics https://t.co/lHOAUSX‚Ä¶RT @CarolineYLChen: Whoa Intellia. Filed S1, and has inked a deal with $REGN to work on up to 10 targets.RT @CarolineYLChen: Well check this out - $320 m in milestone payments *per licensed target* from $REGN to Intellia -- via @business https:‚Ä¶Well check this out - $320 m in milestone payments *per licensed target* from $REGN to Intellia -- via @business https://t.co/VQkkQZnGB0RT @bmgallagherjr: @JohnCFierce The $REGN management team are no slouches themselvesRT @bradloncar: $REGN/Intellia - I love the first target. Transthyretin amyloidosis.RT @JohnCFierce: UPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an #IPO
$REGN
https://t.co/wWu5ELFHoNRT @JohnCFierce: Regeneron commits $125M in quick cash to kickstart a CRISPR/Cas9 deal with Intellia
$REGN
https://t.co/x0OQ5qTgD6RT @JohnCFierce: $125M in cash for Intellia in this $REGN deal. As I said before, Intellia is run by very sharp people
https://t.co/8FOe01B‚Ä¶RT @JohnCFierce: $125M in cash for Intellia in this $REGN deal. As I said before, Intellia is run by very sharp people
https://t.co/8FOe01B‚Ä¶RT MarketCurrents: Regeneron inks deal to develop drugs using gene editing technology CRISPR/Cas9 https://t.co/E67lLCFTIR $REGN,www.blackb‚Ä¶RT @JohnCFierce: UPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an #IPO
$REGN
https://t.co/wWu5ELFHoNUPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an #IPO
$REGN
https://t.co/wWu5ELFHoNRT @AndyBiotech: $NTLA @intelliatweets inks $REGN deal and files for $120M #IPO 
https://t.co/yWNOLGK1Km

$EDIT #CRISPR competitor https://‚Ä¶RT @JohnCFierce: Regeneron commits $125M in quick cash to kickstart a CRISPR/Cas9 deal with Intellia
$REGN
https://t.co/x0OQ5qTgD6RT @jonathanrockoff: $REGN to pay $75mn upfront to  Intellia Therapeutics to develop CRISPR-Cas9 drugs against ten targets: https://t.co/bi‚Ä¶RT @jonathanrockoff: $REGN to pay $75mn upfront to  Intellia Therapeutics to develop CRISPR-Cas9 drugs against ten targets: https://t.co/bi‚Ä¶Regeneron inks deal to develop drugs using gene editing technology CRISPR/Cas9 https://t.co/vjSWwTJ0Rq $REGNRegeneron inks deal to develop drugs using gene editing technology CRISPR/Cas9 https://t.co/tCNO5AUnoD $REGNRegeneron inks deal to develop drugs using gene editing technology CRISPR/Cas9 https://t.co/1DSAjbIljK $REGNRT @jonathanrockoff: $REGN to pay $75mn upfront to  Intellia Therapeutics to develop CRISPR-Cas9 drugs against ten targets: https://t.co/bi‚Ä¶RT @AndyBiotech: $NTLA @intelliatweets inks $REGN deal and files for $120M #IPO 
https://t.co/yWNOLGK1Km

$EDIT #CRISPR competitor https://‚Ä¶RT @JohnCFierce: Regeneron commits $125M in quick cash to kickstart a CRISPR/Cas9 deal with Intellia
$REGN
https://t.co/x0OQ5qTgD6RT @jonathanrockoff: $REGN to pay $75mn upfront to  Intellia Therapeutics to develop CRISPR-Cas9 drugs against ten targets: https://t.co/bi‚Ä¶RT @JohnCFierce: Regeneron commits $125M in quick cash to kickstart a CRISPR/Cas9 deal with Intellia
$REGN
https://t.co/x0OQ5qTgD6Regeneron commits $125M in quick cash to kickstart a CRISPR/Cas9 deal with Intellia
$REGN
https://t.co/x0OQ5qTgD6RT @jonathanrockoff: $REGN to pay $75mn upfront to  Intellia Therapeutics to develop CRISPR-Cas9 drugs against ten targets: https://t.co/bi‚Ä¶RT @AndyBiotech: $NTLA @intelliatweets inks $REGN deal and files for $120M #IPO 
https://t.co/yWNOLGK1Km

$EDIT #CRISPR competitor https://‚Ä¶$NTLA @intelliatweets inks $REGN deal and files for $120M #IPO 
https://t.co/yWNOLGK1Km

$EDIT #CRISPR competitor https://t.co/dh3RnuxdPF$REGN to pay $75mn upfront to  Intellia Therapeutics to develop CRISPR-Cas9 drugs against ten targets: https://t.co/bi6q4AuUeQRT @bradloncar: $REGN and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics https://t.co/lHOAUSX‚Ä¶RT @JohnCFierce: $125M in cash for Intellia in this $REGN deal. As I said before, Intellia is run by very sharp people
https://t.co/8FOe01B‚Ä¶@JohnCFierce The $REGN management team are no slouches themselvesWhoa Intellia. Filed S1, and has inked a deal with $REGN to work on up to 10 targets.$REGN/Intellia - I love the first target. Transthyretin amyloidosis.RT @JohnCFierce: $125M in cash for Intellia in this $REGN deal. As I said before, Intellia is run by very sharp people
https://t.co/8FOe01B‚Ä¶RT @bradloncar: $REGN and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics https://t.co/lHOAUSX‚Ä¶RT @JohnCFierce: $125M in cash for Intellia in this $REGN deal. As I said before, Intellia is run by very sharp people
https://t.co/8FOe01B‚Ä¶$125M in cash for Intellia in this $REGN deal. As I said before, Intellia is run by very sharp people
https://t.co/8FOe01BIrLRT @bradloncar: $REGN and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics https://t.co/lHOAUSX‚Ä¶RT @bradloncar: $REGN and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics https://t.co/lHOAUSX‚Ä¶RT @bradloncar: $REGN and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics https://t.co/lHOAUSX‚Ä¶RT @HumbleBioTrader: $REGN, Intellia Therap Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics https://t.co/CYXqrrjChm‚Ä¶$REGN 
Regeneron and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics
https://t.co/BspTRdlWah$REGN Regeneron Pharma &amp; Intellia Thera announce licensing agreement to advance Crispr/Cas gene-editing technology. HOT areaRT @bradloncar: $REGN and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics https://t.co/lHOAUSX‚Ä¶$REGN and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics https://t.co/lHOAUSXJ8r$REGN Regeneron and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeut
From our Stock News Alerts AppIntellia will receive a $75 million upfront payment &amp; $REGN has also agreed to invest up to $50 million in #Intellia's next equity financing$REGN, Intellia Therap Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics https://t.co/CYXqrrjChm via @Street_Insider#Regeneron Pharmaceuticals : and Intellia Therapeutics Announce Collaboration ... https://t.co/2qp0Mio1bz $REGN$REGN and #Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics#RegeneronPharmaceuticals Inc Receives Average Recommendation of ""Hold"" from Analysts. Read more: https://t.co/Wybhb9C9e5 $REGN#RegeneronPharmaceuticals Inc Receives Average Recommendation of ""Hold"" from Analysts. Read more: https://t.co/pHG8oub6ci $REGNRegeneron Pharmaceuticals Inc $REGN Receives Average Recommendation of ‚ÄúHold‚Äù from Analysts https://t.co/cj0T70CvwJRegeneron Pharmaceuticals Inc $REGN Receives Average Recommendation of ‚ÄúHold‚Äù from Analysts https://t.co/NKKTiyekre$REGN:

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Given Average ‚Ä¶:

https://t.co/8AriL8nFwg$REGN SPECULATION - Existing IntraDAY LONG from 395.XX averaged down to 393.XX on DIP to 5 MIN LOW. https://t.co/Qjy7QgFT7B$REGN Just like $LABU, Everything given back. Reason 4 having stops. STOPS are a must have, let them taken em out, but leave us with R CASH$REGN SPECULATION - NEW LONG at 395.XXShares of #RegeneronPharmaceuticals, Inc. Struggled in March -- Here's Why. Read more: https://t.co/hmBbMTyKBp $REGNShares of #RegeneronPharmaceuticals, Inc. Struggled in March -- Here's Why. Read more: https://t.co/OJt20dax4I $REGNShares of #RegeneronPharmaceuticals, Inc. Struggled in March -- Here's Why. Read more: https://t.co/2zAnlaGCs1 $REGNRT @agrudadvisors: Regeneron Pharmaceuticals loses 3.24% to $404.94 on Friday : Among top 10 losers on S&amp;P500 $REGN #pharma #healthcare #st‚Ä¶Shares of #RegeneronPharmaceuticals, Inc. Struggled in March -- Here's Why. Read more: https://t.co/8wcqVkq5jf $REGNOut of $AMGN one year later. I'm tired of waiting here. The story of Q2 will be long $REGN and small NASH m&amp;a pickups. #biotechMTRX Company Info
See Here ---&gt; https://t.co/Y2u5bCQFpF

$MTRX $CE $REGN #shareLR ""The slow PCSK9 initial launch is primarily due to formulary access,
patient reluctance to use injectables, our survey shows"" $AMGN $REGN@bradloncar simial rto $REGN $SNY as $CELG keeps addingRT @AndysCycles: $IBB components sorted by RS (23d 130d 260d weighted): 
$AMGN $CELG $ILMN $GILD $BIIB $MYL $ALXN $BMRN $REGN $VRTX https:/‚Ä¶RT @AmericanBanking: $REGN - Leerink Swann Reiterates Buy Rating for Regeneron Pharmaceuticals Inc #REGN https://t.co/jpH7z2guRo$REGN undervalued here imo - 100 DMA still long way off at 458. Lots of upside for this revenue beast$REGN watching for break of previous week's low based on shooting star candlestick and overly bullish sentiment https://t.co/xJXe7csMDf$CPB $REGN $GPS options have the largest change in price. Free options screener. https://t.co/EiI9Sxvl29Where were you (invested) when the biotech sector woke up?
$IBB $CELG $REGN $GILD $BMY $AMGN

Invest wisely with https://t.co/iClE4419yPWatch List: $TSLA $REGN $AGN $VRX#DYK that $REGN is one of #NY‚Äôs fastest growing companies, according to @CrainsNewYork? https://t.co/bvwrB10ppAREGN Shares
See Here ---&gt; https://t.co/JsshwBluzY

$REGN $CW $BA #stockmarketCambridge Investment Research Advisors Inc. Acquires 38 Shares of Regeneron Pharmaceuticals Inc $REGN https://t.co/p5r1Z8nnXbRegeneron Pharmaceuticals loses 3.24% to $404.94 on Friday : Among top 10 losers on S&amp;P500 $REGN #pharma #healthcare #stockmarket #NASDAQRegeneron Pharmaceuticals Inc $REGN Price Target Lowered to $415.00 at Morgan Stanley https://t.co/wdqe0IqZztRT @Options_Experts: We are #1 in option spread trading.  Expert trade alerts https://t.co/jxlS58pqQu ~ $SPY $AAPL $VRX $EOG $GOOGL $PCLN $‚Ä¶GLDD Message Board Posts
See Here ---&gt; https://t.co/33lNq1UFz2

$GLDD $SAGE $REGN #shareRT @Options_Experts: We are #1 in option spread trading.  Expert trade alerts https://t.co/jxlS58pqQu ~ $SPY $AAPL $VRX $EOG $GOOGL $PCLN $‚Ä¶We are #1 in option spread trading.  Expert trade alerts https://t.co/jxlS58pqQu ~ $SPY $AAPL $VRX $EOG $GOOGL $PCLN $FCX $REGN$REGN - Leerink Swann Reiterates Buy Rating for Regeneron Pharmaceuticals Inc #REGN https://t.co/jpH7z2guRoRT @MikeF_trading: $IBB pullback friday after big day wednesday, still on my watch list

$SPY $GILD $REGN
#daytrading https://t.co/VGV82Vd5‚Ä¶RT @MikeF_trading: $IBB pullback friday after big day wednesday, still on my watch list

$SPY $GILD $REGN
#daytrading https://t.co/VGV82Vd5‚Ä¶Regeneron Pharmaceuticals, Inc.  Reiterated Rating by Leerink Swann (Ranked 69th) to Buy $REGN #REGN https://t.co/6KTXk3W2QE23:15-&gt;https://t.co/vqaokSKgmf

Also,see:https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/yMnOK5Po1w$IBB #biotech #chart and #TechnicalAnalysis https://t.co/4VmjNefONP $REGN $CELG $GILD #etf #wallstreet #cnbc #bloomberg #fox #stocks #option",2016-04-11,REGN,1
9,"#RegeneronPharmaceuticals Regeneron, Intellia Strike Deal for CRISPR/Cas Platform. Read more: https://t.co/HSa7ni6PJE $REGN#RegeneronPharmaceuticals Regeneron, Intellia Strike Deal for CRISPR/Cas Platform. Read more: https://t.co/gxkrVsPJ5P $REGNQuality set ups today for points. $CMG $REGN  $VRX $AGN. #Trade #NOBS #realtrades and #executed  #live. Iconicdaytrading @IconicTrading$REGN may go up 6% if the bull pattern is confirmed. Chk confirmation [69%] @ https://t.co/u0JXvIHf7y. Buy level:408.0700.Enter Ichimoku https://t.co/LNfZltpzSV $UNG $BBVA $EBAY $ESRX $MTU $SMFG $BBBY $COST $WNR $VMW $IDRA $LEI $XON $PHH $FMX $REGN $HUM $EIGIRT @BioWorld: Intellia files for $120M IPO, inks $125M deal with $REGN for CRISPR-based candidates23:15-&gt;https://t.co/vqaokSKgmf

Also,see:https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/cElatJ5arL#RegeneronPharmaceuticals How Regeneron's Eylea Growth, Amgen, Sanofi Deal Figure In Stock. Read more: https://t.co/u7pLaiN0m0 $REGN#RegeneronPharmaceuticals How Regeneron's Eylea Growth, Amgen, Sanofi Deal Figure In Stock. Read more: https://t.co/abzjIs3Ux8 $REGN$REGN Gene-Editing Company Intellia Discloses IPO Plan, Regene‚Ä¶ https://t.co/eoEzEDI9iu$REGN $SNY:

Active Pipeline Sustains Growth for Regeneron Pharmaceuticals Inc ‚Ä¶:

https://t.co/GxTRjw45MNRT @BioPharmaDive: CRISPR biotech Intellia strikes licensing deal with $REGN for $75M upfront, potentially $320M in milestones https://t.co‚Ä¶$SPY stocks with the greatest decrease in momo last 5 days $CMG $AGN $ENDP $REGN $VRTX $PRGO $HRB $ICE $AN $DE https://t.co/TJb74igIA2#RegeneronPharmaceuticals Regeneron's Bold Bet on the Future of Medicine. Read more: https://t.co/j4Bp5lAckv $REGN#RegeneronPharmaceuticals Regeneron's Bold Bet on the Future of Medicine. Read more: https://t.co/Riwe5As6Tn $REGNPitcairn Co. Sells 235 Shares of #RegeneronPharmaceuticals Inc (). Read more: https://t.co/8xfGMYFTTc $REGNPitcairn Co. Sells 235 Shares of #RegeneronPharmaceuticals Inc (). Read more: https://t.co/zGLayollmk $REGNWF $NTLA $REGN Gene Editing Deal Could Provide Longer Term Opportunity Regeneron Pharmaceuticals (REGN) and (cont) https://t.co/uMW1WYlCyERT @BioWorld: Intellia files for $120M IPO, inks $125M deal with $REGN for CRISPR-based candidates$REGN: 3mRunaway+:2 [+3%,.2%offHi], allTFs+; TLM:1.5; ILM:2.1, DyVol:750T:0.7x:0.6x, DyRng:4%:1.1x:0.9x (PotLONG); vl:6; rs:+2,RT @BioWorld: Intellia files for $120M IPO, inks $125M deal with $REGN for CRISPR-based candidatesBios $REGN $LABU set up for a huge day in next 48 hrs#RegeneronPharmaceuticals Cambridge gene-editing firm eyes IPO, discloses Novartis deal. Read more: https://t.co/aQAJFGGOKy $REGN#RegeneronPharmaceuticals Cambridge gene-editing firm eyes IPO, discloses Novartis deal. Read more: https://t.co/uJZDrmJgXA $REGNIntellia files for $120M IPO, inks $125M deal with $REGN for CRISPR-based candidatesZacks Investment Research Upgrades #RegeneronPharmaceuticals Inc to Hold. Read more: https://t.co/DxkwpwyUA9 $REGNZacks Investment Research Upgrades #RegeneronPharmaceuticals Inc to Hold. Read more: https://t.co/65tEQJhism $REGN#RegeneronPharmaceuticals Regeneron and Intellia Therapeutics Announce Collaboration to Dis... Read more: https://t.co/BAjc9pH9Ck $REGN#RegeneronPharmaceuticals Regeneron and Intellia Therapeutics Announce Collaboration to Dis... Read more: https://t.co/k3LTLIDxVY $REGNRegeneron Pharmaceuticals upgraded by Zacks Investment Research to hold. https://t.co/RCWxsOi5oO $REGN #REGN#RegeneronPharmaceuticals Regeneron Joins Hands with Intellia on Crispr-Cas9 Therapeutics: ... Read more: https://t.co/bTjbvzCayw $REGN#RegeneronPharmaceuticals Regeneron Joins Hands with Intellia on Crispr-Cas9 Therapeutics: ... Read more: https://t.co/TPWOlvwSYE $REGNRegeneron Pharmaceuticals upgraded by Zacks Investment Research to hold. https://t.co/MOnIFjNNdD $REGN #REGNCRISPR biotech Intellia strikes licensing deal with $REGN for $75M upfront, potentially $320M in milestones https://t.co/RRI45jKjvMAdded $REGN at 402RT @JohnCFierce: ICYMI: $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for IPO
$REGN
https://t.co/niUtiZgxwx$REGN:

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Stock ‚Ä¶:

https://t.co/RBy5xfjaL7#RegeneronPharmaceuticals Bay States's Intellia Discloses a  $125 Million CRISPR/Cas Deal w... Read more: https://t.co/WxAEw1REjX $REGN#RegeneronPharmaceuticals Bay States's Intellia Discloses a  $125 Million CRISPR/Cas Deal w... Read more: https://t.co/FngiCaKQTs $REGN#RegeneronPharmaceuticals Regeneron and Intellia Therapeutics to jointly develop CRISPR/Cas... Read more: https://t.co/fQAipzbZBg $REGN#RegeneronPharmaceuticals Regeneron and Intellia Therapeutics to jointly develop CRISPR/Cas... Read more: https://t.co/ztimdHePyz $REGN$REGN: Regeneron Pharma &amp; Intellia Therapeutics announce a licensing and collaboration agreement to advance... https://t.co/jOTqlRmuzW$REGN  https://t.co/DquRR82Huc via https://t.co/11Wpw9y7t1RT @GENbio: $REGN, @intelliatweets partner to develop #CRISPR/Cas therapeutics: https://t.co/RqvIA6gzEcGENbio: $REGN, intelliatweets partner to develop #CRISPR/Cas therapeutics: https://t.co/on6dmcESnR
Link: https://t.co/p6bcJKrku8RT @GENbio: $REGN, @intelliatweets partner to develop #CRISPR/Cas therapeutics: https://t.co/RqvIA6gzEc$REGN, @intelliatweets partner to develop #CRISPR/Cas therapeutics: https://t.co/RqvIA6gzEc#RegeneronPharmaceuticals Regeneron and Intellia Therapeutics form pact to develop CRISPR/C... Read more: https://t.co/4Rc3pA2jO8 $REGN#RegeneronPharmaceuticals Regeneron and Intellia Therapeutics form pact to develop CRISPR/C... Read more: https://t.co/EyxH0scAlO $REGNPitcairn Co. Sells 235 Shares of Regeneron Pharmaceuticals Inc $REGN https://t.co/CP6tNYwL0k$REGN CORRECTION - SPECULATION-CLOSED SWING LONG (from 4/11/16) from 393.XX at 394.XX for about a $1 GAIN | NOT l... https://t.co/J3sw05LxHc$REGN SPECULATION-CLOSED SWING LONG (from 4/12/16) from 393.XX at 394.XX for about a $1 GAIN | NOT liking price a... https://t.co/uWaICrEcPH$GTY $REGN:

Top News: Getty Realty Corp. (NYSE:GTY), FXCM (NYSE:FXCM ‚Ä¶:

https://t.co/bWDrxQtQHs#RegeneronPharmaceuticals Inc Price Target Cut to $415.00. Read more: https://t.co/kKItPKhLoH $REGNCRISPR biotech Intellia strikes licensing deal with $REGN, readies IPO https://t.co/RRI45jKjvM#RegeneronPharmaceuticals Inc Price Target Cut to $415.00. Read more: https://t.co/q5zMXwFfVo $REGNJMP $REGN $EDIT https://t.co/QWNYvTQ3A6#CRISPR Developer @intelliatweets Deals With Regeneron, Jumps Into #IPO Queue | https://t.co/CDWjAv38LI $NTLA $REGN #EXOMECRISPR Developer Intellia Deals With Regeneron, Jumps Into IPO Queue $REGN 
https://t.co/qXSRTdWcU0RT @JohnCFierce: ICYMI: $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for IPO
$REGN
https://t.co/niUtiZgxwx$REGN signs agreement with Intellia¬†Therapeutics https://t.co/ruuHCQ6eDzICYMI: $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for IPO
$REGN
https://t.co/niUtiZgxwxRT @AndyBiotech: $NTLA @intelliatweets inks $REGN deal and files for $120M #IPO 
https://t.co/yWNOLGK1Km

$EDIT #CRISPR competitor https://‚Ä¶$REGN Regeneron and Intellia Therapeutics Announce Collaborati‚Ä¶ https://t.co/31NdUnS0s5$CPB $REGN $GPS options have the largest change in price. Free options screener. https://t.co/EiI9Sxvl29RT @AndyBiotech: $NTLA @intelliatweets inks $REGN deal and files for $120M #IPO 
https://t.co/yWNOLGK1Km

$EDIT #CRISPR competitor https://‚Ä¶Traders Buy #RegeneronPharmaceuticals Inc on Weakness After Analyst Downgrade. Read more: https://t.co/gsjwF722Gj $REGNTraders Buy #RegeneronPharmaceuticals Inc on Weakness After Analyst Downgrade. Read more: https://t.co/nruVbyhgti $REGNRegeneron Pharmaceuticals Inc $REGN Director Sells $850,000.00 in Stock https://t.co/NGObykahMWRT @AndyBiotech: $NTLA @intelliatweets inks $REGN deal and files for $120M #IPO 
https://t.co/yWNOLGK1Km

$EDIT #CRISPR competitor https://‚Ä¶Regeneron inks deal to develop drugs using gene editing technology CRISPR/Cas9 $REGN https://t.co/0yMYpetzNhRT @bradloncar: $REGN and Intellia Therapeutics Announce Collaboration to Discover and Develop CRISPR/Cas Therapeutics https://t.co/lHOAUSX‚Ä¶Traders Buy Regeneron Pharmaceuticals Inc $REGN on Weakness After Analyst Downgrade https://t.co/bEd3bVdH4v#RegeneronPharmaceuticals Intellia partners with Regeneron, files for IPO. Read more: https://t.co/1wN7AriPfb $REGN#RegeneronPharmaceuticals Intellia partners with Regeneron, files for IPO. Read more: https://t.co/33HQH4FyZs $REGNRT @CarolineYLChen: Well check this out - $320 m in milestone payments *per licensed target* from $REGN to Intellia -- via @business https:‚Ä¶Ranks #1 with over 80% in alert gains today. Click here https://t.co/ewcYkLb72h .. $HBAN $REGN $BBGIRT @JohnCFierce: Regeneron commits $125M in quick cash to kickstart a CRISPR/Cas9 deal with Intellia
$REGN
https://t.co/x0OQ5qTgD6Regeneron inks deal to develop drugs using gene editing technology CRISPR/Cas9 $REGN https://t.co/70lLBil7r9$REGN:

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Closes -2.17 ‚Ä¶:

https://t.co/VEjZCAMBhxRT @RNAiAnalyst: So now it's clear that $REGN has done all these non-MAb-related (mouse) genetics studies w/ orphan/genome editing drug dev‚Ä¶PCSK9 Drugs Are Overhyped -  https://t.co/hUiDKgPxNq $AMGN, $ALNY, $AZN, $CATB, $ESPR, $LLY, $MDCO, $MRK, $PFE, $REGN, $SNYRT @JohnCFierce: UPDATED: With a $125M Regeneron deal in hand, CRISPR/Cas9 star Intellia files for an #IPO
$REGN
https://t.co/wWu5ELFHoNRT @JohnCFierce: $125M in cash for Intellia in this $REGN deal. As I said before, Intellia is run by very sharp people
https://t.co/8FOe01B‚Ä¶",2016-04-12,REGN,1
10,"#RegeneronPharmaceuticals' ""Buy"" Rating Reaffirmed at Brean Capital. Read more: https://t.co/lmVA5SYIRP $REGN#RegeneronPharmaceuticals' ""Buy"" Rating Reaffirmed at Brean Capital. Read more: https://t.co/eA4kJylsNj $REGNRT @JohnCFierce: Regeneron commits $125M in quick cash to kickstart a CRISPR/Cas9 deal with Intellia
$REGN
https://t.co/x0OQ5qTgD6We believe that the next blockbuster pharma will be $FOLD- Amicus Therapeutics. Looks like $REGN when we discovered a years ago.Regeneron Pharmaceuticals, Inc.  Reiterated Rating by Brean Capital (Ranked 67th) to Buy $REGN #REGN https://t.co/6KTXk3W2QERegeneron Pharmaceuticals's buy rating reiterated at Brean Capital. https://t.co/q8gIBwwy85 $REGN #REGNRegeneron Pharmaceuticals's buy rating reiterated at Brean Capital. https://t.co/62WBwvQJzl $REGN #REGN""valuations in the sector are particularly attractive and for large caps at a decade low"" #biotech $IBB $AMGN $BIIB $CELG $GILD $REGN ...$REGN:

Checking EPS Growth for Regeneron Pharmaceuticals, Inc ‚Ä¶:

https://t.co/vP44iNbp6a$REGN We stick to ourselves, we have a BUY alert at $380s, so we go on that advice ONLY. Everything else is noise to us.XLV Remains Stable as Big Healthcare Stocks Try to Turn the Tide $ALXN $CI $REGN $SPY https://t.co/D6k7ukVlJnActive Pipeline Sustains Growth for Regeneron Pharmaceuticals $REGN https://t.co/qJRDPTO9jv via @wstranscriptNasdaq100 #Stocks Performance $ALXN $ENDP $SBAC $REGN $TSCO $INCY $BMRN $MAT $CSX $EBAY $FB $BBBY $NFLX  more@ https://t.co/YdSIjFJqHfMorgan Stanley Trims Regeneron Pharmaceuticals Inc $REGN Target Price to $415.00 https://t.co/CVCmIfI9axMorgan Stanley Trims Regeneron Pharmaceuticals Inc $REGN Target Price to $415.00 https://t.co/ONbpwR6BoS#RegeneronPharmaceuticals : Hires Sally A. Paull as Senior Vice President, Human Resources. Read more: https://t.co/yC7WRdWimz $REGN#RegeneronPharmaceuticals : Hires Sally A. Paull as Senior Vice President, Human Resources. Read more: https://t.co/0uizweIeib $REGNJBEM pick FLKS data release on 4/19. Read here: https://t.co/RJhHbIwnlX $REGL $REGN $REI $REIS $REK $RELL $RELV $RELXRT @AndyBiotech: $NTLA @intelliatweets inks $REGN deal and files for $120M #IPO 
https://t.co/yWNOLGK1Km

$EDIT #CRISPR competitor https://‚Ä¶RT @BioPharmaDive: CRISPR biotech Intellia strikes licensing deal with $REGN for $75M upfront, potentially $320M in milestones https://t.co‚Ä¶#RegeneronPharmaceuticals Inc Upgraded by Zacks Investment Research to ""Hold"". Read more: https://t.co/blKo39r0Wq $REGN#RegeneronPharmaceuticals Inc Upgraded by Zacks Investment Research to ""Hold"". Read more: https://t.co/kTofDDjX6U $REGNRegeneron Pharmaceuticals Inc $REGN Upgraded by Zacks Investment Research to ‚ÄúHold‚Äù https://t.co/G1GJ3w2I4u$REGN $HLX:

Big Movers: Regeneron Pharmaceuticals, (NASDAQ:REGN), Helix ‚Ä¶:

https://t.co/7FnVxqWHmTTraders Sell Regeneron Pharmaceuticals Inc $REGN on Strength $REGN https://t.co/ewm0wOXlNVTraders Sell Regeneron Pharmaceuticals Inc $REGN on Strength $REGN https://t.co/pTZH7smX95Regeneron Pharmaceuticals Inc $REGN Position Decreased by Hartford Investment Management Co. https://t.co/NldkzPYNXk#Biotech Will Blast Past Its 2015 Highs https://t.co/eBzBBywaQA $GILD $LABU $REGN $IBBRT @AndyBiotech: $NTLA @intelliatweets inks $REGN deal and files for $120M #IPO 
https://t.co/yWNOLGK1Km

$EDIT #CRISPR competitor https://‚Ä¶RT @GENbio: $REGN, @intelliatweets partner to develop #CRISPR/Cas therapeutics: https://t.co/RqvIA6gzEcRT @GENbio: $REGN, @intelliatweets partner to develop #CRISPR/Cas therapeutics: https://t.co/RqvIA6gzEcGENbio: $REGN, intelliatweets partner to develop #CRISPR/Cas therapeutics: https://t.co/on6dmcESnR
Link: https://t.co/ZCx4GMs5k8$REGN, @intelliatweets partner to develop #CRISPR/Cas therapeutics: https://t.co/RqvIA6gzEc#RegeneronPharmaceuticals Inc Upgraded to Hold by Zacks Investment Research. Read more: https://t.co/QmET4MW5vH $REGN#RegeneronPharmaceuticals Inc Upgraded to Hold by Zacks Investment Research. Read more: https://t.co/yTb72aOAHH $REGNRT @AmericanBanking: $REGN - Regeneron Pharmaceuticals Inc #REGN Upgraded to Hold by Zacks Investment Research https://t.co/iWdBiKM8ku$REGN - Regeneron Pharmaceuticals Inc #REGN Upgraded to Hold by Zacks Investment Research https://t.co/iWdBiKM8kuRT @pjraitt: Quality set ups today for points. $CMG $REGN  $VRX $AGN. #Trade #NOBS #realtrades and #executed  #live. Iconicdaytrading @Icon‚Ä¶$REGN:

Regeneron Pharmaceuticals Inc (REGN) Upgraded to Hold by ‚Ä¶:

https://t.co/Gu6Uf8btLART @pjraitt: Quality set ups today for points. $CMG $REGN  $VRX $AGN. #Trade #NOBS #realtrades and #executed  #live. Iconicdaytrading @Icon‚Ä¶$REGN:

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Closes +3.01 ‚Ä¶:

https://t.co/GDIHZsNsbQREGN Filings
See Here ---&gt; https://t.co/VVMRCzHKQq

$REGN $DLR $CALA #invest",2016-04-13,REGN,0
11,"Rotating Into Health Care $BSX $VRX $IBB $REGN $AMGN $BIIB $CELG $GILD $ABBV https://t.co/RSXWjVeRxWSold 2/3 $REGN 405, need a bit more time to consolidate hereNew aticle on the hottest area in biotech #CRSPR $EDIT $REGN for premimum subscribers: https://t.co/znE6H7fngy@Roche $REGN Can you compete?$REGN trading like a turd but stock is bottoming IMO.Catalyst Capital Advisors LLC Has $5,592,000 Position in #RegeneronPharmaceuticals Inc (). Read more: https://t.co/JBOurRlnXv $REGNRotating Into Health Care $BSX $VRX $IBB $REGN $AMGN $BIIB $CELG $GILD $ABBV https://t.co/ryU7n7HbtZ@benmat07 ‚ÄúChanging a biochemical marker is not the same as improving the outcome for patients‚Äù #biotech $ESPR $AMGN $REGN $MDCO $MRKResurrected a great article as this cont. to be a hot button topic: Cholesterol Conundrum https://t.co/pAIUJJmKrJ #science $AMGN $REGN $ESPRREGN Current Price
See Here ---&gt; https://t.co/IsVvnBKY2B

$REGN $CANF $HMC #shareRT @BentheFidler: East Coast #Biotech Roundup: Intellia, What‚Äôs Hot, Cydan, Fog &amp; More https://t.co/lRUUuTRzxD $NTLA $EDIT $CELG $SNTA $REGN3 Big-Money Covered Calls -- $GOOG $PCLN $REGN https://t.co/o9WWvYjN6A https://t.co/mstUakTKhCCatalyst Capital Advisors LLC Has $5,592,000 Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/rhilT1kNlJEast Coast #Biotech Roundup: Intellia, What‚Äôs Hot, Cydan, Fog &amp; More https://t.co/lRUUuTRzxD $NTLA $EDIT $CELG $SNTA $REGNJBEM pick CYDY runng hard, FLKS is nxt: https://t.co/RJhHbIwnlX $RCPI $RCPT $REGN $RELISH.BO $RENE.L $REPH $RGBP $RGENEARS EOD Data
See Here ---&gt; https://t.co/cOuZC4FMbf

$EARS $REGN $HRB #financeXBIT Volume
See Here ---&gt; https://t.co/VHkjF4Kxyc

$XBIT $REGN $ARGS #pennystocksFRGI Last Price
See Here ---&gt; https://t.co/1jaf5oU1lQ

$FRGI $REGN $TRIL #stocks$REGN:

Analysts Set Regeneron Pharmaceuticals Inc (NASDAQ:REGN ‚Ä¶:

https://t.co/kDeum9B4jYAnalysts Set Regeneron Pharmaceuticals Inc $REGN Target Price at $512.91 https://t.co/KIQjADfJL1$REGN:

How Many Regeneron Pharmaceuticals Inc (NASDAQ:REGN)‚Äôs ‚Ä¶:

https://t.co/LyNJv0d1JORT @OpenOutcrier: $REGN (+3.2% pre) Regeneron's Skin-Clearing Drug Hits Goals in Final-Stage Trials 

https://t.co/33msjF4YfINow that the kibosh has been put on $AGN M/A What's the likely hood that $PFE buys $REGN and focuses on profits as opposed to tax savingsüò∂$REGN:

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Closes +0.60 ‚Ä¶:

https://t.co/hnh8KnD5OT",2016-04-14,REGN,0
12,"Regeneron Pharmaceuticals Inc $REGN Trading 3.2% Higher https://t.co/KmyeXpOdcERegeneron Pharmaceuticals Inc $REGN Trading 3.2% Higher https://t.co/nLrUcuV1az$REGN the bull pattern is confirmed &amp; a BUY signal is issued @ https://t.co/u0JXvIHf7y. Buy Level: 408.6100   Target: 433.1266#Regeneron Bouncing Off Support $REGN https://t.co/PvGJN4EwHUFor today my 4 best performing stocks ended up being $REGN $GEO $DIS $PYPL  #diversified #stocks$WAT #biotech stock breaking long term resistance

$IBB $REGN $AMGN $GILD https://t.co/WVoeoeixZxAlpine Woods Capital Investors LLC Holds Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/T7vrz910Mf@trader_marky good for you. For me after $SQ $REGN $IBB trade, it's been a little too quiet.$REGN: 1mRunaway+:4 [+4%,.1%offHi], 3mMv:+3, 9:6Accel+, allTFs+; TLM:1.9; ILM:0.8, DyVol:494T:1.1x:0.5x, DyRng:4.3%:2x:1.4x (PotLONG),RT @SleemStockPicks: $DIS $PYPL $REGN leading the S&amp;P 500 today. Good things ahead for $DIS IMO. https://t.co/w7nJjNSKVb$DIS $PYPL $REGN leading the S&amp;P 500 today. Good things ahead for $DIS IMO. https://t.co/w7nJjNSKVbWhat do $GILD, $AMGN, $CELG, $BIIB and $REGN have in common?  https://t.co/1HCajBGEJFWhat do $GILD, $AMGN, $CELG, $BIIB and $REGN have in common?  https://t.co/iStSv03lAvEdgewood Management LLC Has $1,357,000 Stake in #RegeneronPharmaceuticals Inc (). Read more: https://t.co/0XbvUi0yJ0 $REGNEdgewood Management LLC Has $1,357,000 Stake in #RegeneronPharmaceuticals Inc (). Read more: https://t.co/ARl4AUAH3I $REGNBest performing sector today and its names: Healthcare $ENDP $REGN $VRTX $LLY https://t.co/iC7lxcHHSa https://t.co/XkW8SDWrXS$REGN flag continuation.Edgewood Management LLC Has $1,357,000 Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/qTJfprvVslEdgewood Management LLC Has $1,357,000 Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/gnVen5M7ZcNotable gainers among liquid option names this morning include $HAS (+5.6%), $VRTX (+4.4%), $IRM (+3.8%), $REGN (+3.3%), and $TRIP (+3.0%),$REGN &lt;STUDY the CHARTS&gt; Tactical_Trading https://t.co/SKblpxnAR3$IBB $CELG $GILD $REGN $BIIB $XBI

super strong$REGN holding B/O level  https://t.co/faQE7nq3XL via https://t.co/11Wpw9y7t1Utah Retirement Systems Has $7,683,000 Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/nRAwKCPoVgok #aacr16 that's one vote for LAG3...

$REGN preclinical https://t.co/tJI3TaG7m6RT @DiegoDomiguez10: On watch: $TSLA $AAPL $MSFT $NFLX $FIT $FB $DIS $PTCT $REGN $RLYPOn watch: $TSLA $AAPL $MSFT $NFLX $FIT $FB $DIS $PTCT $REGN $RLYP23:15--&gt; https://t.co/vqaokSKgmf

Also, see: https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/pE353zRirtRegeneron Pharmaceuticals‚Äô $REGN Buy Rating Reiterated at Brean Capital https://t.co/hVMytRfgNKRegeneron Pharmaceuticals‚Äô $REGN Buy Rating Reiterated at Brean Capital https://t.co/yQcKHqVUOtRegeneron Pharmaceuticals, Inc.  Reiterated Rating by Cowen &amp; Co (Ranked 53rd) to Hold $REGN #REGN https://t.co/6KTXk3W2QE@biotechnova I'll look at $REGN when 1) MC &lt; $10B , or 2) Profits &gt; $1B/yr; whichever is sooner. Ludicrous valuation :)$REGN:

Top Gainers Today: Regeneron Pharmaceuticals, Inc. (NASDAQ ‚Ä¶:

https://t.co/mSjSg2SGMR@pbmech Agree on PCSK9, but look into Dupilumab.  I think you're missing a lot of $REGN's pipeline, esp. late-stage.@biotechnova $REGN has ways to go before meaningful revenues. Eylea has strong comp in Lucentis, &amp; I m not hopeful Abt PSCK9 CVOTs.@pbmech Ok.  I do know $REGN GAAP vs Non-GAAP has a big discrepancy.@pbmech Are all GAAP btw or just $REGN?",2016-04-18,REGN,0
13,"$REGN:

Top Stocks of the day: Regeneron Pharmaceuticals, Inc. (NASDAQ ‚Ä¶:

https://t.co/RztxUiSEzYHRB Stock Message Board
See Here ---&gt; https://t.co/VOlFWmlgwt

$HRB $REGN $TIVO #investingJeff $REGN Cardiologist Survey Suggests Near-Term Trends Tracking Below ConsensusRT @iviewmarkets: $SPY stocks with greatest monthly momentum, $GOOGL$ GOOGL $AMZN $BLK $ISRG $PCLN $REGN $SHW $WHR https://t.co/X6bFzjtSJd$REGN:

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Reported ‚Ä¶:

https://t.co/ZnuhrDRagg3 Biotech Stocks That Could Endure Hillary Clinton $GILD $REGN $EBS https://t.co/AjpHQNQ3oW https://t.co/b0LhcBzHJ3Investors Sell Shares of Regeneron Pharmaceuticals Inc $REGN on Strength $REGN https://t.co/kgu4HIXWI9Regeneron Pharmaceuticals, Inc.  Reiterated Rating by Jefferies &amp; Co (Ranked 19th) to Hold with 444 PT $REGN #REGN https://t.co/6KTXk3W2QEInvestors Sell Shares of Regeneron Pharmaceuticals Inc $REGN on Strength $REGN https://t.co/jO5E8hF626Regeneron Pharmaceuticals's hold rating reiterated at Jefferies Group. $444.00 PT. https://t.co/mmsSaovDq5 $REGN #REGNRegeneron Pharmaceuticals's hold rating reiterated at Jefferies Group. $444.00 PT. https://t.co/Xd3GAea5ZW $REGN #REGNRegeneron Pharmaceuticals gains 3.85% to $422.38 on Monday : Among top 10 gainers on S&amp;P500. $REGN #pharma #stockmarket #healthcare #Nasdaq$REGN $HUM:

Stocks within Traders Screening: Regeneron Pharmaceuticals, Inc ‚Ä¶:

https://t.co/UXk4Dvnh0yRegeneron Pharmaceuticals $REGN ‚Äì Research Analysts‚Äô Weekly Ratings Changes https://t.co/dndiszqXDx#RegeneronPharmaceuticals - Research Analysts' Weekly Ratings Changes. Read more: https://t.co/TZbykZVbql $REGN$SPY stocks with greatest monthly momentum, $GOOGL$ GOOGL $AMZN $BLK $ISRG $PCLN $REGN $SHW $WHR https://t.co/X6bFzjtSJd#Regeneron Bouncing Off Support $REGN https://t.co/PvGJN4EwHU#Regeneron Bouncing Off Support $REGN https://t.co/fqF57BX83G$REGN flag break out 30 points above$REGN Will see $430 but then needs some giddy-up to get going. Anybody's guess, but remains strong and this is keeping us in this trade!Biggest gainers today large caps:
$ETE 10.06%
$HAS 5.79%
$HES 4.67%
$BHI 4.34%
$CLR 4.33%
$DISH 4.19%
$REGN 3.85%
$EPD 3.75%
$VRX 3.73%Elder Green https://t.co/DsJLDrJ4wu $AEE $DBC $MWW $HOV $TTWO $PAYX $OII $SUPN $PKY $XRAY $MPLX $WEC $FBHS $REGN $QLD $SUM $NNN $RMBS$REGN extended its April rally to 17.2%",2016-04-19,REGN,0
14,"$REGN$REGN:

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Where are ‚Ä¶:

https://t.co/Lat0zG2xjC$REGN Regeneron Pharmaceuticals baj√≥ 3.55% a $399.10. Est√° abajo 22.74% en 2016 &amp; 11.79% en 52 semanas.On the anniversary of Samuel Morse‚Äôs birth, $REGN celebrates a #scientist driven to create &amp; innovate. https://t.co/zICherlADYAnalyst Downgrades https://t.co/fkgF95hSvy $AEIS $BMI $EAT $BT $CJES $CAMP $CPA $HSY $MAR $MPEL $NOV $NTRS $PACD $REGN $SAND $SPR $SAVE $SNVAmazing Day in #AwesomeCalls Another 10 Trading Idea Laid out ALL PreMarket Nailed $NUGT $ISRG $CAMP $REGN $KITE $BLUE $ALDR $ADMS $VMW $VRX#Regeneron #Downgraded To Market Perform From Outperform At Wells Fargo $REGN https://t.co/uqZVh63zrx#RegeneronPharmaceuticals Insurers, Doctors Making It Hard To Get Breakthrough Cholesterol-... Read more: https://t.co/R089qFTcmP $REGN#RegeneronPharmaceuticals Insurers, Doctors Making It Hard To Get Breakthrough Cholesterol-... Read more: https://t.co/buGDIIYPv1 $REGN$REGN -4%, am I missing something?  WFC downgrade today.ya @jimcramer! $REGN Get Some!Noteworthy Wednesday Option Activity: $TSCO  $REGN  $UNH #stockoptions https://t.co/4yB3fv335bAnalyst Downgrades https://t.co/fkgF95hSvy $AEIS $BMI $EAT $BT $CJES $CAMP $CPA $HSY $MAR $MPEL $NOV $NTRS $PACD $REGN $SAND $SPR $SAVE $SNVStarted $REGN 396.6$REGN Bought Regeneron call option
$MACK Bought Merrimack Pharmaceuticals stock$regn BTFDAnalyst Downgrades https://t.co/fkgF95hSvy $AEIS $BMI $EAT $BT $CJES $CAMP $CPA $HSY $MAR $MPEL $NOV $NTRS $PACD $REGN $SAND $SPR $SAVE $SNV$REGN Seriuosly, close matters, so if this wants to flirt with $380s then we are back to where we started. Asking myself why oh why$REGN Feels like $CMG , give me the crappers20 SMA support here @ 395.75, sym. wedge $REGN https://t.co/n1QGj72jyR ~ via https://t.co/Kd2qwcsyit20 SMA support here @ 395.75, sym. wedge $REGN https://t.co/2v0nc85S5QToday's #SP500 biggest winners: $DFS (+8%), $CNX (+7%), $WDC (+6%). The biggest losers: $KO (-5%), $TEL (-4%), $REGN (-4%)Breakthrough cholesterol drugs fizzle amid price pushback $AMGN $REGN $SNY https://t.co/dxL7IhgTgLRegeneron Pharmaceuticals Inc $REGN Receives ‚ÄúHold‚Äù Rating from Jefferies Group https://t.co/vTYXmXtnHkAnalyst Downgrades https://t.co/fkgF95hSvy $AEIS $BMI $EAT $BT $CJES $CAMP $CPA $HSY $MAR $MPEL $NOV $NTRS $PACD $REGN $SAND $SPR $SAVE $SNV$REGN Regeneron Pharmaceuticals down 3.55% at $399.10. Down 22.74% in 2016 &amp; 11.79% in 52 wks. https://t.co/GhV659aEZDVideo: Nasdaq 100 Movers: $CHKP  $BMRN $ISRG $REGN #stocks https://t.co/gJChFBDJ76Analyst Downgrades https://t.co/fkgF95hSvy $AEIS $BMI $EAT $BT $CJES $CAMP $CPA $HSY $MAR $MPEL $NOV $NTRS $PACD $REGN $SAND $SPR $SAVE $SNV#StockNews ‚Äï On The Fly: Top five analyst downgrades $REGN $INTC $BA $EAT $HSY: Full Story https://t.co/ZekxIV4wS5 ‚Üí via @AlertTradeOn The Fly: Top five analyst downgrades  $REGN $INTC $BA $EAT $HSY: Full Story https://t.co/7FaCpLtV69$REGN and $BIIB hell bent on killing biotech tape today. $KITE, $IONS, $CLVS, $INVA, $IBB, $XBI$REGN downgrade today a gift to buy below 400 folks. stock is a monster, load up. going back to 450-500 soon (100DMA and 200DMA)$REGN gap fill to 380 range@jimcramer $REGN a buy at below $400?$REGN @ rising 20DMA support  https://t.co/BQQSCFnqjS via https://t.co/11Wpw9y7t1$REGN loading the boat hereAnalysts' Actions -- Boeing, Hershey, Spirit, Regeneron and More https://t.co/IsNl38Pd4Y via @TheStreet $BA $HSY $REGNAnalyst Downgrades https://t.co/fkgF95hSvy $AEIS $BMI $EAT $BT $CJES $CAMP $CPA $HSY $MAR $MPEL $NOV $NTRS $PACD $REGN $SAND $SPR $SAVE $SNVWells Fargo Downgrades #RegeneronPharmaceuticals Inc to Market Perform. Read more: https://t.co/XIJd0KJI1X $REGNWells Fargo Downgrades #RegeneronPharmaceuticals Inc to Market Perform. Read more: https://t.co/ZRcbioeIJM $REGNTop Downgrades 4/20: $NOV $NTRS $OMC $PACD $PDS $RBC $REGN $SAND $SAVE $SLW $SNV $SPR $SU $TAHO $TTEK (2/2)@Varneyco @JeffDeWitAZ @realDonaldTrump Amen Brother!!! #MakeAmericaGreatAgain $twtr $opht $feye $regn $celg $gildMorning Movers: Boeing Slumps on Merrill Cut; Abbott Labs Jumps on Earnings https://t.co/hRR31I4TO8 v@barronsonline $ABT $BA $KO $REGN $MTRT @theflynews: Regeneron downgraded to Market Perform from Outperform at Wells Fargo $REGN: Full Story https://t.co/XbRzwBW0VyWednesday's Top Analyst Upgrades &amp; Downgrades PT3:
$REGN $SBH $SRPT $SAVE $SNV $TIER $ULTA $UNH 
https://t.co/UmlOL0sHIs$REGN down $7 on all of 300 shares traded pre-market. Let's see what she does at the open$REGN downgraded to Market Perform from Outperform at Wells Fargo PT range changed to $395-$431 from $450-$539 

‚Äù$REGN under pressure after $WFC downgrade. $IBB $BIIB $CELG $GILD$REGN downgraded to Market Perform at Wells Fargo#Regeneron #Downgraded To Market Perform From Outperform At Wells Fargo $REGN https://t.co/VRxsblQeO2April 20 Analyst Upgrades &amp; Downgrades. $CPA $KSU $BA $REGN $INTC $LXK $MPEL $EOG $ULTA $ORCL $ALDR &amp; more. https://t.co/A7PvywhuNvWells Fargo Downgrades Regeneron Pharmaceuticals Inc $REGN to Market Perform https://t.co/4CB8DICvWS$regn lower after downgrades   I remain long#downgrades $MAR $SNV $BMI $AMTD $PACD $NOV $HOS $EAT $BT $CJES $SAVE $REGN $CAMP $MPEL $AEIS $HSY $DV $SPR $NTRS $SAND $TTEK $SURegeneron Pharmaceuticals, Inc.  Downgrade by Wells Fargo (Ranked 5th) to Market Perform $REGN #REGN https://t.co/6KTXk3W2QERegeneron Pharmaceuticals downgraded by Wells Fargo to market perform. https://t.co/JkaOMkpya4 $REGN #REGNRT @AnalystWire: Wells Fargo Downgrades Regeneron Pharma $REGN to Market Perform https://t.co/6IUVeRShlYRT @AnalystWire: Wells Fargo Downgrades Regeneron Pharma $REGN to Market Perform https://t.co/6IUVeRShlY$REGN downgraded at Wells FargoRT @theflynews: Regeneron downgraded to Market Perform from Outperform at Wells Fargo $REGN: Full Story https://t.co/XbRzwBW0VyWells Fargo Downgrades Regeneron Pharma $REGN to Market Perform https://t.co/6IUVeRShlYRT @theflynews: Regeneron downgraded to Market Perform from Outperform at Wells Fargo $REGN: Full Story https://t.co/XbRzwBW0VyABEO Bid Size
See Here ---&gt; https://t.co/Gq99QLTWsx

$ABEO $REGN $NVIV #shareRT @theflynews: Regeneron downgraded to Market Perform from Outperform at Wells Fargo $REGN: Full Story https://t.co/XbRzwBW0Vy#StockNews ‚Äï Regeneron downgraded to Market Perform from Outperform at Wells Fargo $REGN: Full‚Ä¶ https://t.co/HGWU6Zuv1D ‚Üí via @AlertTradeRegeneron downgraded to Market Perform from Outperform at Wells Fargo $REGN: Full Story https://t.co/z0QPyBmh7mRegeneron downgraded to Market Perform from Outperform at Wells Fargo $REGN: Full Story https://t.co/XbRzwBW0VyIHS Chart
See Here ---&gt; https://t.co/6JKw9eF7jT

$IHS $EAT $REGN #pennystocksRT @jonathanrockoff: $REGN to pay $75mn upfront to  Intellia Therapeutics to develop CRISPR-Cas9 drugs against ten targets: https://t.co/bi‚Ä¶REGN Shares
See Here ---&gt; https://t.co/gn6VEVqMEV

$REGN $HOMB $TRXC #finance23:15--&gt; https://t.co/vqaokSKgmf

Also, see: https://t.co/Tx8cJJUe7g

$AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/crmPzU2HGU$REGN:

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Closes -2.04 ‚Ä¶:

https://t.co/mEyzl9qu17",2016-04-20,REGN,1
15,"RT @ScripMandy: Ocrelizumab for MS and dupilumab for atopic dermatitis. $RHHBY $REGN https://t.co/NCLYpycQFK$REGN may go up 6% if the bull pattern is confirmed. Chk confirmation [71%] @ https://t.co/u0JXvIHf7y. Buy level:409.5700.RT @ScripMandy: Ocrelizumab for MS and dupilumab for atopic dermatitis. $RHHBY $REGN https://t.co/NCLYpycQFKRT @iviewmarkets: The Close: $NEM $MPC  $UA $HOG $GM $SLG $ENDP $BIIB $MNK $VRTX $CELG $REGN $SWK $DHR $VIAB $TYC $TSCO $FFIV $CTXS https:/‚Ä¶The Close: $NEM $MPC  $UA $HOG $GM $SLG $ENDP $BIIB $MNK $VRTX $CELG $REGN $SWK $DHR $VIAB $TYC $TSCO $FFIV $CTXS https://t.co/5WwrSGi1CJOcrelizumab for MS and dupilumab for atopic dermatitis. $RHHBY $REGN https://t.co/NCLYpycQFKAn Outlook On Regeneron Pharmaceuticals $REGN take a look at my thoughts on$REGN!  https://t.co/0JdbjOutqG$REGN Max Pain = 400.00. Maturity = 04/22/2016. Previous close = 399.75. bullish https://t.co/X2uN4EDB5t https://t.co/wa37JI6NRbTrade idea : $regn looks really good.. Can gap up tomorrow .. Worth getting calls$REGN:

An Outlook On Regeneron Pharmaceuticals:

https://t.co/0fAFNqmS8lRT SeekingAlpha: An Outlook On Regeneron Pharmaceuticals https://t.co/Q9gtpoprld $REGNAn Outlook On Regeneron Pharmaceuticals https://t.co/vWaZgmYnZZ $REGNAn Outlook On Regeneron Pharmaceuticals https://t.co/XjQsPa3RX9 $REGNRT @ChinaInvest: RT SeekingAlpha: Rotating Into Health Care https://t.co/9Mj0xg935p $ABBV $AMGN $BIIB $BSX $CELG $GILD $GLD $IBB $REGN $TMO‚Ä¶Jefferies Group Reiterates ""Hold"" Rating for #RegeneronPharmaceuticals Inc (). Read more: https://t.co/E2mpg9KK6j $REGNJefferies Group Reiterates ""Hold"" Rating for #RegeneronPharmaceuticals Inc (). Read more: https://t.co/pBN82SkkCE $REGN$REGN 46.62 longRT SeekingAlpha: Rotating Into Health Care https://t.co/9Mj0xg935p $ABBV $AMGN $BIIB $BSX $CELG $GILD $GLD $IBB $REGN $TMO $VRX@OptionsHawk fav play?  I'm thinking of sticking to the big boys like $CELG or $REGNBlackRock Advisors LLC Has $142,485,000 Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/BQGlOrDflQBlackRock Advisors LLC Has $142,485,000 Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/yVzazcFhZe$REGN Back into $400s, that's much better...$REGN:

Upgrades And Downgrades For Regeneron Pharmaceuticals, Inc ‚Ä¶:

https://t.co/yR2N0s0sMI$REGN: 3mRunaway+:2 [+3%,.2%offHi], PDayGp-, 3:4Accel+, allTFs+; TLM:1.6; ILM:1.1, DyVol:338T:0.3x:0.4x, DyRng:3.4%:1.3x:1x (PotLONG),Healthcare best performing Sector today and its names are: $VRTX $REGN $MNK $BIIB $ENDP https://t.co/ukbHsJbmMC$IBB catching a bid -- may finally benefit from rotating bull market. Big biotech ER a catalyst...

$AMGN $REGN $GILD $CELG$XBI $AMGN $REGN $GILD WOW$REGN bouncing strong from analyst DG TomFkery yesterday  https://t.co/yJIx0tSCyL via https://t.co/11Wpw9y7t1$REGN &lt;STUDY the CHARTS&gt; Constructive_Reversal https://t.co/wbpOFUoz0S$xbi 31k calls vs 900 put , call  ratio 32*  ,,caught at day low support, rolling $ibb +4$ $regn $gild took off too ¬¢bio boomRT @regeneron: On the anniversary of Samuel Morse‚Äôs birth, $REGN celebrates a #scientist driven to create &amp; innovate. https://t.co/zICherlA‚Ä¶$regn hope you bought ridiculous dip yesterday of silly'downgrade'. See ya at 500 later this year#FusionIQ NEW Positive Timing Signal on $REGN Today https://t.co/9ImlXz4YNa Please Retweet #Signals$REGN maturity 04/22/2016 oi CallPutRatio of 0.59 puts 909 &amp; calls 1,531 bullish. https://t.co/R2wmikNhns https://t.co/SbkbCqWbRR$biib $regn  let's get this party going. Long weeklies callsBiotech hot again $ibb  $xbi $biib  $regn , sector rotationSFTW Investor long-term stock recommendation: $REGN Regeneron Pharmaceuticals, Inc. (SS: 70) https://t.co/ajLDr7suct$REGN:

Two Stocks within Traders Limelight: Ironwood Pharmaceuticals, Inc ‚Ä¶:

https://t.co/3w0gLgc6MF$IBB trading tight

$GILD $AMGN
$REGN https://t.co/AlQYclu5TWRT @regeneron: On the anniversary of Samuel Morse‚Äôs birth, $REGN celebrates a #scientist driven to create &amp; innovate. https://t.co/zICherlA‚Ä¶New heart drugs struggle to win sales as doctors hold back - #PCSK9 $AMGN $REGN $NVS #entresto $ESPR https://t.co/3T8nWAiSWpMacquarie Group Ltd. Reduces Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/6sc8HZBQYi@asco $REGN A first-in-human study of REGN2810, in combination with immunomodulators including hypofractionated radiotherapy (hfRT).Regeneron Pharmaceuticals Inc $REGN  Shares Down 3.7% https://t.co/3dL4LINmDiRegeneron Pharmaceuticals Inc $REGN  Shares Down 3.7% https://t.co/4TUdo2H2Z3Next up $REGN #Analyst d/g grade to $395 I told Subs, scale in SHORT at the pop at open $405-$410 an fade it to $395 https://t.co/VQXFPTn4C6Some stocks were RED when the market turned NEW HIGH(4/20/2016)
$SQ $CARA $CDI $CMRX $FEYE $FLOW $IMGN $IRWD $KS $NG $ODP $REGN $SAVE $SBNY$REGN OI for maturity 04/22/2016. 395.00 Highest put. 425.00 Highest call.  https://t.co/R2wmikNhns https://t.co/R5Qoetsjhy$REGN  GDF8 Antibody in reformulation mode! https://t.co/4Pz3273nisBiggest losers today large caps:
$KO -4.79%
$CHU -3.69%
$TEL -3.53%
$CMS -3.49%
$XEL -3.47%
$WEC -3.42%
$REGN -3.39%
$ED -3.35%#Regeneron #Downgraded To Market Perform From Outperform At Wells Fargo $REGN https://t.co/VRxsblQeO2$REGN:

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Closes -3.39 ‚Ä¶:

https://t.co/Lv8E15uMEi",2016-04-21,REGN,0
16,"Eaton Vance Management Has $2,334,000 Position in #RegeneronPharmaceuticals Inc (). Read more: https://t.co/a70by8P5lQ $REGNEaton Vance Management Has $2,334,000 Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/8LvDTSSXvrRT @ByJonGardner: 2016 looking like the year payers start to get a grip on pharma prices: https://t.co/GYq8CBAE6a $NVS $SNY $REGN $RHHBY#RegeneronPharmaceuticals Inc Stake Increased by US Bancorp DE. Read more: https://t.co/qTZ6O4m2Bz $REGNRT @AlexBo6: $REGN thinks it's April 1st ,@MikeF_trading$REGN thinks it's April 1st ,@MikeF_tradingRT @ByJonGardner: 2016 looking like the year payers start to get a grip on pharma prices: https://t.co/GYq8CBAE6a $NVS $SNY $REGN $RHHBYWells Fargo Lowers Regeneron Pharmaceuticals Inc $REGN to Market Perform https://t.co/oUxPw9trHMRT @ByJonGardner: 2016 looking like the year payers start to get a grip on pharma prices: https://t.co/GYq8CBAE6a $NVS $SNY $REGN $RHHBYRT @ByJonGardner: 2016 looking like the year payers start to get a grip on pharma prices: https://t.co/GYq8CBAE6a $NVS $SNY $REGN $RHHBY$REGN - SELL Signal at 404.38 on Apr 22, 16 By https://t.co/6PpjiKmc9G Trading Robot #Stockstowatch #Stockmarket #trading #trade #investingRegeneron Pharmaceuticals Inc $REGN Stake Increased by Dimensional Fund Advisors LP https://t.co/JldkfAUrXnRT @ByJonGardner: 2016 looking like the year payers start to get a grip on pharma prices: https://t.co/GYq8CBAE6a $NVS $SNY $REGN $RHHBYRT @ByJonGardner: 2016 looking like the year payers start to get a grip on pharma prices: https://t.co/GYq8CBAE6a $NVS $SNY $REGN $RHHBYRT @ByJonGardner: 2016 looking like the year payers start to get a grip on pharma prices: https://t.co/GYq8CBAE6a $NVS $SNY $REGN $RHHBYRT @ByJonGardner: 2016 looking like the year payers start to get a grip on pharma prices: https://t.co/GYq8CBAE6a $NVS $SNY $REGN $RHHBYRT @ByJonGardner: 2016 looking like the year payers start to get a grip on pharma prices: https://t.co/GYq8CBAE6a $NVS $SNY $REGN $RHHBY2016 looking like the year payers start to get a grip on pharma prices: https://t.co/txigzkQjTp $NVS $SNY $REGN $RHHBY2016 looking like the year payers start to get a grip on pharma prices: https://t.co/GYq8CBAE6a $NVS $SNY $REGN $RHHBYRT @DozenStocks: Nasdaq100 #Stocks Performance $TMUS $MNST $COST $ULTA $CHKP $MXIM $REGN $TSCO $FISV $BIIB $TSLA $INCY $CELG more@ https://‚Ä¶Nasdaq100 #Stocks Performance $TMUS $MNST $COST $ULTA $CHKP $MXIM $REGN $TSCO $FISV $BIIB $TSLA $INCY $CELG more@ https://t.co/YdSIjFJqHfBRK.B News
See Here ---&gt; https://t.co/ywC8MEgfb6

$BRK.B $REGN $AGM #shareDMRC Day Low
See Here ---&gt; https://t.co/JicKt3WyJW

$DMRC $REGN $SPWH #invest$IBB under the ""keep it simple"" banner, this ETF is only selling at 18X.  Heavy exposure to $AMGN, $BIIB, $CELG $GILD $REGN. Down from $400.REGN Company Info
See Here ---&gt; https://t.co/cZKpjDzfG1

$REGN $AXON $YGE #stockmarketRT @markcarson161: GMAN Company Info
See Here ---&gt; https://t.co/mynxprp3Qe

$GMAN $GMLP $REGN #stocksGMAN Company Info
See Here ---&gt; https://t.co/mynxprp3Qe

$GMAN $GMLP $REGN #stocks$REGN - SELL Signal at 404.38 on Apr 22, 16 By https://t.co/6PpjiKmc9G Trading Robot #Stockstowatch #Stockmarket #trading #trade #investing$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/1skbYLsG8y",2016-04-25,REGN,0
17,"$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/C6i5caNlE3$REGN:

New SEC Filing for REGN: Form DEFA14A (No. 0001104659-16-114231):

https://t.co/R4qd1xC5iw https://t.co/g133TxI1hr$REGN New SEC Document(s) for Regeneron Pharmaceuticals, Inc.
From our Stock News Alerts AppRegeneron Pharmaceuticals releases salary data. CEO sees compensation rise 13%25 https://t.co/wz0OtDPG2V $REGNThe madness of crowds. $OGXI $IONS $RAS $SRPT  $Blue $RYLP $IBB $REGN $PTCT $RGLS $ARWROut of #googl, 30% gain in 5 minutes time.  Still got $regn calls, and cmg call spreads.  Love the volatilityRegeneron Pharmaceuticals Inc $REGN Stake Held by Nicholas Co. Inc. WI https://t.co/IgwUvZMGwXRegeneron Pharmaceuticals Inc $REGN Stake Held by Nicholas Co. Inc. WI https://t.co/ssPjzevL4tRT @BobbyAxelrod__: $REGN looks ready to make a move.Do You Wish For More Consistent Winning Trades? If so, colleague @IBD_Aelliott shows how to average up https://t.co/NvCpyca63t #stocks $REGNFELE Last Price
See Here ---&gt; https://t.co/F2DMm1iDpL

$FELE $XLRN $REGN #financeConnor Clark &amp; Lunn Investment Management Ltd. Decreases Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/UVFMkCstwNUpdate For Exchange Traded Bonds And Preferred Stocks Basket Strategy As Of  4/26/16¬† $REGN https://t.co/0TNKPP1KMZBack long $regn weeklies calls, bullish action above 410INFO: $REGN TRUST indicator (as seen by investors in News &amp; Social Media) marks stock as trustworthy. https://t.co/1kUh7lwpCA@Chub519 Yeah, definitely improving here.  BUT, if broader markets tank, may head back down. Watch $CELG, $GILD, $BIIB and $REGN.$REGN looks ready to make a move.HII Current Price
See Here ---&gt; https://t.co/l4lqgXKovW

$HII $REGN $GLP #investRT @MikeF_trading: $BIIB breaking out

#biotech $GILD
$IBB $REGN https://t.co/zaYZaT1HXS$BIIB breaking out

#biotech $GILD
$IBB $REGN https://t.co/zaYZaT1HXSStocks at support w/ high trade quality $ANAC $CARA $NVCR $REGN $SGMS $SONC $TRVN https://t.co/6RpXxLUBQa #stocks https://t.co/oHf6ITaTEqREGN Current Price
See Here ---&gt; https://t.co/G47cME3sLG

$REGN $UTL $CVGI #shareRT @OptionsHawk: $REGN - Bayer Eylea sales +47% Y/YRT @OptionsHawk: $REGN - Bayer Eylea sales +47% Y/YRT @OptionsHawk: $REGN - Bayer Eylea sales +47% Y/YRT @OptionsHawk: $REGN - Bayer Eylea sales +47% Y/YRT @OptionsHawk: $REGN - Bayer Eylea sales +47% Y/Y$REGN - Bayer Eylea sales +47% Y/YCNX Prev Close
See Here ---&gt; https://t.co/xHHcaTYp9U

$CNX $REGN $SEIC #stock",2016-04-26,REGN,0
18,"Parabolic SAR Sell https://t.co/TA8enrHTdd $ISRG $REGN $PNRA $BIDU $AVB $CSGP $IYH $ANTM $TYL $VHT $CBPO $ROK $ASH $JNJ $DEO $FB $EXPE$REGN apparently the bull pattern is not confirmed. Prices continue to fall. https://t.co/u0JXvIHf7y@jimcramer Wait a week or two for an entry into $REGN. https://t.co/ISEMqVPE0y$REGN E-ISI price target on 2/26 was 566, on 4/12 it was 395. My respond to him (MS, and similar ones) is: FUCx OFF!@AgentMuD007 today my worst performers were $TWTR $CMG $AAPL $UA / $UA-C and $REGN#CRISPR Firm #Intellia will go public with an IPO at $16 to $18 per share $REGN $NVS https://t.co/8zLlhZO4ya by @genomewebKBC Group NV Has $7,928,000 Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/IjYuXC0gFcThe 10 Best Stocks of the Past 10 Years $PCLN $REGN $NFLX $AMZN ... https://t.co/FZxQfMIxdY https://t.co/EhfzA1Ax8K$REGN killibg this thing before it kills me -4.72% lossRegeneron CEO, R&amp;D chief's paychecks both top $40M https://t.co/aBcP1N30PN $REGN #pharma by @TracyStaton$REGN - Someone big is bailing. Out myself. Will come back when this selling is over. https://t.co/dIoprvXPJ3$REGN Will be aggressively looking to get some of this CASH working soon.$REGN Sorry, not interested in booking losses so CASHISKING$REGN STOPPED Out just above Break-Even. Looks like the market wants us to be mostly in CASH. So-Be-It! Bio's being Brutal 4 booking Profit$REGN lets see how long it takes to hit PT  https://t.co/bHJGP2uCkF$NTLA Gene editing Co Intellia Rx aims to raise $80-90M for market cap of ~$600M $REGN and Novartis to invest: https://t.co/9OHVRIIsodRT @BobbyAxelrod__: Looks like they are trying to shame'em out of $REGN before earnings next week.Low volume selling thinking this one turn‚Ä¶More information about $REGN on https://t.co/ObOqOqfuAR$regn added 393Regeneron Pharmaceuticals (NASDAQ: $REGN)- latest Analyst Consensus  https://t.co/eUOpFFzPVOLooks like they are trying to shame'em out of $REGN before earnings next week.Low volume selling thinking this one turns and makes a big runAEP Last Trade
See Here ---&gt; https://t.co/OU02Y1Av0s

$AEP $IESC $REGN #stocks@jimcramer biotech is not out of bear market. $REGN $IMGN $GILD ERs coming.@tgtxdough Limited near-term competitive threats.  maintains a 3-year headstart over PDGF competition; $REGN  PDGF/VEGF co-formulation@tgtxdough $OPHT could trade up to $115-$125/sh ($4- 4.5B MCap) over time on positive data (largely in-line with $REGN positive Eylea dataCBI P/E Ratio
See Here ---&gt; https://t.co/6N1OBq3xuD

$CBI $GCAP $REGN #nasdaqBK Prev Close
See Here ---&gt; https://t.co/fHKEH8XGLF

$BK $REGN $USNA #invest$REGN Additional Proxy Soliciting Materials (definitive) (defa‚Ä¶ https://t.co/dOwxQtOooU$REGN Additional Proxy Soliciting Materials (definitive) (defa‚Ä¶ https://t.co/jFJ6HJ2HKD$REGN Proxy Statement (definitive) (def 14a)‚Ä¶ https://t.co/wHpRsIDmXEREGN Ask
See Here ---&gt; https://t.co/kHhzxU7keg

$REGN $WPPGY $ACHC #stockmarketLXFT Ask
See Here ---&gt; https://t.co/kkcBohINyI

$LXFT $REGN $MON #invest",2016-04-27,REGN,1
19,"50 Day Resistance https://t.co/yPGsIn1i4j $TGNA $COST $CLNE $MTG $KORS $WYNN $MACK $PXLW $SYT $FUR $CAKE $INVA $RRGB $DCUC $ADXS $ARAY $REGNNasdaq100 #Stocks Performance $FB $MNST $VRTX $CELG $DISH $CHTR $WFM $MAR $LMCA $MU $BIIB $REGN $TMUS $ADSK more@ https://t.co/YdSIjFJqHfTogether w/ @bcmhouston, $REGN studies gene function using the latest sequencing tech https://t.co/TexTyuuwwo https://t.co/F1vDA3gSVj#RegeneronPharmaceuticals Researchers Submit Patent Application, ""Use of a Vegf Antagonist ... Read more: https://t.co/jsZ3Wyycl6 $REGN$AMGN 16M Repatha .... Maybe if they get $REGN kicked off the market, they can get closer to consensusNasdaq100 #Stocks Performance $FB $VRTX $MNST $CELG $MU $CHTR $WFM $REGN $MAR $LMCA $TRIP $BIIB $AMGN $TMUS more@ https://t.co/YdSIjFJqHf$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/ohahHU90zZ$REGN action lately funky, to me wants to explode higher. low expectations 4 earnings next week. think that will be what releases the beast#RegeneronPharmaceuticals Regeneron Promotes Senior Procurement Manager. Read more: https://t.co/wU51yrS6Ka $REGNRT @Fibonacciqueen: $REGN support decision to define risk against!! https://t.co/fGhgY9H73VRT @Fibonacciqueen: $REGN support decision to define risk against!! https://t.co/fGhgY9H73V$regn earnings next week gut says she runs to 440-450. Such an undervalued beast right now. Next $celg$REGN support decision to define risk against!! https://t.co/fGhgY9H73VRegeneron Pharmaceuticals Inc $REGN Shares Bought by Baird Financial Group Inc. https://t.co/jdZPmJqDcjRegeneron Pharmaceuticals (REGN:NASDAQ) loses 4.03% to $390.28 on Wednesday : Among top 10 losers on S&amp;P500 $REGN #StockMarket #NASDAQRegeneron Pharmaceuticals (REGN:NASDAQ) loses 4.03% to $390.28 on Wednesday : Among top 10 losers on S&amp;P500 $REGN #StockMarket #NASDAQ@jordixiol PBD-conjugate was recent $REGN approach, not $SGEN! $OMEDRT @JohnCFierce: The Intellia S-1 also includes juicy details about its pact with $NVS as well as $REGN
https://t.co/mqYbqpvBQZStopped out $REGNCrossed below 50MA with falling momentum. Where is $REGN heading next? Thoughts? https://t.co/IbABuZY9x5 #stocks https://t.co/o5xj2u0ZhT$ESPR $AMGN $REGN https://t.co/ku1lWuJD33RT @RNAiAnalyst: $NTLA Gene editing Co Intellia Rx aims to raise $80-90M for market cap of ~$600M $REGN and Novartis to invest: https://t.c‚Ä¶RT @AndyBiotech: Biotech and Pharma companies with most Medicare Part B exposure (via GS)

$REGN $AMGN $SGEN $BXLT $BIIB https://t.co/68nii‚Ä¶RT @EquitySystems: Biggest losers today large caps:
$TWTR -16.28%
$CMG -6.44%
$AAPL -6.26%
$CHRW -5.15%
$REGN -4.03%
$VRX -3.62%
$FDC -3.44‚Ä¶Biggest losers today large caps:
$TWTR -16.28%
$CMG -6.44%
$AAPL -6.26%
$CHRW -5.15%
$REGN -4.03%
$VRX -3.62%
$FDC -3.44%
$PSA -3.35%License Agreement: Regeneron Pharmaceuticals, $REGN (Sanofi, $SNY) https://t.co/xIYSAvKixLRT @AndyBiotech: Biotech and Pharma companies with most Medicare Part B exposure (via GS)

$REGN $AMGN $SGEN $BXLT $BIIB https://t.co/68nii‚Ä¶RT @AndyBiotech: Biotech and Pharma companies with most Medicare Part B exposure (via GS)

$REGN $AMGN $SGEN $BXLT $BIIB https://t.co/68nii‚Ä¶",2016-04-28,REGN,0
20,"$REGN Regeneron, unbelievably, but chart H&amp;S pattern suggests possible touch down to the $280 level. NaaahhhhStochastic Buy https://t.co/EwPk5ZbcRM $NLNK $NWBO $PARN $FTEC $LOXO $TARO $TTC $AMRS $FGEN $AXDX $REGN $CHRS $TUBE $SODA $BLCM $RENX $SGMOREGN Last Trade
See Here ---&gt; https://t.co/2AZzo3r1MO

$REGN $PNY $ESLT #invest$REGN  the bull pattern is not confirmed. A new bull pattern is detected. https://t.co/u0JXvIHf7yRT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶Top #sentiment for #SP1500 #stocks at market close: $SYY $AGN $MDT $REGN $IRM (2016/05/02) #stocktrading #predictiveanalytics #bigdataTop sentiment for SP1500 stocks at market close: $SYY $AGN $MDT $REGN $IRM (2016/05/02) #sentiment #stock #alexandriaRT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶#IPO $GWRS $REGN $EDIT $CPP https://t.co/cBp0aDIm5rRT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @tgtxdough: Praluent $REGN prescriptions were up w/w. TRx for the week was 1,460 (678 were NRx), representing a 21.1% increase in TRxPraluent $REGN prescriptions were up w/w. TRx for the week was 1,460 (678 were NRx), representing a 21.1% increase in TRxRT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @FierceBiotech: Regeneron advances its PhIII anti-NGF pain drug after a big rival bails out: https://t.co/d3kYJnCKSv $REGN $JNJ via @Joh‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶Regeneron cites success of PhIII anti-NGF pain drug after big rival bails out: https://t.co/SAZvMbWfhR $REGN via JohnCFierce story from Fi‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶Regeneron cites success of PhIII anti-NGF pain drug after big rival bails out: https://t.co/34Pum7uxEk $REGN via @JohnCFierceTop #sentiment for #SP1500 #stocks at midday: $SYY $AGN $MDT $REGN $NOC (2016/05/02) #stocktrading #predictiveanalytics #bigdataTop sentiment for SP1500 stocks at midday: $SYY $AGN $MDT $REGN $NOC (2016/05/02) #sentiment #stock #alexandria#RegeneronPharmaceuticals Regeneron Q1 Earnings: Stock Likely to Disappoint. Read more: https://t.co/IkzoCvbE5B $REGN#RegeneronPharmaceuticals Regeneron Q1 Earnings: Stock Likely to Disappoint. Read more: https://t.co/ooHATMZKvp $REGNRT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶$REGN https://t.co/RfVygK89ylRT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶Top #sentiment for #SP1500 #stocks at midday: $SYY $AGN $MDT $REGN $HON (2016/05/02) #stocktrading #predictiveanalytics #bigdataTop sentiment for SP1500 stocks at midday: $SYY $AGN $MDT $REGN $HON (2016/05/02) #sentiment #stock #alexandriaRT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @BioStocks: $REGN Announces Positive Topline Results From Phase 2/3 Fasinumab Study In Patients With Osteoarthritis PainRT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://t.co/VaEGN5sIyLRT @MagnoliaG2012: IBB Expecting A Rebound Ahead Of ASCO https://t.co/PcX7DacccS $ABBV $GILD $REGN $SNY $VRX $IBBIBB Expecting A Rebound Ahead Of ASCO https://t.co/PcX7DacccS $ABBV $GILD $REGN $SNY $VRX $IBB#RegeneronPharmaceuticals Regeneron pain drug clears late-stage trial. Read more: https://t.co/k0xt6Px21p $REGN#RegeneronPharmaceuticals Regeneron pain drug clears late-stage trial. Read more: https://t.co/EdXyfc3zE9 $REGN#RegeneronPharmaceuticals Regeneron Arthritis Pain Drug Scores In Mid-Stage Trial. Read more: https://t.co/wdxYZ5dFEl $REGN#RegeneronPharmaceuticals Regeneron Arthritis Pain Drug Scores In Mid-Stage Trial. Read more: https://t.co/BVxPDrshN3 $REGNRT SeekingAlpha: IBB Expecting A Rebound Ahead Of ASCO https://t.co/iLN6G8BN8r $ABBV $GILD $REGN $SNY $VRX $IBBIBB Expecting A Rebound Ahead Of ASCO https://t.co/yZ0553hkPw $ABBV $GILD $REGN $SNY $VRX $IBBIBB Expecting A Rebound Ahead Of ASCO https://t.co/pWcxiNyk3H $ABBV $GILD $REGN $SNY $VRX $IBBIBB Expecting A Rebound Ahead Of ASCO https://t.co/uOemJJtgnm $ABBV $GILD $REGN $SNY $VRX $IBBRT @newbieHH: $REGN @TradeIdeas1  looking to buy when it gets to $355-360 ish.. This week.. https://t.co/amJ05Old5F$REGN @TradeIdeas1  looking to buy when it gets to $355-360 ish.. This week.. https://t.co/amJ05Old5F$REGN's Pain Drug Fasinumab Meets Goals in Late Stage Study https://t.co/8u7B5zvZWK by @BioSpace#RegeneronPharmaceuticals Positive mid-stage results for Regeneron's fasinumab. Read more: https://t.co/Scspeg8gFu $REGN#RegeneronPharmaceuticals Positive mid-stage results for Regeneron's fasinumab. Read more: https://t.co/GAygeCGCuq $REGN@pfizer Rinat have been trying for a long time to beat this.  #Tanezumab  Hope $REGN has better luck.  https://t.co/uKWKOug1iyRegeneron's fasinumab successful in mid-stage study in treatment-resistant arthritis https://t.co/LIfyBueoIr $REGN#CRISPR Firm #Intellia will go public with an IPO at $16 to $18 per share $REGN $NVS https://t.co/gduthVq32G by @genomewebRT @matthewherper: I really hope these work. We need effective pain drugs. $REGN https://t.co/MrJdZABM50RT @matthewherper: I really hope these work. We need effective pain drugs. $REGN https://t.co/MrJdZABM50RT @matthewherper: I really hope these work. We need effective pain drugs. $REGN https://t.co/MrJdZABM50RT @matthewherper: I really hope these work. We need effective pain drugs. $REGN https://t.co/MrJdZABM50$REGN Fasinumab meets primary endpoint in mid-stage¬†study https://t.co/MyKIJHF4t7RT @go2sleepjj: Wow so my longs $SNY $REGN $CPXX $AMZN $EYEG $CDNL $GVSI...all killing it!Regeneron's anti-NGF for arthritis pain shows it's effective, but it still has some safety issues: https://t.co/OOTPyDTMf5 $REGN $JNJWow so my longs $SNY $REGN $CPXX $AMZN $EYEG $CDNL $GVSI...all killing it!$REGN Regeneron Announces Positive Topline Results from Phase ‚Ä¶ https://t.co/7N32iKJuxl#RegeneronPharmaceuticals Regeneron pain drug clears late-stage trial. Read more: https://t.co/eVFx1z7cKC $REGN#RegeneronPharmaceuticals Regeneron pain drug clears late-stage trial. Read more: https://t.co/1Iwf6WxAhT $REGNRT @matthewherper: I really hope these work. We need effective pain drugs. $REGN https://t.co/MrJdZABM50I really hope these work. We need effective pain drugs. $REGN https://t.co/MrJdZABM50Regeneron advances its PhIII anti-NGF pain drug after a big rival bails out: https://t.co/WSoU0jrDkX $REGN $JNJ via JohnCFierce story from‚Ä¶#RegeneronPharmaceuticals BRIEF-Regeneron drug suuceeds in study with patients with osteoar... Read more: https://t.co/pgM8KT5aCj $REGNRT @FierceBiotech: Regeneron advances its PhIII anti-NGF pain drug after a big rival bails out: https://t.co/d3kYJnCKSv $REGN $JNJ via @Joh‚Ä¶#RegeneronPharmaceuticals BRIEF-Regeneron drug suuceeds in study with patients with osteoar... Read more: https://t.co/cFplq6E5JE $REGN#RegeneronPharmaceuticals Regeneron's Fasinumab Meets Goals in Mid-Stage Osteoarthritis Pai... Read more: https://t.co/LFHyEhn4UE $REGN#RegeneronPharmaceuticals Regeneron's Fasinumab Meets Goals in Mid-Stage Osteoarthritis Pai... Read more: https://t.co/1VhGkUQI4q $REGNRegeneron advances its PhIII anti-NGF pain drug after a big rival bails out: https://t.co/d3kYJnCKSv $REGN $JNJ via @JohnCFierce#RegeneronPharmaceuticals Regeneron Announces Positive Topline Results from Phase 23 Fasinu... Read more: https://t.co/BDXvMODzKD $REGN#RegeneronPharmaceuticals Regeneron Announces Positive Topline Results from Phase 2/3 Fasin... Read more: https://t.co/SsuE83OGc5 $REGNTop #sentiment for #SP1500 #stocks at market open: $SYY $REGN $AGN $WY $IP (2016/05/02) #stocktrading #predictiveanalytics #bigdataTop sentiment for SP1500 stocks at market open: $SYY $REGN $AGN $WY $IP (2016/05/02) #sentiment #stock #alexandria#RegeneronPharmaceuticals Regeneron Reports Positive Results From Phase 2/3 Fasinumab Study. Read more: https://t.co/1J54uXMyEV $REGNWhy These Stocks Are Gapping Up Premarket https://t.co/lclkhyEvcJ  $ACAD $APOL $CANF $CYH $DO $GNC $HCHC $KMDA $ORCL $OPWR $PTX $PBMD $REGN$REGN Announces Positive Topline Results from Phase 2/3 Fasinumab Study https://t.co/XvOhobNeL7 #biotechstocks #biotech #stocks#RegeneronPharmaceuticals Regeneron Announces Positive Topline Results from Phase 23 Fasinu... Read more: https://t.co/On7X2kqBLK $REGN#RegeneronPharmaceuticals Regeneron Announces Positive Topline Results from Phase 2/3 Fasin... Read more: https://t.co/mml5NOd9M9 $REGN#RegeneronPharmaceuticals Regeneron Reports Positive Results From Phase 2/3 Fasinumab Study. Read more: https://t.co/tw6a8pTVtN $REGNBiotech‚Äôs Week Ahead: $RLYP $GWPH $REGN $EXEL
https://t.co/MyB3SR3diI$REGN: Regeneron Pharma announces 'positive' topline results from Phase 2/3 Fasinumab Study in patients with... https://t.co/PZhxDJWXqBRegeneron&amp;#39;s fasinumab successful in mid-stage study in treatment-resistant arthritis https://t.co/xe2Zg6WWWp $REGN$REGN Announces Positive Topline Results from Phase 2/3 Fasinumab Study in Patients with Osteoarthritis Pain.  https://t.co/Owmn4LCGopWhy These Stocks Are Gapping Up Premarket https://t.co/lclkhyEvcJ  $ACAD $APOL $CANF $CYH $DO $GNC $HCHC $KMDA $ORCL $OPWR $PTX $PBMD $REGN$regn https://t.co/v0uSl8fMLGWhy REGN Is UP In Premarket Trading Regeneron Pharmaceuticals, Inc. https://t.co/tF2wveSdC0 $REGN$REGN Regeneron Announces Positive Topline Results From Phase 2/3 Fasinumab Study In Patients With Osteoarthritis Pain
(Dow Jones)RT @MarketCurrents: Regeneron's fasinumab successful in mid-stage study in treatment-resistant arthritis https://t.co/j1y2fj8Rw5 #premarket‚Ä¶RT @MarketCurrents: Regeneron's fasinumab successful in mid-stage study in treatment-resistant arthritis https://t.co/j1y2fj8Rw5 #premarket‚Ä¶RT @BioStocks: $REGN Announces Positive Topline Results From Phase 2/3 Fasinumab Study In Patients With Osteoarthritis PainRegeneron's fasinumab successful in mid-stage study in treatment-resistant arthritis https://t.co/VGUgro68ZY #premarket $REGNRegeneron's fasinumab successful in mid-stage study in treatment-resistant arthritis https://t.co/SBW8jM6vJZ #premarket $REGNRegeneron's fasinumab successful in mid-stage study in treatment-resistant arthritis https://t.co/j1y2fj8Rw5 #premarket $REGNUMC Filings
See Here ---&gt; https://t.co/jFmA7fpsQL

$UMC $REGN $IBP #stockmarketRT @BioStocks: $REGN Announces Positive Topline Results From Phase 2/3 Fasinumab Study In Patients With Osteoarthritis PainRT @BioStocks: $REGN Announces Positive Topline Results From Phase 2/3 Fasinumab Study In Patients With Osteoarthritis PainRT @BioStocks: $REGN Announces Positive Topline Results From Phase 2/3 Fasinumab Study In Patients With Osteoarthritis Pain$REGN Regeneron Announces Positive Topline Results from Phase 2/3 Fasinumab Study in Patients with Osteoarthr
From our Stock News Alerts App$REGN Announces Positive Topline Results From Phase 2/3 Fasinumab Study In Patients With Osteoarthritis PainSPXC Investor Opinions
See Here ---&gt; https://t.co/rrtcp103cE

$SPXC $REGN $NVDA #stockBiotech's Week Ahead: Relypsa, GW Pharmaceuticals, Regeneron and Exelixis $REGN $EXEL $GWPH $RLYP https://t.co/e1vfhyuhAjRT @AndyBiotech: $REGN $SNY Praluent Q1 $13M vs $16M cons.

$AMGN Repatha Q1 $16M vs $27M cons.

77% prescription rejection rate at the pha‚Ä¶REGN Investor Opinions
See Here ---&gt; https://t.co/PEAcDg5LWy

$REGN $AMBA $AXP #investRegeneron Pharmaceuticals, Inc.  Reiterated Rating by Leerink Swann (Ranked 66th) to Buy $REGN #REGN https://t.co/6KTXk3W2QERT @MarketSwingPlay: Most Anticipated Earnings Releases  week of May 2 2016 $SPY $PCLN $TSLA $BABA $YELP $REGN https://t.co/9tU8mdJVWf http‚Ä¶RT @MarketSwingPlay: Most Anticipated Earnings Releases  week of May 2 2016 $SPY $PCLN $TSLA $BABA $YELP $REGN https://t.co/9tU8mdJVWf http‚Ä¶RT @MarketSwingPlay: Most Anticipated Earnings Releases  week of May 2 2016 $SPY $PCLN $TSLA $BABA $YELP $REGN https://t.co/9tU8mdJVWf http‚Ä¶Most Anticipated Earnings Releases  week of May 2 2016 $SPY $PCLN $TSLA $BABA $YELP $REGN https://t.co/9tU8mdJVWf https://t.co/aVj5EnmvvERTRX News
See Here ---&gt; https://t.co/IiAFop8keu

$RTRX $REGN $SLF #stockBiotech's Week Ahead: Relypsa, GW Pharmaceuticals, Regeneron and Exelixis $REGN $EXEL $GWPH $RLYP https://t.co/4wvlrwzR7qRT @rosnerstocks: QTMM Quantum Materials Corp. Investor Opinions
https://t.co/oWTfnL4ASs

$QTMM $XLY $BSX $REGN #QTMM #investing #tradeideasHHS Bid
See Here ---&gt; https://t.co/l4U5jjeyw0

$HHS $IPGP $REGN #investing",2016-05-02,REGN,0
21,"$sny you have 23 Million shares of $REGN. Just buy them out. https://t.co/lnfRyxR6hdNice if you were early: Regeneron returned 75 pct a year to investors for five years. https://t.co/lTuoHdx3kS @lailakearney @Reuters $REGN@jimcramer man this Regeneron seller is relentless. Maybe earnings Thursday can turn this name around. Been a rough year for $REGN.@jfdi $ILMN reports after the bell TODAY. $REGN on 5/5Short $REGN too.Martingale Asset Management L P Acquires 500 Shares of Regeneron Pharmaceuticals Inc $REGN https://t.co/EXmdu3532ORegeneron Nips At Amgen And Pfizer's Heels In Pain Drug Race https://t.co/We63nseGf0 $REGN $PFE $AMGNI‚Äôm sure $REGN, $BIIB, etc will be thrilled to know they are ‚Äúbig pharma‚Äù now.$REGN looks like a big seller still out there. Earnings come out Thursday. Could reverse this downtrend or not. Good company worth a shot.RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶Regeneron Pharmaceuticals Inc $REGN Position Cut by Axiom International Investors LLC DE https://t.co/AjFEcrQiSMRegeneron Pharmaceuticals Inc $REGN Position Cut by Axiom International Investors LLC DE https://t.co/z60yuTaV0MRT SeekingAlpha: Regeneron Nips At Amgen And Pfizer's Heels In Pain Drug Race https://t.co/soU0Gm9S5Y $REGN $PFE $AMGNRegeneron Nips At Amgen And Pfizer's Heels In Pain Drug Race https://t.co/cieSzF0kPS $REGN $PFE $AMGNRT @portefeuillefun: Bought 30 $REGN shares at $375.40. New #zzporte position. @zzlangerhansREGN Dividend
See Here ---&gt; https://t.co/RI8Mks14eN

$REGN $TERP $HGG #investingRT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @keeb119: Some of my #favourite CEOs: 
$UA $NFLX $CRM $SBUX
 $DPZ $FB $DIS $SNA $AMZN $HAIN $JPM $TMUS $RH $REGN
$BRK-A $HON $LB $WFC $M‚Ä¶Some of my #favourite CEOs: 
$UA $NFLX $CRM $SBUX
 $DPZ $FB $DIS $SNA $AMZN $HAIN $JPM $TMUS $RH $REGN
$BRK-A $HON $LB $WFC $MCD $AGN $ULTART @Suttmeier: How To Trade Biotechs $BIIB $AMGN $CELG $GILD $REGN
https://t.co/Bzi86aKo1eHow To Trade Biotechs $BIIB $AMGN $CELG $GILD $REGN
https://t.co/Bzi86aKo1eHow To Trade Biotechs $BIIB $AMGN $CELG $GILD $REGN https://t.co/NGcsEvsqTgBought 30 $REGN shares at $375.40. New #zzporte position. @zzlangerhansRT @tgtxdough: Praluent $REGN prescriptions were up w/w. TRx for the week was 1,460 (678 were NRx), representing a 21.1% increase in TRxSIGM Ask
See Here ---&gt; https://t.co/if0pSYbNi5

$SIGM $QNST $REGN #stockmarketSome of my #favourite CEOs: 
$UA $NFLX $CRM $SBUX
 $DPZ $FB $DIS $SNA $AMZN $HAIN $JPM $TMUS $RH $REGN
$BRK-A $HON $LB $WFC $MCD $AGN $ULTART SeekingAlpha: Amgen's Pipeline Makes It A Strong Buy https://t.co/SZQhiHixUw $REGN $SNY $VRX $AMGNINFO: $REGN SENTIMENT indicator (as seen by investors in News &amp; Social Media)  shows very negative perception. https://t.co/WKEc3oJf63Amgen's Pipeline Makes It A Strong Buy https://t.co/ns0D0xOhMF $REGN $SNY $VRX $AMGNAmgen's Pipeline Makes It A Strong Buy https://t.co/E5jDdAbUsD $REGN $SNY $VRX $AMGNPremarket Biotech Digest: $TNXP Completes Enrollment in Phase 3 Study, $REGN‚Äôs Fasinumab Succeeds, $PTX Soars https://t.co/Bc3ClzSLLqBiotech Trade Alerts Archive -2016-05-02-$PGNX, $MCRB, $CEMP, $PRTX, $KMDA, $NRX, $REGN, $MRNS, $PCRX, $BXLT, $BIND https://t.co/I5FMDvkrJJ#RegeneronPharmaceuticals Regeneron unveils encouraging data for osteoarthritis pain drug. Read more: https://t.co/XvSwsUIoG0 $REGN#RegeneronPharmaceuticals Regeneron unveils encouraging data for osteoarthritis pain drug. Read more: https://t.co/FlXgwgGBdI $REGN$REGN Oesteoartritis, nuevos datos favorables en el tratamiento del dolor #biotechRT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶RT @marketexclusive: Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $‚Ä¶Regeneron Pharmaceuticals has Success With Its Arthritis Pain Molecule Trial https://t.co/y4oFITaqO9 $REGN $PFE $LLY $JNJ $AMGN #fasinumabRT @MarketCurrents: Regeneron's fasinumab successful in mid-stage study in treatment-resistant arthritis https://t.co/j1y2fj8Rw5 #premarket‚Ä¶#RegeneronPharmaceuticals Regeneron's anti-NGF mAb meets Phase II/III endpoint. Read more: https://t.co/SJ0fvgPzqd $REGN#RegeneronPharmaceuticals Regeneron's anti-NGF mAb meets Phase II/III endpoint. Read more: https://t.co/aR5vmKDAQ5 $REGNRT @FierceBiotech: Regeneron cites success of PhIII anti-NGF pain drug after big rival bails out: https://t.co/34Pum7uxEk $REGN via @JohnCF‚Ä¶RT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶$REGN #anti-NGF  10K sub., P3,..is this waste of the company resource. https://t.co/M1kdclrQPzRT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶",2016-05-03,REGN,0
22,"#RegeneronPharmaceuticals Regeneron Pain Drug Clears Late-Stage Trial. Read more: https://t.co/pFAWVbGDGr $REGN#RegeneronPharmaceuticals Regeneron Pain Drug Clears Late-Stage Trial. Read more: https://t.co/arPMyDXgK1 $REGNREGN Ideas
See Here ---&gt; https://t.co/1tqQVKKXYk

$REGN $OTIC $PNY #stockRT @WrigleyTom: pm
$TSLA $TRIP $TASR $FIT $WFM
$RLYP $GDDY $HABT $WTW $QRVO
Cramer $HAIN $NOW

am
$BABA $MBLY $DDD
$MGM $GWPH $REGN https:/‚Ä¶EC Chart
See Here ---&gt; https://t.co/sAl8ruACUw

$EC $SFE $REGN #stockmarket#RegeneronPharmaceuticals Inc. Falls 2.88% for May 04. Read more: https://t.co/SQqu9Og9HI $REGN#RegeneronPharmaceuticals Inc. Falls 2.88% for May 04. Read more: https://t.co/ivOZWfiUwG $REGNWatching $REGN post-ER tomorrow.RT @scottrade: #Earnings expected Thurs: $MRK $OXY $EOG $REGN $BDX - 5 largest U.S. companies by market cap. Start your research: https://t‚Ä¶#Earnings expected Thurs: $MRK $OXY $EOG $REGN $BDX - 5 largest U.S. companies by market cap. Start your research: https://t.co/04A3u0BhMBTNDM 52Wk Low
See Here ---&gt; https://t.co/wLCIk59jP0

$TNDM $REGN $CRUS #tradeideasRT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶#Earnings Tomorrow-P24
$REGN $RGEN $RLGY $ROIAK $RPRX $RWLK $SAGE $SBH $SEAS $SFM $SNH $SNI $SNOW $SNR 
https://t.co/wkf0X8RupsRT @bigbear083: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $OXY more@ https://t.co/jVWRiII5eu https:‚Ä¶NASDAQ100 $ATVI and $REGN reporting tmrw.  #options and #earnings Trade #volatility for BigProfit #BigData #trading https://t.co/92QqdJZId0#earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $OXY more@ https://t.co/jVWRiII5eu https://t.co/S2ziJXRSMORT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶RT @WrigleyTom: pm
$TSLA $TRIP $TASR $FIT $WFM
$RLYP $GDDY $HABT $WTW $QRVO
Cramer $HAIN $NOW

am
$BABA $MBLY $DDD
$MGM $GWPH $REGN https:/‚Ä¶RT @WrigleyTom: pm
$TSLA $TRIP $TASR $FIT $WFM
$RLYP $GDDY $HABT $WTW $QRVO
Cramer $HAIN $NOW

am
$BABA $MBLY $DDD
$MGM $GWPH $REGN https:/‚Ä¶RT @WrigleyTom: pm
$TSLA $TRIP $TASR $FIT $WFM
$RLYP $GDDY $HABT $WTW $QRVO
Cramer $HAIN $NOW

am
$BABA $MBLY $DDD
$MGM $GWPH $REGN https:/‚Ä¶RT @WrigleyTom: pm
$TSLA $TRIP $TASR $FIT $WFM
$RLYP $GDDY $HABT $WTW $QRVO
Cramer $HAIN $NOW

am
$BABA $MBLY $DDD
$MGM $GWPH $REGN https:/‚Ä¶RT @WrigleyTom: pm
$TSLA $TRIP $TASR $FIT $WFM
$RLYP $GDDY $HABT $WTW $QRVO
Cramer $HAIN $NOW

am
$BABA $MBLY $DDD
$MGM $GWPH $REGN https:/‚Ä¶RT @WrigleyTom: pm
$TSLA $TRIP $TASR $FIT $WFM
$RLYP $GDDY $HABT $WTW $QRVO
Cramer $HAIN $NOW

am
$BABA $MBLY $DDD
$MGM $GWPH $REGN https:/‚Ä¶RT @WrigleyTom: pm
$TSLA $TRIP $TASR $FIT $WFM
$RLYP $GDDY $HABT $WTW $QRVO
Cramer $HAIN $NOW

am
$BABA $MBLY $DDD
$MGM $GWPH $REGN https:/‚Ä¶RT @WrigleyTom: pm
$TSLA $TRIP $TASR $FIT $WFM
$RLYP $GDDY $HABT $WTW $QRVO
Cramer $HAIN $NOW

am
$BABA $MBLY $DDD
$MGM $GWPH $REGN https:/‚Ä¶RT @WrigleyTom: pm
$TSLA $TRIP $TASR $FIT $WFM
$RLYP $GDDY $HABT $WTW $QRVO
Cramer $HAIN $NOW

am
$BABA $MBLY $DDD
$MGM $GWPH $REGN https:/‚Ä¶RT @WrigleyTom: pm
$TSLA $TRIP $TASR $FIT $WFM
$RLYP $GDDY $HABT $WTW $QRVO
Cramer $HAIN $NOW

am
$BABA $MBLY $DDD
$MGM $GWPH $REGN https:/‚Ä¶pm
$TSLA $TRIP $TASR $FIT $WFM
$RLYP $GDDY $HABT $WTW $QRVO
Cramer $HAIN $NOW

am
$BABA $MBLY $DDD
$MGM $GWPH $REGN https://t.co/rEacsFkCIv$REGN employees, who was your favorite teacher &amp; why? Share a memory or a photo &amp; we'll retweet it during #TeacherAppreciationWeek$REGN reports with ugly chart heading into earnings premarket tomorrow...  $IBBToday's Gambles (Earnings Trades)  https://t.co/KTIJyBU3aX  $TSLA $WBMD $TSO $DDD $MBLY $BABA $MCK $REGN$Regn 434 a month ago. R we having fun yet?MGM Shares
See Here ---&gt; https://t.co/Wct92PKuZR

$MGM $MPC $REGN #financeRT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶Van ECK Associates Corp Sells 7,071 Shares of Regeneron Pharmaceuticals Inc $REGN https://t.co/CbsGouVD51Into ER, some key piv\u2026 $REGN https://t.co/fSFWzBpiPRRT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶$REGN - Great fade play, Also made a great set up &amp; risk level was good. Great morning cushion made. #shortselling https://t.co/VK1AJ7TqTgRT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶RT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶#earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https://t.co/p2rvL0yrtC$REGN earnings tomorrow morning. Playing for upside via options with $SNY. Cheap premium. They own more than 20% of the company. #TradeIdeasDumped $ILMN on the gap fill for a flat trade, still short $GILD and $REGN@bradloncar $REGN's earnings tomorow. $IBB bounce or continued sell off? Big cap biotechs pretty disappointing revenues so far imo@sanofi is down over $400 Million on their $REGN investment for the year. When do they start to defend that instead of pursuing $MDVN? $sfy#InterestingWeakness

Financial
$BCS
$CS
$RBS
$MFG

BioMedical
$INCY
$AGN
$VRTX
$REGN$REGN Getting cheap.. Put on ur watch list..Brown Brothers Harriman &amp; Co. Has $1,049,000 Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/u2rSubXykABrown Brothers Harriman &amp; Co. Has $1,049,000 Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/sn9s1VMIfa$REGN oversold.  May be worth buying with December #FDA catalysts.Regeneron Pharmaceuticals hits a 1 month low https://t.co/ljMX9dmC2H $REGN #RegeneronPharmaceuticals https://t.co/LQaD2RBGlZWARNING: $REGN OPTIMISM indicator (as seen by investors in News &amp; Social Media)  is very pessimistic! https://t.co/IPpe8P99YbTop Earnings Thurs 5/5 Pre: $PGNX $PWR $RDUS $REGN $RLGY $SEAS $SFM $SNI $TDC $THS $TIME $UNT $USCR $VG $VLP $WIN $WPC $WRLD (3/3)RT @regeneron: We're holding our $REGN Q1 2016 earnings call on May 5 @ 8:30 am ET. Tune in tomorrow https://t.co/SuJvZz4Txp https://t.co/8‚Ä¶RT @regeneron: We're holding our $REGN Q1 2016 earnings call on May 5 @ 8:30 am ET. Tune in tomorrow https://t.co/SuJvZz4Txp https://t.co/8‚Ä¶We're holding our $REGN Q1 2016 earnings call on May 5 @ 8:30 am ET. Tune in tomorrow https://t.co/SuJvZz4Txp https://t.co/8WOi2IxpKYRT @tgtxdough: $REGN Regeneron ‚Äì May 4, 2016 ‚Äì Competing Roche data at ARVO: Data for Roche‚Äôs RG7716 in wet AMD will be presented at ARVO$REGN Regeneron ‚Äì May 4, 2016 ‚Äì Competing Roche data at ARVO: Data for Roche‚Äôs RG7716 in wet AMD will be presented at ARVORT @StockTwits: Earnings this week

Mon - $AIG
Tue - $PFE $S $ETSY $GRUB $CBS
Wed - $WFM $TSLA $FIT
Thu - $BABA $GPRO $FEYE $REGN

https://‚Ä¶These #Biopharma Companies Are the World's Top Shareholder Value Creators $REGN $GILD $BIIB 
https://t.co/ysSMjN0Sm3Descending TBB https://t.co/VubDWGs5W0 $GDXS $HAR $HHS $HOV $IHD $LAKE $LMCK $MLNK $MVIS $NEPT $NGE $OCN $OESX $PBMD $PERI $RDNT $REGN",2016-05-04,REGN,1
23,"Price cut: $14,000 to $5,780 per patient year $AMGN $REGN #PCSK9 $ESPR  https://t.co/7QjTEV0breRT @FiercePharma: Regeneron ups Eylea forecast after Q1 revenue beat https://t.co/gnyItVODsL $REGN #pharma by @CarlyHFierceEnter Ichimoku https://t.co/gVzcBcp0Cq $VRTX $CRUS $LVLT $ARMH $TDW $REGN $TPX $CAA $CSRA $PII $BMRN $QGEN $SALT $AKRX $EIGI $CAKE $JBHT$REGN Regeneron Raises Sales Expectations for Eylea -- Update‚Ä¶ https://t.co/QlT8maathh$REGN Correction to Regeneron Raises Sales Expectations Story‚Ä¶ https://t.co/RCQ47vHth4$REGN U.S. Hot Stocks: Hot Stocks to Watch‚Ä¶ https://t.co/JPDsF3ueXU$REGN Regeneron Raises Sales Expectations for Eylea‚Ä¶ https://t.co/hSZ8ckDcqA$REGN Regeneron Raises Sales Expectations for Eylea‚Ä¶ https://t.co/IIRPrW4zf9$REGN Quarterly Report (10-q)‚Ä¶ https://t.co/xOawXKmjJt$REGN Current Report Filing (8-k)‚Ä¶ https://t.co/AVqn8P2rTY$REGN Regeneron Reports First Quarter 2016 Financial and Opera‚Ä¶ https://t.co/3xuc220DZpRT @pjraitt: Saw pennant forming on $REGN looking heavy #Doji gave it away as a ss at 10:18  377.00 called in room. Did not take ugh 5point‚Ä¶Regeneron Pharmaceuticals's outperform rating reiterated at Robert W. Baird. $505.00 PT. https://t.co/FbI1XoS6Fo $REGN #REGNRegeneron Pharmaceuticals‚Äô $REGN Outperform Rating Reaffirmed at Robert W. Baird https://t.co/bbr3gbX8Wn#RegeneronPharmaceuticals Inc Given Average Recommendation of ""Hold"" by Brokerages. Read more: https://t.co/XvdLOVeNU2 $REGN#RegeneronPharmaceuticals Inc Given Average Recommendation of ""Hold"" by Brokerages. Read more: https://t.co/7ygP9Tsp5F $REGNRT @361Capital: The Good
$GDX+3.3%
$GREK+3.2%
$XOP+2.2%
$AMLP+1.9%
$USO+1.1%
$XLE+0.9%
$INDA+0.8%
$TLT $FM+0.7%
$EWJ+0.6%
$XLV $UUP+0.5%
$R‚Ä¶Regeneron Pharmaceuticals Inc $REGN Given Average Recommendation of ‚ÄúHold‚Äù by Brokerages https://t.co/B0EG4f8F8NThe Good
$GDX+3.3%
$GREK+3.2%
$XOP+2.2%
$AMLP+1.9%
$USO+1.1%
$XLE+0.9%
$INDA+0.8%
$TLT $FM+0.7%
$EWJ+0.6%
$XLV $UUP+0.5%
$REGN $MCK+5%#RegeneronPharmaceuticals Inc. Pops 4.74% for May 05. Read more: https://t.co/wMQNOmt4FZ $REGN#RegeneronPharmaceuticals Inc. Pops 4.74% for May 05. Read more: https://t.co/t7dCBDPQRs $REGNRegeneron Reports Fantastic First Quarter 2016 Financial and Operating Results https://t.co/eb3KV5Wt1l $REGN9 Figures That Sum Up Regeneron Pharmaceuticals' First Quarter -- $REGN The Motley Fool https://t.co/wqyMmSYXCART @bigbear083: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $OXY more@ https://t.co/jVWRiII5eu https:‚Ä¶IYR Current Price
See Here ---&gt; https://t.co/r3uZog0gjS

$IYR $REGN $SRSC #share#RegeneronPharmaceuticals Regeneron Up As Eylea Beats Views; Merck Down As Lead Drugs Slip. Read more: https://t.co/ruWLLpL8Zb $REGN#RegeneronPharmaceuticals Regeneron Up As Eylea Beats Views; Merck Down As Lead Drugs Slip. Read more: https://t.co/oYMazHoZP1 $REGNRT @SPGEarnings: $REGN beats on top and bottom lines. EPS $2.57 vs $2.55. Sales $1.2B vs $1.18B est. Global total sales of EYLEA +44% to $7‚Ä¶TSLA Filings
See Here ---&gt; https://t.co/83WbK5Aqi9

$TSLA $REGN $BLK #stockmarketTop #sentiment for #SP1500 #stocks at market close: $MDU $MLM $CBS $REGN $CHD (2016/05/05) #stocktrading #predictiveanalytics #bigdataTop sentiment for SP1500 stocks at market close: $MDU $MLM $CBS $REGN $CHD (2016/05/05) #sentiment #stock #alexandriaS&amp;P500 #Stocks Performance $TDC $APA $XEC $WFM $REGN $MCK $WMB $CHK $NFX $CXO $DISCA $JEC $SNI $SE $CB  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Performance $WFM $REGN $DISCA $ILMN $VRTX $YHOO $INCY $FAST $LMCA $NXPI $NTES $MU $ATVI  more@ https://t.co/YdSIjFJqHfRegeneron Pharmaceuticals Inc $REGN Issues Quarterly  Earnings Results https://t.co/kJE2prOGWU8 Great Stocks to Buy Now for Big Summer Gains $AMZN $GOOGL $REGN $V ... https://t.co/zTSIwNXcjm https://t.co/dqHX6ZSwWKThursday Sector Leaders: Energy, Healthcare $XEC $APA $XLE $REGN $MCK #stocks https://t.co/WIyVAprk6TAmazing Day in #AwesomeCalls Another 10 Trading Idea Laid out ALL Pre-Market Nailed $SRPT $VRX $REGN $AAWW $TSLA $FCEL $SYNC $CHK $WTW $BABART @Miljenkoz: @bradloncar $REGN Added bi-specif (REGN1979 for ALL) arm to PD-1 Lymphoma trial. https://t.co/0ySeUDWF5URT @tgtxdough: $REGN Sarilumab U.S. BLA has an FDA PDUFA date of October 30, 2016. $SNY and $REGN will file for approvals outside of the U.‚Ä¶RT @bradloncar: I didn‚Äôt hear the call but Credit Suisse highlights how $REGN will have PD-1 data at #ASCO16. And they might do a squamous‚Ä¶More Q1 earnings: Eylea generates cash for $REGN, but Praluent plodding@bradloncar $REGN Added bi-specif (REGN1979 for ALL) arm to PD-1 Lymphoma trial. https://t.co/0ySeUDWF5U#RegeneronPharmaceuticals Regeneron secures more coverage for cholesterol drug Praluent. Read more: https://t.co/DcGkWJcFq0 $REGN#RegeneronPharmaceuticals Regeneron secures more coverage for cholesterol drug Praluent. Read more: https://t.co/zaZw1exoW5 $REGN#RegeneronPharmaceuticals Regeneron secures more coverage for cholesterol drug Praluent. Read more: https://t.co/yG3XWQmrJs $REGN#RegeneronPharmaceuticals Regeneron secures more coverage for cholesterol drug Praluent. Read more: https://t.co/Ruc1E7FjEr $REGN#RegeneronPharmaceuticals Regeneron Tops Q1 Earnings, Ups 2016 Eylea View. Read more: https://t.co/RrgVRHL1FM $REGN#RegeneronPharmaceuticals Regeneron Tops Q1 Earnings, Ups 2016 Eylea View. Read more: https://t.co/f8uIqllKXZ $REGNBiotech Bear Market: Another Bad Day IBB Down 2.9% $BMY $SNY $TMO $RHHBY $IBB $ILMN $MDVN $REGN $GILD $XBI... https://t.co/dBCnwrxljFRegeneron &amp; Merck both report mixed Q1s and raise guidance, but the devil is in the details: https://t.co/MZUk6gCc4r $REGN $MRK $GILD $BMY$REGN Nice move up today. Momentum in biotechs again? https://t.co/ABDobtRnN6#RegeneronPharmaceuticals Regeneron reaping profits of eye disease treatment, 1st qtr figur... Read more: https://t.co/Gv02kgD51Q $REGN#RegeneronPharmaceuticals Regeneron reaping profits of eye disease treatment, 1st qtr figur... Read more: https://t.co/jpeW3jDF36 $REGN$REGN - it was mentioned in their press release as well. https://t.co/Z24XJk5ZfHI didn‚Äôt hear the call but Credit Suisse highlights how $REGN will have PD-1 data at #ASCO16. And they might do a squamous carcinoma pivotal#RegeneronPharmaceuticals Regeneron Gains 4% Following Q1 Earnings Release. Read more: https://t.co/MXQkTSYp36 $REGN#RegeneronPharmaceuticals Regeneron Misses on Q1 Earnings, Beats on Revenues. Read more: https://t.co/XXmL5eSclw $REGN#RegeneronPharmaceuticals Regeneron Misses on Q1 Earnings, Beats on Revenues. Read more: https://t.co/e4USetkD9z $REGN#RegeneronPharmaceuticals Regeneron Gains 4% Following Q1 Earnings Release. Read more: https://t.co/zrln2QhcwN $REGN#RegeneronPharmaceuticals Regeneron Beats on Q1 Earnings and Revenues. Read more: https://t.co/fKv4EVcQKd $REGN#RegeneronPharmaceuticals Regeneron Beats on Q1 Earnings and Revenues. Read more: https://t.co/B6EvoORFeP $REGNRegeneron ups Eylea forecast after Q1 revenue beat https://t.co/gnyItVODsL $REGN #pharma by @CarlyHFierceRegeneron Reports Q1; Why I Bought More Despite Some Challenges $REGN
https://t.co/Ffnyy522FvRegeneron secures more insurance coverage for cholesterol drug Praluent; ramp remains sluggish d... https://t.co/2bH7I7xdTA $REGN $SNY $AMGNYour Update on the Health Care SPDR ETF (XLV): The May 3 Story $ENDP $MNK $PFE $REGN https://t.co/NVfu1usjsc#RegeneronPharmaceuticals Regeneron says antiNGF fasinumab works in pain. Read more: https://t.co/2K0rLPY4yP $REGN#RegeneronPharmaceuticals Regeneron says antiNGF fasinumab works in pain. Read more: https://t.co/m1e0QVjda5 $REGNRegeneron ups Eylea forecast after Q1 revenue beat: https://t.co/gl5Ocqdv5U $REGN #pharma#FusionIQ NEW Negative Timing Signal on $REGN Today https://t.co/9ImlXz4YNa Please Retweet #Signals$REGN: Regeneron Pharma beats by $0.02, beats on revs; updates guidance https://t.co/sLIQfimFtGRegeneron secures more insurance coverage for cholesterol drug Praluent; ramp remains sluggish d... https://t.co/m3pAGe5Z0f $REGN $SNY $AMGNRegeneron secures more insurance coverage for cholesterol drug Praluent; ramp remains sluggish d... https://t.co/em2qLGaE83 $REGN $SNY $AMGNRegeneron secures more insurance coverage for cholesterol drug Praluent; ramp remains sluggish d... https://t.co/dQo9bsAuAA $REGN $SNY $AMGN$REGN  at resis.. @TradeIdeas1 https://t.co/ktcdsLgmTT$REGN extending earning gains, up over 5%S&amp;P500 #Stocks Performance $APA $SNI $NFX $DISCA $MCK $XEC $TDC $WFM $SE $REGN $SWN $RIG $EOG $WMB $ALL  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Performance $DISCA $WFM $REGN $YHOO $MU $VRTX $LMCA $FAST $NXPI $ILMN $NTES $VIAB $INCY  more@ https://t.co/YdSIjFJqHfRegeneron Phar., $REGN, is up 5.1% - https://t.co/Kf4DUbqz1m#RegeneronPharmaceuticals Regeneron Reports First Quarter 2016 Financial And Operating Resu... Read more: https://t.co/CQ7UjajB1k $REGN#RegeneronPharmaceuticals Regeneron Reports First Quarter 2016 Financial And Operating Resu... Read more: https://t.co/EH7pdbO2zB $REGNOn this Thursday morning these are my 4 best performing stocks so far $REGN $EOG $WDAY and $PYPL#RegeneronPharmaceuticals Reports Q1 EPS Beat, Revenue In Line (NASDAQ:). Read more: https://t.co/Xs4W88uxBG $REGN#RegeneronPharmaceuticals Reports Q1 EPS Beat, Revenue In Line (NASDAQ:). Read more: https://t.co/BAKZpuuWcM $REGN@JustHitTheBid for what tweet. I think I just tweeted about $TSLA  $REGN and $Z let me know my friend.@karenfinerman do you have any thoughts on the SUPER #innovative $REGN and their #pipeline??$REGN morning gap filled, can run &gt; 381  https://t.co/g6f7eRIvj3 via https://t.co/11Wpw9y7t1Saw pennant forming on $REGN looking heavy #Doji gave it away as a ss at 10:18  377.00 called in room. Did not take ugh 5pointer. #nexttrade$REGN, $RDUS, $BCRX, $MRK, $CNCE, $SNSS quarterly¬†results https://t.co/HjqNxn2TmzRT @zbiotech: $REGN is a touch frustrated, piissing and moaning about PBMs re PCSK9Post earnings trades on $TSLA  STO May 6 235/240 call credit spread $REGN STO May 345/350 put credit spread$REGN rests public fears of slowing EYELEA sales and raises expectations! Always believed in you..
https://t.co/w5PGRogSpV by @austenhufford$IBB„ÄÄ„Éê„Ç§„Ç™Ê†™ETF„ÄÅ250„Éâ„É´Ââ≤„Çä„Åù„ÅÜ„ÄÇ
$REGN„ÄÄ„É™„Ç∏„Çß„Éç„É≠„É≥„Å†„Åë„ÅåÈ†ëÂºµ„Å£„Å¶„ÇãÊÑü„Åò„ÄÇ
https://t.co/0wQfsGEuu5

ÈáëÈâ±Ê†™„Éñ„É´3ÂÄç„ÅØ100„Éâ„É´Ââ≤„Å£„Å¶„Çã„Åå„ÄÅÂÖàÂ∞éÊ†™„ÅØ‰∏äÂÄ§„ÇíÊÉ≥ÂÆö„Åô„Åπ„Åç„Åß„ÅØ„Å™„ÅÑ„Å™„ÄÇ„ÄÄ$NUGTRegeneron Pharmaceuticals: The Eyleas Have It https://t.co/Rq7vz795SO via @barronsonline $REGN $AMGN $SNY $IBB$REGN Form 8-K https://t.co/c2xF90a1PdRT @SPGEarnings: $REGN beats on top and bottom lines. EPS $2.57 vs $2.55. Sales $1.2B vs $1.18B est. Global total sales of EYLEA +44% to $7‚Ä¶$REGN beats on top and bottom lines. EPS $2.57 vs $2.55. Sales $1.2B vs $1.18B est. Global total sales of EYLEA +44% to $781MM. #biotechRT @tgtxdough: $REGN Sarilumab U.S. BLA has an FDA PDUFA date of October 30, 2016. $SNY and $REGN will file for approvals outside of the U.‚Ä¶RT @codytrades: $REGN Eylea sales bode very well for $OPHT, I'll continue rebuilding this position here in the low 40s.$REGN Eylea sales bode very well for $OPHT, I'll continue rebuilding this position here in the low 40s.$REGN $XLRN 2 bios doing very well today $IBBjim50: REGN Gapped up +8.91 $REGN Last Price 377.13 Day https://t.co/GizEds3GIR#RegeneronPharmaceuticals Regeneron Pharma Q1 Profit Surges. Read more: https://t.co/b6pJa5PIBS $REGN#RegeneronPharmaceuticals Regeneron Pharma Q1 Profit Surges. Read more: https://t.co/EIOAh1cIbI $REGN$REGN Form 8-K https://t.co/IYlRi5f4eY #biotechstocks #biotech #stocks#RegeneronPharmaceuticals Regeneron Pharma Q1 Profit Surges . Read more: https://t.co/IkbnMg44MU $REGN#RegeneronPharmaceuticals Regeneron Pharma Q1 Profit Surges . Read more: https://t.co/JJd2ReTS98 $REGNRT @Momentum_PR: The markets just opened &amp; these are the most talked about among #Investors. 
$CHK $TSLA $BABA $WTW $FCEL $LB $RTN $REGN $M‚Ä¶$REGNRT @FajaJake: $REGN carrying $IBBThe markets just opened &amp; these are the most talked about among #Investors. 
$CHK $TSLA $BABA $WTW $FCEL $LB $RTN $REGN $MBLY $WFMPre-Market Gainers as of 9:10am: Gainers: $MEET +7% $SDRL 7% $CLR 6% $SGYP 6% $OAS 5% $REGN 5% $BABA 5%  $AUY 5%$REGN carrying $IBB#RegeneronPharmaceuticals Announces 13% Decline In Q1 Bottom Line. Read more: https://t.co/CWVclulS8T $REGN#RegeneronPharmaceuticals Announces 13% Decline In Q1 Bottom Line. Read more: https://t.co/vrJqEELJxg $REGN#RegeneronPharmaceuticals REGENERON PHARMACEUTICALS INC - 10-Q - MANAGEMENT'S DISCUSSION AN... Read more: https://t.co/Lg0gile9Od $REGN#RegeneronPharmaceuticals REGENERON PHARMACEUTICALS INC - 10-Q - MANAGEMENT'S DISCUSSION AN... Read more: https://t.co/jxOmXUuEwc $REGNRT @RobInTheBlack: #Mindthegap $SYNC $TCAP $RRTS $FIT $ABC $LB $PSXP $COST $BABA $TSLA $QRVO $KHC $FRSH $WTW $REGN$REGN mgmt complaining over Part B CMS proposed change but its highly likely to go into effect.#RegeneronPharmaceuticals REGENERON PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS ... Read more: https://t.co/bywiATF1J2 $REGN#RegeneronPharmaceuticals REGENERON PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS ... Read more: https://t.co/KortNXn5az $REGNIn Play Longs: $BABA $DDD $DVN $ETSY $FCEL $KNC $REGN $TASR $WBMD $WLL $WTW $YHOORT @bigbear083: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $OXY more@ https://t.co/jVWRiII5eu https:‚Ä¶RT @bigbear083: Most actives PreMarket: $CHK $TSLA $BABA $FCEL $WTW $LB $REGN $MLBY $KHC $SCTY $SPX &amp; more @ https://t.co/jVWRiII5eu https:‚Ä¶RT @zbiotech: $REGN is a touch frustrated, piissing and moaning about PBMs re PCSK9#earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $OXY more@ https://t.co/jVWRiII5eu https://t.co/ppgta51KGqMost actives PreMarket: $CHK $TSLA $BABA $FCEL $WTW $LB $REGN $MLBY $KHC $SCTY $SPX &amp; more @ https://t.co/jVWRiII5eu https://t.co/c7oQhn1wqK$REGN reported 38% YoY revenue growth and a 118% in net income. #growthstocks #Eylea@DewDiligence @zbiotech maybe they can buy Phildor? :) $REGN#Mindthegap $SYNC $TCAP $RRTS $FIT $ABC $LB $PSXP $COST $BABA $TSLA $QRVO $KHC $FRSH $WTW $REGNRT @OpenOutcrier: $REGN (+4.8% pre) Regeneron beats revenue estimates, raises Eylea sales forecast 

https://t.co/TgayNSA2K0#RegeneronPharmaceuticals Regeneron Reports First Quarter 2016 Financial and Operating Resu... Read more: https://t.co/tQuHklUqHA $REGN#RegeneronPharmaceuticals Regeneron Reports First Quarter 2016 Financial and Operating Resu... Read more: https://t.co/Zq7kSgdXzX $REGN$REGN Sarilumab U.S. BLA has an FDA PDUFA date of October 30, 2016. $SNY and $REGN will file for approvals outside of the U.S. later in 2016$REGN like you get picked on a lot, maybe a small peeepeeee? Whatever it is its digging at ya.$REGN (+4.8% pre) Regeneron beats revenue estimates, raises Eylea sales forecast 

https://t.co/TgayNSA2K0Regeneron $REGN beats on earnings &amp; revenues, raises sales forecast for Eyelea. 1st Q profit more than doubles.  https://t.co/t0xOQHXhetLongs: $REGN, $TSLA, $BABA, $AMZN, $KHC, $WTW, $YHOO, $FCEL, $WBMD, $CHK, $LGCY! Shorts: $ABC, $LB, $PSXP, $FIT, $CTL, $SEAS, ADC, MBLY, WFTRT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶Popular: $CHK, $FCEL, $WTW, $REGN, $MBLY, $T.CA, $TU, $DISCA, $UWTI, $WIN, $WFT, $EPE, $PM, $K, $GNCA, $LXRX, $DWTI, $AMCX, $ANIP, $USO@zbiotech $REGN has financial muscle 2buy a PBM co, LOL.$REGN warns on call that Eylea sales will be pressured if CMS Part B proposal goes through$REGN is a touch frustrated, piissing and moaning about PBMs re PCSK9#RegeneronPharmaceuticals Why Analysts See $5 Billion Revenue Potential For Sanofi SA (ADR)... Read more: https://t.co/9tb2A553cW $REGN#RegeneronPharmaceuticals Why Analysts See $5 Billion Revenue Potential For Sanofi SA (ADR)... Read more: https://t.co/HNtKUQKi1j $REGNa % or so here or there seems like shud b irrelevant re eylea growth, esp given competitive landscape and reimbursement impacts ahead $REGNWatch Idea - Gappers: $TSLA $YHOO $REGN $BABA $WTW $TASR $COST $FIT $RRTS $TRIP #stocks #trading #options  -rRegeneron Q1 top line up 38%, EPS up 120%; Praluent sales $13M; shares up 4% premarket https://t.co/lcONGiLJGr $REGN$REGN up in pre  fits the big bio bounce thesis I have been looking forMorning Movers: Regeneron Gains on Earnings; Chesapeake Energy Flies https://t.co/Mnh6WTMT5b @barronsonline $CHK $KHC $REGN $RIG $WTWanti-NGF move fwd simply a bad move given safety issues $REGN12 Stocks Moving In Thursday's #PreMarket Session $AVP $BABA $COST $SYNC $LGCY $ZNGA $KHC $REGN $TSLA $FIT $LB $TRIP https://t.co/XF4vHweACkRT @bradloncar: Q1 eylea sales of $781M compares to $768M consensus. Plus a guidance increase to boot. $REGN https://t.co/GjHl3Isrgj#RegeneronPharmaceuticals Inc Issues Quarterly  Earnings Results. Read more: https://t.co/6ABdzh7CvE $REGN#RegeneronPharmaceuticals Inc Issues Quarterly  Earnings Results. Read more: https://t.co/nrAczW2Is6 $REGNLIVE NOW: $REGN said in full-year 2016 it expects EYLEA US net product sales to be up 20-25% over 2015. https://t.co/fY1vPG63s1$REGN Misses Q1 EPS by 1c; Reaffirms https://t.co/21Jhqp8mnZNotable companies reporting #earnings today - $BABA $MRK $EOG $REGN $ATVI $MSI $MBLY $NWS $HLF &amp; more https://t.co/byCSYAaMzC via ScutifyNotable companies reporting #earnings today $BABA $MRK $EOG $REGN $ATVI $MSI $MBLY $NWS $HLF https://t.co/0y8B0170wd https://t.co/rmatzKfzaD#RegeneronPharmaceuticals Bayer AG (ADR)(OTCMKTS:BAYRY) putting $130 million bet on Regener... Read more: https://t.co/w3rABMU86d $REGN#RegeneronPharmaceuticals Bayer AG (ADR)(OTCMKTS:BAYRY) putting $130 million bet on Regener... Read more: https://t.co/YvTNhr3Da3 $REGNRT @bradloncar: Q1 eylea sales of $781M compares to $768M consensus. Plus a guidance increase to boot. $REGN https://t.co/GjHl3Isrgj$REGN Q1 2016 Earnings Release is now available #earnings https://t.co/Cvw83xXj1ZSharing our earnings today at 8:30am ET. Listen in: https://t.co/H11stMOuyq $REGNRT @BioStocks: $REGN raises FY'16 Eylea sales growth view to 20%-25% from 20%#RegeneronPharmaceuticals REGENERON PHARMACEUTICALS INC : Results of Operations and Financi... Read more: https://t.co/LddvFQzTPT $REGN#RegeneronPharmaceuticals REGENERON PHARMACEUTICALS INC : Results of Operations and Financi... Read more: https://t.co/zV6g9mjzMF $REGNRT @bradloncar: Q1 eylea sales of $781M compares to $768M consensus. Plus a guidance increase to boot. $REGN https://t.co/GjHl3Isrgj$regn regeneron beats on top and bottom. Look for rebound in is price.    Ibb hopefully holds at critical level and reboundsQ1 eylea sales of $781M compares to $768M consensus. Plus a guidance increase to boot. $REGN https://t.co/GjHl3IsrgjRegeneron Reports First Quarter 2016 Financial and Operating Results #pharma #biotech $REGN https://t.co/Hm2wJDaUpo https://t.co/KbdUhpIxye$REGN:

New SEC Filing for REGN: Form 8-K (No. 0001532176-16-000053):

https://t.co/pB8MkkK2Ss https://t.co/eFcMp6PEJNRT @MarketCurrents: Regeneron Q1 top line up 38%, EPS up 120%; Praluent sales $13M; shares up 4% premarket https://t.co/ve3CRmkA8L #premark‚Ä¶Biotech Bear Market: Another Bad Day IBB Down 2.9% $BMY $SNY $TMO $RHHBY $IBB $ILMN $MDVN $REGN $GILD $XBI... https://t.co/vAxiLRP2o3RT @Lin_ling_88: $REGN Reports First Quarter 2016 Financial and Operating Results - #Profit Doubled  https://t.co/0FQ2PZcPR6RT @BentheFidler: East Coast #Biotech Roundup: Homology, Biogen, Intellia &amp; More https://t.co/bHUquqjy7d $BIIB $NTLA $ALNY $FMI $BIND $REGNRT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶$REGN 
https://t.co/kBJJBelxOM
#pharma #biotechRegeneron Q1 top line up 38%, EPS up 120%; Praluent sales $13M; shares up 4% premarket https://t.co/5a9YujFYh3 #premarket $REGNRegeneron Q1 top line up 38%, EPS up 120%; Praluent sales $13M; shares up 4% premarket https://t.co/mWZJlDwZwc #premarket $REGNRegeneron Q1 top line up 38%, EPS up 120%; Praluent sales $13M; shares up 4% premarket https://t.co/0GUZtbKwdT #premarket $REGNRegeneron Q1 top line up 38%, EPS up 120%; Praluent sales $13M; shares up 4% premarket https://t.co/ve3CRmkA8L #premarket $REGN$REGN reported an increase in 1Q16 results. Net income was $166MM or or $1.45 per share https://t.co/rcXGEwCrdj https://t.co/IEFNKfNvN1$REGN New SEC Document(s) for Regeneron Pharmaceuticals, Inc.
From our Stock News Alerts AppRT @Lin_ling_88: $REGN Reports First Quarter 2016 Financial and Operating Results - #Profit Doubled  https://t.co/0FQ2PZcPR6$REGN Reports First Quarter 2016 Financial and Operating Results - #Profit Doubled  https://t.co/0FQ2PZcPR6$REGN .75% weighting $QQQ $NDX $NQ_F  https://t.co/weuMOhkPPL$REGN +2.6% should cushion IBB/$NQ#RegeneronPharmaceuticals Sanofi SA (ADR)(NYSE:SNY), Regeneron post remarkable Praluent Pha... Read more: https://t.co/g1xhCuDzRt $REGN#RegeneronPharmaceuticals Sanofi SA (ADR)(NYSE:SNY), Regeneron post remarkable Praluent Pha... Read more: https://t.co/ETOQuLkPwi $REGNSanofi SA (ADR)(NYSE:SNY) And #RegeneronPharmaceuticals Inc Battles Out With Amgen, Inc.(NA... Read more: https://t.co/LqSKgakYqo $REGNSanofi SA (ADR)(NYSE:SNY) And #RegeneronPharmaceuticals Inc Battles Out With Amgen, Inc.(NA... Read more: https://t.co/4sZmC5b4Sz $REGN#RegeneronPharmaceuticals, Inc. (NASDAQ:), Sanofi SA (ADR) (NYSE:SNY) Releases Positve Sari... Read more: https://t.co/fR3B7heSED $REGN#RegeneronPharmaceuticals, Inc. (NASDAQ:), Sanofi SA (ADR) (NYSE:SNY) Releases Positve Sari... Read more: https://t.co/WdkQcvTyL5 $REGNEast Coast #Biotech Roundup: Homology, Biogen, Intellia &amp; More https://t.co/bHUquqjy7d $BIIB $NTLA $ALNY $FMI $BIND $REGN$REGN beatsUnicorn Bay rating for $REGN is 2.69 out of 5. https://t.co/ztJMzVmErJRT @BioStocks: $REGN Q1 EYLEA global net sales $1.20B.RT @BioStocks: $REGN raises FY'16 Eylea sales growth view to 20%-25% from 20%RT @BioStocks: $REGN raises FY'16 Eylea sales growth view to 20%-25% from 20%This morning's winner for $REGN is Analyst_6884290 who beats 46 other analysts and the Wall Street Consensus - https://t.co/fYZ4OVu0Yo$REGN misses the Estimize EPS Consensus by 1c and beats the Estimize Revenue Consensus by $13.99M - https://t.co/LfPJZN25AR$REGN reports FQ1 earnings of $2.57 EPS and $1.20B Revs - https://t.co/6qYo6U6aVxRT @BioStocks: $REGN raises FY'16 Eylea sales growth view to 20%-25% from 20%RT @biotechnova: $REGN $2.57 vs $2.58 and $1.2 billion rev. vs $1.18 billionRT @BioStocks: $REGN Q1 EYLEA global net sales $1.20B.RT @BioStocks: $REGN raises FY'16 Eylea sales growth view to 20%-25% from 20%$REGN $2.57 vs $2.58 and $1.2 billion rev. vs $1.18 billionRT @MarketCurrents: Regeneron Pharmaceuticals misses by $0.01, beats on revenue https://t.co/FquP65NCYL #premarket $REGNRT @BioStocks: $REGN Q1 EYLEA global net sales $1.20B.RT @BioStocks: $REGN Q1 EYLEA global net sales $1.20B.RT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶$REGN raises FY'16 Eylea sales growth view to 20%-25% from 20%RT @1ResilientSoul: Earnings scheduled today:
$BABA $K $MRK $ABC $GPRO $MGM $ATVI $WYNN $BDX $ATVI $REGN $CHK $JEC &amp; many more..‚úçüèºüòèüìÉ https:‚Ä¶RT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶$REGN Q1 EYLEA global net sales $1.20B.$REGN Regeneron Reports First Quarter 2016 Financial and Operating Results
From our Stock News Alerts AppRegeneron Pharmaceuticals misses by $0.01, beats on revenue https://t.co/9INcaIPzzp #premarket $REGNRegeneron Pharmaceuticals misses by $0.01, beats on revenue https://t.co/DoWqm5d0Kx #premarket $REGNRegeneron Pharmaceuticals misses by $0.01, beats on revenue https://t.co/FquP65NCYL #premarket $REGNRT @1ResilientSoul: Earnings scheduled today:
$BABA $K $MRK $ABC $GPRO $MGM $ATVI $WYNN $BDX $ATVI $REGN $CHK $JEC &amp; many more..‚úçüèºüòèüìÉ https:‚Ä¶RT @1ResilientSoul: Earnings scheduled today:
$BABA $K $MRK $ABC $GPRO $MGM $ATVI $WYNN $BDX $ATVI $REGN $CHK $JEC &amp; many more..‚úçüèºüòèüìÉ https:‚Ä¶Do you know that #WallStreet price for $REGN is $475.95 https://t.co/DAg0b95jpjEarnings scheduled today:
$BABA $K $MRK $ABC $GPRO $MGM $ATVI $WYNN $BDX $ATVI $REGN $CHK $JEC &amp; many more..‚úçüèºüòèüìÉ https://t.co/Szciryakbi#Update US Earnings Release for today: $BABA $MRK $OXY $REGN $BDX $CNQ $MFC $K $EOG $ATVI $ED $FISV $CERN $EC $MHK $MSIBiotech Bear Market: Another Bad Day IBB Down 2.9% $BMY $SNY $TMO $RHHBY $IBB $ILMN $MDVN $REGN $GILD $XBI... https://t.co/dBCnwrfJV5RT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶Earnings-Reaction to Watch on Thursday $MRK, $CHK, $APA, $REGN, $K, $AVP, $SEAS, $MBLY, $ABC, $THS, $SNI, $DDD, $SBH https://t.co/XtK6g8HEdvRT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶RT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶",2016-05-05,REGN,0
24,"Nasdaq100 #Stocks Performance $BMRN $CERN $INCY $VRTX $MYL $BIIB $CELG $DISH $ROST $ALXN $TRIP $REGN $COST  more@ https://t.co/YdSIjFJqHf#LargeCap #Biopharmaceuticals Q1 Metrics: #Earnings Show Limited Growth Prospects $BMY $R $RHHBY $IBB $REGN $AMGN... https://t.co/HhxFX4cBdfNasdaq100 #Stocks Performance $INCY $BMRN $VRTX $MYL $BIIB $CERN $ALXN $CELG $REGN $TRIP $ROST $DISH $AMGN  more@ https://t.co/YdSIjFJqHfRT @paulwoll: $REGN tomorrow see if &gt; 380-381.75 for a play to 390s...$REGN tomorrow see if &gt; 380-381.75 for a play to 390s...RT @BosBizDon: Gene editing firm Intellia $NTLA raises $163M in largest biotech IPO of 2016 $NVS $REGN $ALNY $EDIT https://t.co/vwcST0gGQmSJR Prev Close
See Here ---&gt; https://t.co/kHodfTZEkL

$SJR $KKD $REGN #financeBest performing sector today Healthcare and its names $AGN $MNK $REGN $PRGO https://t.co/iC7lxcHHSa https://t.co/UNuoyabW5MU.K. cost agency recommends new PCSK9 drugs, but only after further discounts  https://t.co/EzATxr9rwy $AMGN $SNy $REGN$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/XNX2HmPtmbRT @VailshireCap: $GILD gets the most attention, but the management, pipeline &amp; vision of both $CELG and $REGN make them best buys for the‚Ä¶RT @paulwoll: $REGN good bounce past earnings now... keep an eye.. for more.  390 looks good for 1st target.S&amp;P500 #Stocks Performance $AGN $MNK $HCP $CMG $CERN $KR $PRGO $HRL $REGN $TRIP $JWN $MYL $ABC $MCK $CAH  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Performance $CERN $REGN $TRIP $MYL $BMRN $DISH $VRTX $GILD $BIIB $ALXN $CELG $AMGN $COST  more@ https://t.co/YdSIjFJqHfBIOS PHarmas look strong today $LABU $REGN#LargeCap #Biopharmaceuticals Q1 Metrics: #Earnings Show Limited Growth Prospects $BMY $R $RHHBY $IBB $REGN $AMGN... https://t.co/8ixv4fdMhb$IBB bullish reversal candles on 60 min &amp; daily charts. now see if it can hold. $AMGN $BIIB $CELG $GILD $REGN $ALXN https://t.co/XEUx9LBY2QStill in $Biib. $regn wakingAGIO Company Info
See Here ---&gt; https://t.co/AnD0wHcHwR

$AGIO $REGN $MAR #stocks$REGN good bounce past earnings now... keep an eye.. for more.  390 looks good for 1st target.$REGN @ 8EMA  https://t.co/Hm2rX8I1WJ via https://t.co/11Wpw9y7t1$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/RNnaSg1m44REGN Last Trade
See Here ---&gt; https://t.co/2g6YLuy2rG

$REGN $CBSH $CCI #tradeideasJefferies Group LLC Takes Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/zvCRENCFUOTune in tomorrow @ 11am ET to hear our $REGN webcast @BankofAmerica Healthcare Conference https://t.co/W3rGcQa0aTbiotechs looking to come out hot  $ARNA $INO $HZNP $REGN $DEPO $ACAD $GEVO$GILD gets the most attention, but the management, pipeline &amp; vision of both $CELG and $REGN make them best buys for the foreseeable future.$REGN - Regeneron Pharmaceuticals Inc #REGN Given ""Hold"" Rating at Canaccord Genuity https://t.co/qOa8Jmr0BC$REGN - Regeneron Pharmaceuticals Inc #REGN Given ""Hold"" Rating at Canaccord Genuity https://t.co/IlGGpwEeYU$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/v8NXzrWN5P105.5% earnings üå±growthüå± in 3 years.. What‚Äôs your opinion? Regeneron Pharmaceuticals $REGN https://t.co/G3pECmhfYL https://t.co/MbG0E3i7EJRVP Last Price
See Here ---&gt; https://t.co/2AydVCNJd8

$RVP $GRNH $REGN #nasdaq#LargeCap #Biopharmaceuticals Q1 Metrics: #Earnings Show Limited Growth Prospects $BMY $R $RHHBY $IBB $REGN $AMGN... https://t.co/HhxFX4cBdfRT @bradloncar: I didn‚Äôt hear the call but Credit Suisse highlights how $REGN will have PD-1 data at #ASCO16. And they might do a squamous‚Ä¶RT @IBD_Areeves: Regeneron's anti-NGF for arthritis pain shows it's effective, but it still has some safety issues: https://t.co/OOTPyDTMf5‚Ä¶CONE Quotes
See Here ---&gt; https://t.co/LvWdXBUb3k

$CONE $REGN $MYRG #shareRT @eWhispers: #earnings before open $BABA $CHK $DDD $REGN $MBLY $MRK $MGM $GWPH $SFM $CLMT $PTX $PGNX $OXY https://t.co/lObOE0uRjZ https:/‚Ä¶$REGN https://t.co/fs74Wav3fh",2016-05-09,REGN,1
25,"Enter Ichimoku https://t.co/NBzoD4Iaos $SBUX $CIG $KOS $DRII $AME $SYT $ASHR $AGU $CZR $HDP $DRRX $MEOH $COWN $VSTO $CERS $REGN $TEAMNasdaq100 #Stocks Performance $TRIP $BMRN $WDC $AKAM $AMZN $NTES $PCAR $REGN $NFLX $CTXS $AAL $TMUS $MU  more@ https://t.co/YdSIjFJqHf$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/vVwW0LSpcHNasdaq100 #Stocks Performance $TRIP $WDC $NTES $AKAM $BMRN $AMZN $PCAR $ENDP $TMUS $AAL $REGN $MU $CTXS  more@ https://t.co/YdSIjFJqHf@paulwoll $regn nice call. Where you see this heading over the next month?RT @newbieHH: $REGN @TradeIdeas1 I forgot about this.. Damn.. https://t.co/MmhMxV5IW1Impressive turnaround day $IBB
w/some red2green

Top 10 holdings, 9/10 nHod
$AMGN $BIIB $CELG $GILD
$REGN $ALXN $VRTX $ILMN $BMRN

$MYL flatRT @newbieHH: $REGN @TradeIdeas1 I forgot about this.. Damn.. https://t.co/MmhMxV5IW1$REGN @TradeIdeas1 I forgot about this.. Damn.. https://t.co/MmhMxV5IW1Regeneron Pharmaceuticals downgraded by Zacks Investment Research to sell. https://t.co/qUrQO35gEL $REGN #REGNRegeneron Pharmaceuticals downgraded by Zacks Investment Research to sell. https://t.co/CDceWpVWJ5 $REGN #REGN$REGN 1-hr coming out of base  https://t.co/6yZNwI5qdN via https://t.co/11Wpw9y7t1Robert W. Baird Reaffirms Outperform Rating for Regeneron Pharmaceuticals Inc $REGN https://t.co/EmIZtxH1PiRegeneron Pharmaceuticals Inc $REGN Stock Rating Reaffirmed by Canaccord Genuity https://t.co/5k5Y9AL7MWRegeneron Pharmaceuticals Inc $REGN Stock Rating Reaffirmed by Canaccord Genuity https://t.co/KLwIZ7ERAQRegeneron Pharmaceuticals Inc $REGN Stock Rating Reaffirmed by Canaccord Genuity https://t.co/RsbPZguI3JRegeneron Pharmaceuticals Inc $REGN Stock Rating Reaffirmed by Canaccord Genuity https://t.co/ACCWjNxWz9RT @shaneblackmon: $NTLA insiders bought 42% of this IPO and $REGN took down another $50m in a separate deal https://t.co/IL16gCXxBI$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/bqja0PGXe0$SPY names with the greatest decrease in momentum las 30 days $GOOGL $AGN $CMG $PRGO $UA $SRCL $PSA $REGN $APPL https://t.co/Bswii0HlDhRT @shaneblackmon: $NTLA insiders bought 42% of this IPO and $REGN took down another $50m in a separate deal https://t.co/IL16gCXxBIRT @shaneblackmon: $NTLA insiders bought 42% of this IPO and $REGN took down another $50m in a separate deal https://t.co/IL16gCXxBI$NTLA insiders bought 42% of this IPO and $REGN took down another $50m in a separate deal https://t.co/IL16gCXxBIRT @TalkMarkets: #LargeCap #Biopharmaceuticals Q1 Metrics: #Earnings Show Limited Growth Prospects $BMY $R $RHHBY $IBB $REGN $AMGN... https‚Ä¶REGN 52Wk Low
See Here ---&gt; https://t.co/1p0uBm5Git

$REGN $CDZI $COL #share$REGN still undervalued, should be at least trading at 100DMA = 420+yes, this is a bearish consolidation, but I like $REGN as long as it's above $355. below that, not so much. https://t.co/Or8CKAOcN7Regeneron Pharmaceuticals Inc $REGN Shares Bought by Cubist Systematic Strategies LLC https://t.co/wAB8YIicX4QS Investors LLC Has $15,050,000 Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/JqX3FkGcwTHELE Last Price
See Here ---&gt; https://t.co/hHoM3Se7TD

$HELE $ECOL $REGN #investingRegeneron Pharmaceuticals Inc $REGN Stake Reduced by Deutsche Bank AG https://t.co/xBYOrUnUfXRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfpRT @MikeF_trading: $IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfp$IBB breaking... giving a chance to those who missed it!

$GILD $AMGN $REGN https://t.co/EV4wwKWTfp",2016-05-10,REGN,0
26,"$REGN Health Insurers Push to Tie Drug Prices to Outcomes--Upd‚Ä¶ https://t.co/plMLI5NWTRCommerce Bank Purchases 93 Shares of Regeneron Pharmaceuticals Inc $REGN https://t.co/qD1sY9VMIY$REGN Health Insurers Push to Tie Drug Prices to Outcomes‚Ä¶ https://t.co/4l6nZRrprNCharts of Interest - $IBB $CELG $REGN $ILMN $GILD https://t.co/8op6DlveWVBelow Ichimoku https://t.co/XODG9FntZu $TERP $AN $TLRD $ALXN $IBB $DAN $SHOO $GMED $PLUG $ASHR $CCP $CERS $LAZ $BAH $REGN $QGEN $RARE$REGN may go down 5% if the bear pattern is confirmed. Chk confirmation [75%] @ https://t.co/u0JXvIHf7y. Short level:371.8600.$REGN:

New SEC Filing for REGN: Form SC 13G (No. 0001104659-16-120084):

https://t.co/U4dPQUgLQW https://t.co/XkqMziedDNRT @newbieHH: $REGN @TradeIdeas1 https://t.co/aHmY0GAAZJ$REGN @TradeIdeas1 https://t.co/aHmY0GAAZJRegeneron Pharmaceuticals Inc $REGN Receives ‚ÄúOutperform‚Äù Rating from Robert W. Baird https://t.co/SXJ9vQYtHnCigna will pay makers of two new, pricey cholesterol drugs based on how well patients respond https://t.co/Ba32hLWDdj $REGN $AMGN#RegeneronPharmaceuticals Cigna inks outcome-based payment contracts with makers of Praluen... Read more: https://t.co/axACoyrGoO $REGN#RegeneronPharmaceuticals Cigna inks outcome-based payment contracts with makers of Praluen... Read more: https://t.co/bz80R6sj86 $REGNRT @regeneron: $REGN and @sanofigenzyme to present pivotal phase 2b data in adults with uncontrolled persistent asthma at #ATS2016 https://‚Ä¶RT @regeneron: $REGN and @sanofigenzyme to present pivotal phase 2b data in adults with uncontrolled persistent asthma at #ATS2016 https://‚Ä¶$REGN and @sanofigenzyme to present pivotal phase 2b data in adults with uncontrolled persistent asthma at #ATS2016 https://t.co/ivFc0UGHt2RT @BMTArmando: $CI Cigna announces coverage deals with both $AMGN Amgen and $REGN Regeneron for their PCSK9 inhibitors https://t.co/Ly77ek‚Ä¶$CI Cigna announces coverage deals with both $AMGN Amgen and $REGN Regeneron for their PCSK9 inhibitors https://t.co/Ly77ekV87r$IONS Kynamro reduces cardiovascular events in HoFH #cardiology #biotech #ASO $IBB $AEGR $AMGN $REGN $SNY $MRK https://t.co/zcL3Es454IXLV Gains May 10, Trades above Its 20-Day Moving Average $AGN $CNC $REGN $XLV https://t.co/ILO9UUnUdHCigna makes deals with Amgen, Sanofi for pricey cholesterol drugs https://t.co/fdU3JNcgDI via @CarolineHumer $AMGN $SASY $REGN$REGN completing the 1st target (premarket I mentioned other day).RT @fwpharma: US health insurer Cigna reaches value-based contracts for PCSK9 inhibitors Repatha, Praluent https://t.co/3kLplutGDe $AMGN $S‚Ä¶RT @fwpharma: US health insurer Cigna reaches value-based contracts for PCSK9 inhibitors Repatha, Praluent https://t.co/3kLplutGDe $AMGN $S‚Ä¶RT @fwpharma: US health insurer Cigna reaches value-based contracts for PCSK9 inhibitors Repatha, Praluent https://t.co/3kLplutGDe $AMGN $S‚Ä¶Cigna inks value-based contracts with Amgen and Sanofi/Regeneron for high-priced ... https://t.co/C8T1RSBtqc #premarket $CI $AMGN $SNY $REGNCigna inks value-based contracts with Amgen and Sanofi/Regeneron for high-priced ... https://t.co/eUnzXmwauD #premarket $CI $AMGN $SNY $REGNCigna inks value-based contracts with Amgen and Sanofi/Regeneron for high-priced ... https://t.co/YVYeAzM5Ou #premarket $CI $AMGN $SNY $REGNUS health insurer Cigna reaches value-based contracts for PCSK9 inhibitors Repatha, Praluent https://t.co/3kLplutGDe $AMGN $SNY $REGN$CI targetting discounts for PCSK9 drugs $AMGN $SNY $REGN https://t.co/vZ9Lbzy7rQPharmalot.. Pharmalittle.. Good Morning.. sunshine, coffee &amp; headlines.. https://t.co/GIr7gTjyae #pharma $AMGN $SNY $REGN $MDVN #NIH #FDARock Springs Capital Management LP Holds Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/45RVEQROdARegeneron Pharmaceuticals Inc $REGN Position Boosted by Northwestern Mutual Investment Management Company LLC https://t.co/EUOzXSfF6g@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/mMiqzR3mnBXRM News
See Here ---&gt; https://t.co/4fO30ynFNN

$XRM $REGN $CACQ #nasdaqFIL Ltd Maintains Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/UzyW4vFjnY",2016-05-11,REGN,0
27,"@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/LS5cm9bqrSREGN Shares
See Here ---&gt; https://t.co/iiAeaw6RkI

$REGN $TWC $ENV #share$REGN the bear pattern is confirmed &amp; a SHORT signal is issued @ https://t.co/u0JXvIHf7y. Short Level: 371.4700  Target: 352.8965@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/N0Dr5FEN61$REGN Regeneron CEO says drug price critique by independent group unscientific https://t.co/T0jUy0EN1X via @YahooFinanceOHRP Last Price
See Here ---&gt; https://t.co/G7wLtc8Me8

$OHRP $REGN $NGCG #stocksYancopoulos @regeneron: Merck was great when run by scientist; same with Genentech; now $REGN. Scientists running company matters.Yancopoulos @regeneron: price $REGN up and down for 15 yrs‚Ä¶overnight success started in 1991. Homegrown pipeline. 4 meds approved.Yancopoulos @regeneron says $REGN invents 50/50 deal‚Ä¶being the company that brought drugs to market‚Ä¶brought in co-partners. $Amgn was first.Biotechs Enter Pocket of Turbulence. https://t.co/bwiuA59c65
$gild $incy $regn $vrtx $celg $regn $mdvn $nbix $jazz $juno #biotech #stocksCigna signs value-based pricing deals with $AMGN, $SNY for PCSK9 drugs https://t.co/XNOsx7FY42 $REGNRT @BentheFidler: East Coast #Biotech Roundup: NY Bio, Gender Gap, Zafgen, PureTech &amp; More https://t.co/YqmiQzH0A5 $BIIB $REGN $AEGR $ZFGN‚Ä¶Noteworthy Thursday Option Activity: $FDX  $REGN  $RIG #stockoptions https://t.co/SXqb3i3i5KRT @Taarriqq: $XLV FAILED AT DAY TOP RESISTANCE, WHOLE SECTOR DOWN $XBI $LABU $BIIB $REGN$XLV FAILED AT DAY TOP RESISTANCE, WHOLE SECTOR DOWN $XBI $LABU $BIIB $REGNRT SeekingAlpha: Large-Cap Stocks Primed For Big Returns https://t.co/Z8FBxV1OtS $AAPL #APPLE $CELG $CMG $CTSH $GILD $MRK $PCLN $REGN $TRI‚Ä¶RT @SA_Portfolio: Large-Cap Stocks Primed For Big Returns https://t.co/M2XA8LU6B9 $AAPL #APPLE $CELG $CMG $CTSH $GILD $MRK $PCLN $REGN $TRI‚Ä¶RT @SEEKINGALPHA_FS: Large-Cap Stocks Primed For Big Returns https://t.co/kim5l4IOlz $AAPL #APPLE $CELG $CMG $CTSH $GILD $MRK $PCLN $REGN $‚Ä¶Large-Cap Stocks Primed For Big Returns https://t.co/kim5l4IOlz $AAPL #APPLE $CELG $CMG $CTSH $GILD $MRK $PCLN $REGN $TRIP $ULTA $VMWLarge-Cap Stocks Primed For Big Returns https://t.co/M2XA8LU6B9 $AAPL #APPLE $CELG $CMG $CTSH $GILD $MRK $PCLN $REGN $TRIP $ULTA $VMWEast Coast #Biotech Roundup: NY Bio, Gender Gap, Zafgen, PureTech &amp; More https://t.co/YqmiQzH0A5 $BIIB $REGN $AEGR $ZFGN $NTLART @regeneron: How is the industry that transformed infectious, heart and vision diseases ranked just below the used car industry? $REGN CE‚Ä¶Amgen, #RegeneronPharmaceuticals May See Higher PCSK9 Sales Going Forward. Read more: https://t.co/Chc3BV2kXH $REGNAmgen, #RegeneronPharmaceuticals May See Higher PCSK9 Sales Going Forward. Read more: https://t.co/7AX2Tsztpa $REGNHow Did Regeneron‚Äôs Key Drug Eylea Perform in 1Q16? $REGN https://t.co/8pDUHeVHMaPNRA Ex-Div Date
See Here ---&gt; https://t.co/iuo6TQSh7L

$PNRA $XLU $REGN #tradeideasRT @regeneron: If we are going to have more new medicines in the future, we need a system that preserves the biopharma industry - $REGN CEO‚Ä¶RT @regeneron: How is the industry that transformed infectious, heart and vision diseases ranked just below the used car industry? $REGN CE‚Ä¶If we are going to have more new medicines in the future, we need a system that preserves the biopharma industry - $REGN CEO #FTLiveHealthHow is the industry that transformed infectious, heart and vision diseases ranked just below the used car industry? $REGN CEO #FTLiveHealth#Trivia Answer: $REGN was founded in #NYC. Did you guess right? Learn more about our history https://t.co/QGOI34JsIE https://t.co/PCTyRxhdgJ$REGN's Len says a lot of pricing issues are ""self-inflicted"" wounds by the pharma industry$REGN close.#Cigna Reaches Pay-for-Performance Deals for #PCSK9 Inhibitors $SNY $REGN $AMGN https://t.co/VNywZA9ZDl via @ajmc_journalNOTICE: $REGN OPTIMISM indicator (as seen by investors in News &amp; Social Media)  shows high expectations. https://t.co/6ETIrHFnJvRT @iviewmarkets: Stocks with greatest increase in MACD of the Strongest 20 $SPY names $AMZN $CMG $GOOG $REGN $AZO $NOC https://t.co/RA25fh‚Ä¶RT @iviewmarkets: Stocks with greatest increase in MACD of the Strongest 20 $SPY names $AMZN $CMG $GOOG $REGN $AZO $NOC https://t.co/RA25fh‚Ä¶RT @iviewmarkets: Stocks with greatest increase in MACD of the Strongest 20 $SPY names $AMZN $CMG $GOOG $REGN $AZO $NOC https://t.co/RA25fh‚Ä¶RT @iviewmarkets: Stocks with greatest increase in MACD of the Strongest 20 $SPY names $AMZN $CMG $GOOG $REGN $AZO $NOC https://t.co/RA25fh‚Ä¶RT @iviewmarkets: Stocks with greatest increase in MACD of the Strongest 20 $SPY names $AMZN $CMG $GOOG $REGN $AZO $NOC https://t.co/RA25fh‚Ä¶Stocks with greatest increase in MACD of the Strongest 20 $SPY names $AMZN $CMG $GOOG $REGN $AZO $NOC https://t.co/RA25fhOnysRT @go2sleepjj: Opening $PBMD, current - $MGT$ACUR $AERI $ATHX $CPXX $INO $SNY $REGN $JNUG $BMIX $SPCL $CDNL $GEQU $LEAS $MLCG $MSPC $SBES‚Ä¶Opening $PBMD, current - $MGT$ACUR $AERI $ATHX $CPXX $INO $SNY $REGN $JNUG $BMIX $SPCL $CDNL $GEQU $LEAS $MLCG $MSPC $SBES $FILM $ONOV....Want automatic email alerts for $CBSH $HBAN $REGN $MAKO $QEP? Subscribe to MarketBeat Daily https://t.co/nSJuDsYidjRT @fwpharma: US health insurer Cigna reaches value-based contracts for PCSK9 inhibitors Repatha, Praluent https://t.co/3kLplutGDe $AMGN $S‚Ä¶chartguy89: 2016 Trending Stocks: REGN 371.86 Stock Charts $REGN Regeneron https://t.co/TsG9j3s6nT",2016-05-12,REGN,1
28,"Do you know that #WallStreet price for $REGN is $473.48 https://t.co/DAg0b95jpjRT @sssvenky: $REGN has had a nice 2 day move so far. MACD crossing up/RSI turning back up. Has room to Upper T/Ls if need be. W/L https://‚Ä¶$REGN Don't Buy Buffet PicksS&amp;P500 #Stocks Trend $REGN $TYC $JCI $NVDA $VAR $LLY $PDCO $INTU $INTC $FFIV $ADBE $HSIC $IFF $EQIX $MDT $DNB  @ https://t.co/RPeaHBHYi0S&amp;P500 #Stocks Performance $FCX $WMB $REGN $TYC $FTI $JCI $NEM $MRO $MOS $HUM $AAPL $NOV $ALXN $TJX $DAL  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $REGN $NTES $INCY $NVDA $INTU $INTC $ADBE $HSIC $EA $ATVI $CA $LBTYA $ALXN $CTSH $MSFT  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $REGN $NTES $BIDU $INCY $LBTYA $AAPL $ALXN $MYL $DLTR $NVDA $SWKS $YHOO $ROST more@ https://t.co/YdSIjFJqHfDo you know that #Book Value for $REGN is $36.1 https://t.co/3c8A2sMKGLParabolic SAR Buy https://t.co/meGapbBWth $REGN $IBB $JNUG $BWLD $TARO $LGND $SPGI $CVX $ASML $SRCL $CMPR $AAPL $FEIC $SOXX $VAR $CHKP $ELLIToday's #SP500 biggest winners: $DNR (+8%), $WMB (+6%), $REGN (+6%). The biggest losers: $RRC (-10%), $CHK (-4%), $CMG (-3%)$REGN the bull pattern is confirmed &amp; a BUY signal is issued @ https://t.co/u0JXvIHf7y. Buy Level: 380.4200   Target: 399.441$REGN has had a nice 2 day move so far. MACD crossing up/RSI turning back up. Has room to Upper T/Ls if need be. W/L https://t.co/HIWf4O69HkScan results - Expansion Pivot Buy Setup today: $BAM $LOW $PDCO $PRTA $REGN $ROP $LLTC $BABA $BBCN $GCI ... https://t.co/5Ev0UqzWhuRT @chessNwine: NEW POST: Stock Market Recap 05/16/16 {Video} https://t.co/Wa6eMqplfk $AAPL $HD $QQQ $REGN $SPYTIF Prev Close
See Here ---&gt; https://t.co/kykQsBwxUW

$TIF $REGN $POT #stockRT @FierceBiotech: Pfizer pays $5.2B for eczema specialist Anacor, sets up rivalry with Sanofi/Regeneron's dupilumab: https://t.co/FObZvFNG‚Ä¶RT @chessNwine: NEW POST: Stock Market Recap 05/16/16 {Video} https://t.co/Wa6eMqplfk $AAPL $HD $QQQ $REGN $SPYWhat Pfizer's Anacor Deal May Mean For It And For Regeneron $REGN https://t.co/4HdrLUnb4bRT @ACInvestorBlog: Stocks to Watch for May 17, 2016 https://t.co/0bshscWj8L $AAPL $CBYL $GALE $PTLA $REGN $WMB Have a great evening everyo‚Ä¶RT @ACInvestorBlog: Stocks to Watch for May 17, 2016 https://t.co/0bshscWj8L $AAPL $CBYL $GALE $PTLA $REGN $WMB Have a great evening everyo‚Ä¶RT @ACInvestorBlog: Stocks to Watch for May 17, 2016 https://t.co/0bshscWj8L $AAPL $CBYL $GALE $PTLA $REGN $WMB Have a great evening everyo‚Ä¶Stocks to Watch for May 17, 2016 https://t.co/0bshscWj8L $AAPL $CBYL $GALE $PTLA $REGN $WMB Have a great evening everyone !!SAlphaTrending: What Pfizer's Anacor Deal May Mean For It And For Regeneron https://t.co/Si2kngh0rj $ANAC $IBB $NVS $PFE $SNY $REGNWhat Pfizer's Anacor Deal May Mean For It And For Regeneron https://t.co/PBejo0SeNM $ANAC $IBB $NVS $PFE $SNY $REGNNEW POST: Stock Market Recap 05/16/16 {Video} https://t.co/Wa6eMqplfk $AAPL $HD $QQQ $REGN $SPYRT SeekingAlpha: What Pfizer's Anacor Deal May Mean For It And For Regeneron https://t.co/SgitIGnoGV $ANAC $IBB $NVS $PFE $SNY $REGNRT @BentheFidler: East Coast #Biotech Roundup: NY Bio, Gender Gap, Zafgen, PureTech &amp; More https://t.co/YqmiQzH0A5 $BIIB $REGN $AEGR $ZFGN‚Ä¶SeekingAlpha: What Pfizer's Anacor Deal May Mean For It And For Regeneron https://t.co/3Q31L8aDM5 $ANAC $IBB $NVS $PFE $SNY $REGNWhat Pfizer's Anacor Deal May Mean For It And For Regeneron $REGN https://t.co/L7moywJwUA$REGN spike not tied to $PFE's $ANAC deal, but it doesn't hurt https://t.co/38VRanR0Ak https://t.co/pToYXF1Lm4What Pfizer's Anacor Deal May Mean For It And For Regeneron https://t.co/ZPrltMUKgQ $ANAC $IBB $NVS $PFE $SNY $REGNWhat Pfizer's Anacor Deal May Mean For It And For Regeneron https://t.co/fivqUIKWID $ANAC $IBB $NVS $PFE $SNY $REGN$ANAC $A $VRX $AAPL $REGN $SPY $IBB Market recap 5/16 https://t.co/PcznZhSOKlCrossed the 20/50 SMA like butte\u2026 $REGN https://t.co/Zo9jVMdLfeRT @barronsonline: Regeneron: The Single Best Bet in Biotech https://t.co/1uoJnZIKDV $REGN https://t.co/Ncg8zHVTK0RT @FierceBiotech: Pfizer pays $5.2B for eczema specialist Anacor, sets up rivalry with Sanofi/Regeneron's dupilumab: https://t.co/FObZvFNG‚Ä¶S&amp;P500 #Stocks Trend $REGN $TYC $NVDA $LOW $LLY $VAR $PDCO $INTU $INTC $BCR $ADBE $SNA $BDX $FFIV $IFF $MDT  @ https://t.co/RPeaHBHYi0S&amp;P500 #Stocks Performance $FCX $REGN $WMB $FTI $TYC $MRO $NVDA $AAPL $NEM $APA $NOV $MOS $JCI $RIG $MUR  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $REGN $NTES $NVDA $INCY $INTU $INTC $ADBE $HSIC $EA $LLTC $ATVI $CA $LBTYA $TXN $CTXS  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $REGN $NTES $BIDU $NVDA $LBTYA $AAPL $INCY $SWKS $NXPI $YHOO $ALXN $DLTR $MYL more@ https://t.co/YdSIjFJqHf#RegeneronPharmaceuticals Drug developer negotiating deal to buy Pitney Bowes building. Read more: https://t.co/q5zguQJ5ZF $REGN#RegeneronPharmaceuticals Drug developer negotiating deal to buy Pitney Bowes building. Read more: https://t.co/lCmxCSgKEn $REGN#RegeneronPharmaceuticals Drug developer negotiating deal to buy Pitney Bowes building. Read more: https://t.co/nsAbxrQ0TG $REGN#RegeneronPharmaceuticals Drug developer negotiating deal to buy Pitney Bowes building. Read more: https://t.co/lUZ9ARe2eg $REGNRT @VictorZubarev: $REGN #Regeneron 393.67
For Mon May16
VZVOLBO:
Get Long at the O=380.00
Today's H=394.47
ATR tgt=386.50 MET
@vxx46 
@bir‚Ä¶$REGN #Regeneron 393.67
For Mon May16
VZVOLBO:
Get Long at the O=380.00
Today's H=394.47
ATR tgt=386.50 MET
@vxx46 
@birol92$REGN awesome pop today help boost $IBB biotech rules Monday$REGN breaking https://t.co/G3AUiSOXpk$IBB Weary of a value trap here, up big but on low volume again mostly due to $REGN.  Waiting for the insiders to come play then I'm all in.$REGN chart from 5/8  https://t.co/6r55wwVUfX Support. Demand.$REGN told myself to buy this fri it was right on support got sidetracked and didn't now this üò£üî´ time to get on the focus factor hahaRT @AlbBizChelsea: Regeneron $REGN in negotiations to buy former MapInfo (current Pitney Bowes) building: https://t.co/KFLWwTbjKx https://t‚Ä¶RT @AlbBizAndrew: NEWS ALERT ‚Äî Regeneron $REGN in negotiations to buy former MapInfo building: https://t.co/037jWcOIy0 https://t.co/XlmAmQM‚Ä¶Regeneron $REGN in negotiations to buy former MapInfo (current Pitney Bowes) building: https://t.co/KFLWwTbjKx https://t.co/OWIQWxHeQO$AAPL $REGN $IWM $SPX Thanks ! PBYI AGN BMRN All Large$ WINNERS too https://t.co/MoPc6sgdko$AAPL $REGN $IWM $SPX special congrats to @ClueLess8_Trading for a stellar profit day all while going against the bearish sentimentRegeneron: The Best Bet in #Biotech Stocks - Barron's https://t.co/GeZiaRIaRB $REGN #investingNEWS ALERT ‚Äî Regeneron $REGN in negotiations to buy former MapInfo building: https://t.co/037jWcOIy0 https://t.co/XlmAmQM155NEWS ALERT ‚Äî Regeneron $REGN in negotiations to buy former MapInfo building: https://t.co/jSXzKMwgSS https://t.co/BW9M8C2F1y$REGN added to long swing todayRT @WrigleyTom: $REGN 388.06 (long setup)
+ve diverg emerging
see if can t/o diag, close &gt; 50sma
+ve Barrons
presents Thur, Barclays https:‚Ä¶CMLviz: RT Oldie_Records: $IBB $GILD $CELG $AMGN $BIIB $REGN $KITE
Get #Bullish--#BioTech #Stocks?
#StockMarket #T‚Ä¶ https://t.co/P6oQgOZJjTRT @iviewmarkets: 3rd best performing sector today and its names: $REGN $MYL $ALZN $DVA $BMY https://t.co/iC7lxcq6tA https://t.co/l4g5bwMk3MRT @Oldie_Records: $IBB $GILD $CELG $AMGN $BIIB $REGN $KITE
Get #Bullish--#BioTech #Stocks?
#StockMarket #Trading #SwingTrade #Daytrade htt‚Ä¶Gupta Wealth Management LLC Cuts Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/XBk9MAihmx3rd best performing sector today and its names: $REGN $MYL $ALZN $DVA $BMY https://t.co/iC7lxcq6tA https://t.co/l4g5bwMk3MToday Actives:

$aapl $bac $ge $rrc $aa $nvda $gb $chk $fcx

Gainers:

$fcx $wmb $mro $regn $dvn $fti $rig $apc $apa $murSector WinnersL $FCX $WMB $MRO $AAPL $PVH $NAVI $REGN $ALXN $MYL $DOV $TYC $MCK $NVDA $YHOO https://t.co/iC7lxcq6tA https://t.co/p9rDBpspQOBarron‚Äôs promotion $REGN https://t.co/imEXQSaI08One more member needed to join the $OHRP Squalamine project and it's possible we could execute this Wed! $NVS $REGN https://t.co/Mq0FqTmAe7RT @Bidnessetc: Regeneron Pharmaceuticals #Stock Can Surge 35% in a Year; Here‚Äôs Why $REGN ‚ûú https://t.co/7ujOPeKHby https://t.co/4NrHVfS25n@HalftimeReport @ReformedBroker I like your call on $REGN. They have a great pipeline and the sentiment on pharma is soooo negativeüëç@WrigleyTom i believe the halftime report will be covering $REGN nextRT @WrigleyTom: $REGN 388.06 (long setup)
+ve diverg emerging
see if can t/o diag, close &gt; 50sma
+ve Barrons
presents Thur, Barclays https:‚Ä¶Barron's cover story even working more than it usually does as algos chase daily winners - $REGNRT @WrigleyTom: $REGN 388.06 (long setup)
+ve diverg emerging
see if can t/o diag, close &gt; 50sma
+ve Barrons
presents Thur, Barclays https:‚Ä¶RT @WrigleyTom: $REGN 388.06 (long setup)
+ve diverg emerging
see if can t/o diag, close &gt; 50sma
+ve Barrons
presents Thur, Barclays https:‚Ä¶RT @WrigleyTom: $REGN 388.06 (long setup)
+ve diverg emerging
see if can t/o diag, close &gt; 50sma
+ve Barrons
presents Thur, Barclays https:‚Ä¶$REGN 388.06 (long setup)
+ve diverg emerging
see if can t/o diag, close &gt; 50sma
+ve Barrons
presents Thur, Barclays https://t.co/WF7tSKEfNzRT @FierceBiotech: Pfizer pays $5.2B for eczema specialist Anacor, sets up rivalry with Sanofi/Regeneron's dupilumab: https://t.co/FObZvFNG‚Ä¶@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $REGN $CELG https://t.co/3IUcVhGIx2Big day for $REGN but it has to get through the 21 &amp; 50 day averages on at least one closing basis. https://t.co/ai3PoEzizyRT @DozenStocks: Nasdaq100 #Stocks Performance $REGN $BIDU $NTES $AAPL $NVDA $INCY $YHOO $NXPI $DLTR $NFLX $LBTYA $TSLA  more@ https://t.co‚Ä¶S&amp;P500 #Stocks Performance $FCX $MRO $FTI $REGN $WMB $RIG $NEM $APA $MUR $SWN $NOV $AAPL $NBL $MCK $APC  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $NTES $NVDA $INCY $EA $ATVI $CA $ALXN $ISRG $REGN $YHOO $INTU $TXN $MNST $ADBE $HSIC  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $REGN $BIDU $NTES $AAPL $NVDA $INCY $YHOO $NXPI $DLTR $NFLX $LBTYA $TSLA  more@ https://t.co/YdSIjFJqHfRegeneron Phar., $REGN, is up 5.2% - https://t.co/Kf4DUbqz1mSome #stocks that have *gapped higher* this AM: $ANAC $REGN $TPUB $CMCT and $ASML.RT @FierceBiotech: Pfizer pays $5.2B for eczema specialist Anacor, sets up rivalry with Sanofi/Regeneron's dupilumab: https://t.co/FObZvFNG‚Ä¶Regeneron Pharmaceuticals #Stock Can Surge 35% in a Year; Here‚Äôs Why $REGN ‚ûú https://t.co/7ujOPeKHby https://t.co/4NrHVfS25nRT @davidmoble: These are my 4 top performing stocks so far on this Monday morning $REGN $AAPL $EOG and $TSLART @FierceBiotech: Pfizer pays $5.2B for eczema specialist Anacor, sets up rivalry with Sanofi/Regeneron's dupilumab: https://t.co/FObZvFNG‚Ä¶RT @bored2tears: NASDAQ #Biotech Index +1.78% ‚Ä¢
Regeneron gains after positive mention in Barron's: $REGN +4.14% at 384.76 ‚Ä¢
$IBB +1.85% at‚Ä¶NASDAQ #Biotech Index +1.78% ‚Ä¢
Regeneron gains after positive mention in Barron's: $REGN +4.14% at 384.76 ‚Ä¢
$IBB +1.85% at 258.59 #stocksThese are my 4 top performing stocks so far on this Monday morning $REGN $AAPL $EOG and $TSLART @FierceBiotech: Pfizer pays $5.2B for eczema specialist Anacor, sets up rivalry with Sanofi/Regeneron's dupilumab: https://t.co/FObZvFNG‚Ä¶$IBB nice gap up probably helped by Barrons on $REGN and the M&amp;A today.$REGN Is kicking some bootay today. About to buy some weeklys. Definitely good for a swing too!Pfizer bolts another one on its innovative business, buying Anacor for its eczema candidate: https://t.co/Z3QK4XhBgE $PFE $ANAC $REGN $NVS$REGN a beauty! https://t.co/apba4Jt6PS via https://t.co/11Wpw9y7t1RT @crystalkimmm: Barron's cover this week $REGN Regeneron: The Best Bet in Biotech Stocks https://t.co/D2FGF662oc via @barronsonline https‚Ä¶Barron's cover this week $REGN Regeneron: The Best Bet in Biotech Stocks https://t.co/D2FGF662oc via @barronsonline https://t.co/0jGuupphaFRT @ACInvestorBlog: Pre-market movers $NSPH $ANAC $MRD $GLBL $INO $UBIO $REGN $ASML $MEMP $TPUB $GSAT $SRNE $TEX $BCEIRT @RobInTheBlack: #Mindthegap $ANAC $REGN $TRVN $CHTR $TWC $TPUB $DLR $ADXS $YHOO $GWPHRT @1ResilientSoul: #premarket gainersüòèüìà
$ANAC +54.30%
$MRD +10.78%
$INO +4.82%
$MEMP +4.29%
$USLV +4%
$REGN +2.98%
$UBIO +2.74%
$ASLM +2.6‚Ä¶RT @1ResilientSoul: #premarket gainersüòèüìà
$ANAC +54.30%
$MRD +10.78%
$INO +4.82%
$MEMP +4.29%
$USLV +4%
$REGN +2.98%
$UBIO +2.74%
$ASLM +2.6‚Ä¶RT @ACInvestorBlog: Pre-market movers $NSPH $ANAC $MRD $GLBL $INO $UBIO $REGN $ASML $MEMP $TPUB $GSAT $SRNE $TEX $BCEIRT @ACInvestorBlog: Pre-market movers $NSPH $ANAC $MRD $GLBL $INO $UBIO $REGN $ASML $MEMP $TPUB $GSAT $SRNE $TEX $BCEIPfizer pays $5.2B for eczema specialist Anacor, sets up rivalry with Sanofi/Regeneron's dupilumab: https://t.co/FyWiR6X5pj $PFE $SNY $REGN‚Ä¶Pfizer pays $5.2B for eczema specialist Anacor, sets up rivalry with Sanofi/Regeneron's dupilumab: https://t.co/cxVk4jxM75 $PFE $SNY $REGNPfizer pays $5.2B for eczema specialist Anacor, sets up rivalry with Sanofi/Regeneron's dupilumab: https://t.co/FObZvFNGIX $PFE $SNY $REGNPre-market movers $NSPH $ANAC $MRD $GLBL $INO $UBIO $REGN $ASML $MEMP $TPUB $GSAT $SRNE $TEX $BCEIIn Play Longs: $AAPL $ANAC $DLR $GSAT $JCP $MBT $REGN $TEX $YHOO $TPUBWarren Buffett announces a stake in #Apple and that stock may bounce off daily support today. Watch $AAPL $TEX $REGN $SRNE$REGN Also REGN positive on cover of Barron's, with ANAC/PFE deal finally some positive news AND positive press for bios@MattCFCayman @smartertrader @NYCPunter @PhillyBob11 oil is texas tea but you may be on to something with $regnRT @zbiotech: barclays PBM survey not great takeaways re eylea $REGN https://t.co/zHySdCtmpFPremarket most advanced stocks: $ANAC, $MRD, $GLBL, $USLV, $INO, $UGLD, $UBIO, $REGN, $ASML, $MEMP$REGN should lift $IBB early.  Bios due for a bounce. $BIIB $GILD https://t.co/2CNIooQ7KlRT @1ResilientSoul: #premarket gainersüòèüìà
$ANAC +54.30%
$MRD +10.78%
$INO +4.82%
$MEMP +4.29%
$USLV +4%
$REGN +2.98%
$UBIO +2.74%
$ASLM +2.6‚Ä¶barclays PBM survey not great takeaways re eylea $REGN https://t.co/zHySdCtmpF#Philosophy is #universal, #strategy is #personal, &amp; #discipline is required. $ANAC $MRD $REGN $AAPL $TPUB $QIHU $EDIT $ASML $SCTY $SRPT#Mindthegap $ANAC $REGN $TRVN $CHTR $TWC $TPUB $DLR $ADXS $YHOO $GWPH$ANAC healthy for $IBB $LABU $XBI - great $REGN article over weekend. How not at/above 100dma ~416 still baffling. not for long i hopeRT @takingstock614: üëÄ open. A lot of activity in bio space.  $LMNX $REGN $BIIB#premarket gainersüòèüìà
$ANAC +54.30%
$MRD +10.78%
$INO +4.82%
$MEMP +4.29%
$USLV +4%
$REGN +2.98%
$UBIO +2.74%
$ASLM +2.65%
$GPRO +2.48%
$BIBüëÄ open. A lot of activity in bio space.  $LMNX $REGN $BIIBBenzinga: 10 Stocks Moving In Monday's Pre-Market Session $AAPL $ANAC $BBEP $PFE $MRD $RRC $TEX $REGN $TRVN $TPUB https://t.co/XhPCmZohLJRT @upsidetrader: $IBB bump on $REGN Barrons cover and $ANAC buyout10 Stocks Moving In Monday's Pre-Market Session $AAPL $ANAC $BBEP $PFE $MRD $RRC $TEX $REGN $TRVN $TPUB https://t.co/ONHEvRC9L1$REGN and $USLV are significant Pre-Market Gainers this AM on SpeculatingStocks Pre-Market, https://t.co/ayAi1CAXh910 Stocks Moving In Monday's Pre-Market Session $AAPL $ANAC $BBEP $REGN  #premarket https://t.co/3NteZWL3Um via @benzingaRT SeekingAlpha: Many Risks For The Merus B.V. IPO https://t.co/tYwlCxeug1 $AFMD $MACK $MGNX $OMED $REGN $MRUSRT @upsidetrader: $IBB bump on $REGN Barrons cover and $ANAC buyoutSeekingAlpha: Many Risks For The Merus B.V. IPO https://t.co/GBOLpBJInN $AFMD $MACK $MGNX $OMED $REGN $MRUSRT @TrevorPalumbo: Premarket Top % Gainers: $ANAC 52%, $GSAT 16%, $MGT 11%, $MRD 9%, $GPL 7%, $REGN 7%, $IAG 5%, $DGAZ 5%, #stocks #investi‚Ä¶Many Risks For The Merus B.V. IPO https://t.co/IV9xYkUCIm $AFMD $MACK $MGNX $OMED $REGN $MRUSMany Risks For The Merus B.V. IPO https://t.co/Dsk8LNQ1ce $AFMD $MACK $MGNX $OMED $REGN $MRUSMany Risks For The Merus B.V. IPO https://t.co/wSyR4RLkqy $AFMD $MACK $MGNX $OMED $REGN $MRUSPremarket Top % Gainers: $ANAC 52%, $GSAT 16%, $MGT 11%, $MRD 9%, $GPL 7%, $REGN 7%, $IAG 5%, $DGAZ 5%, #stocks #investing #tradeideasRT @upsidetrader: $IBB bump on $REGN Barrons cover and $ANAC buyoutRT @upsidetrader: $IBB bump on $REGN Barrons cover and $ANAC buyout$IBB bump on $REGN Barrons cover and $ANAC buyoutKentucky Retirement Systems Insurance Trust Fund Invests $1,579,000 in Regeneron Pharmaceuticals Inc $REGN https://t.co/DghgrIVQooKentucky Retirement Systems Insurance Trust Fund Invests $1,579,000 in Regeneron Pharmaceuticals Inc $REGN https://t.co/RMJUHXSP3pRT @WrigleyTom: GM all

Flat Monday despite
$ANAC $REGN $TPUB $MRD $TRVN 

It‚Äôs all about oil ..Fed speakers
https://t.co/GEqRkr3qtr https:‚Ä¶GM all

Flat Monday despite
$ANAC $REGN $TPUB $MRD $TRVN 

It‚Äôs all about oil ..Fed speakers
https://t.co/GEqRkr3qtr https://t.co/oCBVyB37A4Zacks Investment Research Downgrades Regeneron Pharmaceuticals Inc $REGN to Sell https://t.co/siRwCci9lsBenzinga: Barron's Picks And Pans: Regeneron, Axalta, Alleghany And More $AXTA $BBT $ETN $REGN $Y $PG https://t.co/upyJHISVZ7Barron's Picks And Pans: Regeneron, Axalta, Alleghany And More $AXTA $BBT $ETN $REGN $Y $PG https://t.co/xLyUeX3d7q@maralgr @BioStocks that's said 'after' buying; it's more like $1B (so ~ 5x); $ANAC data is mild vs $REGN Dupi; that can be $2B/urWe calculated 21-day Expected Return of $REGN for you: -8.53% https://t.co/SwUMTR2sdFPopular: $DIA, $QQQ, $ANAC, $IWM, $MRD, $HD, $ZIOP, $PN, $RRC, $GBX, $BRK.A, $PFE, $PG, $PTCT, $REGN, $CSCO, $IYT, $LPL, $IEP, $INOWondering about risks of $REGN? The 63-day volatility is 23.02% https://t.co/kvPzzNkYBK#Premarket Top % Gainers: $ANAC 52%, $GSAT 16%, $MGT 11%, $MRD 9%, $GPL 7%, $REGN 7%, $IAG 5%, $DGAZ 5%, $UWTI, $NUGT, $YINN $HMY $UCO $USLV#Premarket Top % Gainers: $ANAC 52%, $GSAT 16%, $MGT 11%, $MRD 9%, $GPL 7%, $REGN 7%, $IAG 5%, $DGAZ 5%, $UWTI, $NUGT, $YINN $HMY $UCO $USLVREGN Volume
See Here ---&gt; https://t.co/1Re9ogmB4j

$REGN $PRSC $CLR #stockRegeneron Pharmaceuticals Inc $REGN Shares Sold by Stifel Financial Corp https://t.co/xX2HTmKzufRegeneron Pharmaceuticals Inc $REGN Shares Sold by Stifel Financial Corp https://t.co/hCJOxzUnEf$IBB $GILD $CELG $AMGN $BIIB $REGN $KITE
Get #Bullish--#BioTech #Stocks?
#StockMarket #Trading #SwingTrade #Daytrade https://t.co/9XMROfJix4@ntbiotech @TravisMKnight $ANAC might not get &gt;$3B type bid,in light of $REGN Dupilumab Ph3.Dep on how big boys perceive this oppy, or waitI'm trying $regn at open https://t.co/hg1kZyFcA5Not sure what to do with $REGN? Explore our #fundamental pros and cons.  https://t.co/5ue7vzjlWZBtw, Estimated #Earnings Per Share for $REGN is $2.84 it's 0.77% of the current price https://t.co/lIcyQkq3YgRT @BiotechOptions2: #Regeneron $REGN: The Best Bet in #Biotech Stocks -- https://t.co/Z4AvIQw9tjRT @Biobullstock: So run right out and buy a $370 a share company worth $40 billion. $REGN https://t.co/nY5vUuk6FsWe calculated 63-day Expected Return of $REGN for you: 0.1% https://t.co/SwUMTR2sdFDo you know that #WallStreet price for $REGN is $473.48 https://t.co/MpPO5UGKo6Do you know that #WallStreet price for $REGN is $473.48 https://t.co/DAg0b95jpj$REGN on the front page of BARRONS weekend edition yesterday. Let's see if it gets ""THE BOUNCE"" .",2016-05-16,REGN,0
29,"RT @TradeWithSuper: Benzinga: Has A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/c4tS24SE4QRT @Benzinga: Has A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/KshODCHP0nBenzinga: Has A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/c4tS24SE4QHas A Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD $CELG $REGN https://t.co/KshODCHP0n$AYA $REGN: significant After Hours Decliners as seen on SpeculatingStocks After-Hours, https://t.co/0sHRjqRl7f #stocksRegeneron Pharmaceuticals Inc $REGN Receives Buy Rating from Robert W. Baird https://t.co/tNsBVRaAacS&amp;P500 #Stocks Trend $WMB $A $TRIP $LYB $ROP $MCK $NVDA $TYC $EMC $REGN $EQT $NFX $ALLE $NEM $QCOM $CTSH $IFF  @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $VOD $TRIP $NTES $NVDA $REGN $INCY $QCOM $CTSH $CA $YHOO $EA $TMUS $ATVI $MNST $CTRP  @ https://t.co/YdSIjFJqHfRegeneron Pharmaceuticals Inc $REGN Given ‚ÄúBuy‚Äù Rating at Robert W. Baird https://t.co/rVj98oqJ9ORegeneron Pharmaceuticals Inc $REGN Given ‚ÄúBuy‚Äù Rating at Robert W. Baird https://t.co/lYqrJCMncbRegeneron Pharmaceuticals Inc $REGN Given ‚ÄúBuy‚Äù Rating at Robert W. Baird https://t.co/f8LmE0fkM5RT @biospace: Delving Into Pfizer $PFE's Acquisition Strategy and Its Impact on Regeneron $REGN https://t.co/AXN4jx99s6 https://t.co/V4JgmH‚Ä¶What Pfizer's Anacor Deal May Mean For It And For Regeneron https://t.co/VdI0hawWWA $ANAC $IBB $PFE $SNY $REGNRegeneron Pharmaceuticals, Inc.  Reiterated Rating by Robert W. Baird (Ranked 19th) to Buy $REGN #REGN https://t.co/6KTXk3W2QERT @biospace: Delving Into Pfizer $PFE's Acquisition Strategy and Its Impact on Regeneron $REGN https://t.co/AXN4jx99s6 https://t.co/V4JgmH‚Ä¶Delving Into Pfizer $PFE's Acquisition Strategy and Its Impact on Regeneron $REGN https://t.co/AXN4jx99s6 https://t.co/V4JgmHSEOiRT @BioStocks: $REGN - The Best Bet in #Biotech Stocks https://t.co/YCEiSb0vbDREGN 394.00 Regeneron Pharmaceut $REGN added to my watch list. Right now with REGN I am watching the last pric https://t.co/VfoqR8CJsI13 users on Vetr are bullish on Regeneron Pharmaceuticals, Inc., indicating a BUY Rating (4 stars) for $REGN https://t.co/Xy6N0XHB1R#Pfizer's #Anacor deal showcases new wave of #eczema therapies  https://t.co/LOkQrHhqzT via @Reuters $PFE $ANAC $REGN $CELG $DERM$REGN is a typical reflexive stock, where stock price basically determines the fundamentals. P/E is 65 and it broke hardly from highs.Eqis Capital Management Inc. Has $1,571,000 Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/NSQlbdj50L$REGN - Eqis Capital Management Inc. Has $1,571,000 Position in Regeneron Pharmaceuticals‚Ä¶ https://t.co/p2hxbZm9A1$REGN - Eqis Capital Management Inc. Has $1,571,000 Position in Regeneron Pharmaceuticals‚Ä¶ https://t.co/FrHwJgJMNiLarge-Cap Stocks Primed For Big Returns https://t.co/hlt2Ailncm $AAPL $CELG $CMG $CTSH $GILD $MRK $PCLN $REGN $TRIP $ULTA $VMW $YELPPTEN Chart
See Here ---&gt; https://t.co/uhU3wxeSoP

$PTEN $AMAT $REGN #stocksRT @iviewmarkets: $SPY names moving back above their 50day $APC $REGN $LOW $FTI $ADSK $CA $UTX $TRIP data here https://t.co/iC7lxcq6tA http‚Ä¶$SPY names moving back above their 50day $APC $REGN $LOW $FTI $ADSK $CA $UTX $TRIP data here https://t.co/iC7lxcq6tA https://t.co/t3qeLt3rgBGME Filings
See Here ---&gt; https://t.co/dIzNaY1k90

$GME $REGN $ALDR #stockmarketExxonmobil Investment Management Inc. TX Buys 1,609 Shares of Regeneron Pharmaceuticals Inc $REGN https://t.co/NQQ1k89TLiRegeneron Pharmaceuticals (REGN:NASDAQ) gains 6.09% to $391.95 on Monday : Among top 10 gainers on S&amp;P500 $REGN #NASDAQ #stockmarket #pharmaRegeneron Pharmaceuticals (REGN:NASDAQ) gains 6.09% to $391.95 on Monday : Among top 10 gainers on S&amp;P500 $REGN #NASDAQ #stockmarket #pharmaWeekly S&amp;P500 #Stocks Trend $NVDA $EA $MON $DNB $TYC $IFF $ATVI $CA $FFIV $PDCO $JCI $REGN $A $LLY $EMC $NI  @ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Trend $NVDA $EA $NTES $ATVI $CA $INCY $REGN $ADBE $INTU $HSIC $INTC $LBTYA $ALXN $CTSH @ https://t.co/YdSIjFJqHfWeekly Nasdaq100 #Stocks Performance $NVDA $EA $NTES $ATVI $CA $INCY $AMZN $REGN $MSFT $PCLN $BMRN $TRIP  more@ https://t.co/YdSIjFJqHfRT @FierceBiotech: Pfizer pays $5.2B for eczema specialist Anacor, sets up rivalry with Sanofi/Regeneron's dupilumab: https://t.co/FObZvFNG‚Ä¶Can watch $REGN tomorrow for a 2nd day runner https://t.co/LXCf1MzH6HBIDU Bid Size
See Here ---&gt; https://t.co/9H2N1ofWoc

$BIDU $CNA $REGN #tradeideasRT @BiotechMoney18: $REGN Barron's ""Best bet in biotech"", could rise 35% in a year. Break the short-term down trend today. TA https://t.co/‚Ä¶Regeneron Pharmaceuticals Inc $REGN Lowered to Buy at Vetr Inc. https://t.co/6NCD3DvApRRegeneron Pharmaceuticals Inc $REGN Lowered to Buy at Vetr Inc. https://t.co/CRgtPcKxpFREGN Tick
See Here ---&gt; https://t.co/mXYslK3pap

$REGN $EMR $ODP #shareCharts For Tuesday ‚Äì $AAPL $INTC $HAL $LOW $DDD $MRVL $CTRP $REGN $KITE $SWHC https://t.co/3qBxeCu5noRegeneron Pharmaceuticals Inc $REGN Stock Rating Lowered by Vetr Inc. https://t.co/bxHkDW6e2mRegeneron Pharmaceuticals downgraded by Vetr Inc. to buy. $427.43 PT. https://t.co/tB55Q9zv0y $REGN #REGNBiggest gainers today large caps:
$WPZ 6.99%
$WMB 6.41%
$ETP 6.38%
$REGN 6.09%
$FCX 6.05%
$NTES 5.36%
$BIDU 5.14%
$ASML 4.96%
$TYC 4.85%Big #Biotech What‚Äôs the Worst Case Scenario? This doesn't sound too bad to me #stocks $CELG $GILD $BIIB $REGN
https://t.co/cPj7OmLhTrWe calculated 21-day Expected Return of $REGN for you: -8.53% https://t.co/SwUMTR2sdFWondering about risks of $REGN? The 63-day volatility is 23.02% https://t.co/kvPzzNkYBKRT @ryanmathews: $SPY - despite today's move, market still seems vulnerable. I'm long a few positions, but heavy in cash. Added $REGN today‚Ä¶Regeneron Pharmaceuticals Inc $REGN Trading Up 5.8% https://t.co/jCWltqU5cfRT @scalpthatstock: T3 Live Daily Recap: Surprise Rally
https://t.co/wtxIyYS9k6
  $AAPL $IBM $USO $ARIA $IBB $REGN $AMZN $GOOGL $FB $BIDU $‚Ä¶RT @ryanmathews: $SPY - despite today's move, market still seems vulnerable. I'm long a few positions, but heavy in cash. Added $REGN today‚Ä¶$SPY - despite today's move, market still seems vulnerable. I'm long a few positions, but heavy in cash. Added $REGN today for swingT3 Live Daily Recap: Surprise Rally
https://t.co/wtxIyYS9k6
  $AAPL $IBM $USO $ARIA $IBB $REGN $AMZN $GOOGL $FB $BIDU $BABA $VRX@DrPaulyDeSantis @jq1234t @AndyBiotech Ofcourse; those were steroid valuations; &amp; $ANAC has strong $REGN competition; decent deal they got$REGN Barron's ""Best bet in biotech"", could rise 35% in a year. Break the short-term down trend today. TA https://t.co/VDG4fJt7iDWe calculated 63-day Expected Return of $REGN for you: 0.1% https://t.co/SwUMTR2sdF",2016-05-17,REGN,1
30,"Nasdaq100 #Stocks Trend $CHTR $INCY $NVDA $VOD $QCOM $REGN $NXPI $CTSH $BMRN $ALXN $LLTC $TXN $NTES $CA $ATVI  @ https://t.co/YdSIjFJqHfChevy Chase Trust Holdings Inc. Has $25,958,000 Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/HYApnjxX2cREGN 52Wk Low
See Here ---&gt; https://t.co/g4b8uBQWDM

$REGN $POT $XLRN #pennystocks$TSLA $CRM $REGN $NUGT $GDX $DUST $SPY $XBI $IBB https://t.co/AMUUQdB049$TSLA $CRM $REGN $NUGT $GDX $DUST $SPY $XBI $IBB Market recap for 5/18 https://t.co/FQH0cqfCS4Has A #Biotech Recovery Started Yet? $ALXN $AMGN $BIIB $GILD$CELG $REGN  https://t.co/RmLjOqsBNY via @benzinga #stocks$REGN holding gains &gt;50DMA https://t.co/QtAbTcz7S5 via https://t.co/11Wpw9y7t1@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/m83pkEcmYWRegeneron Pharmaceuticals Inc $REGN Shares Bought by Banced Corp https://t.co/9BzjTvtC6w$REGN Biotech company provides solid buying opportunity. Watch this video https://t.co/HM7Fp4OKMi @XplosiveOptions https://t.co/QR5BvA07ThMSCC Ex-Div Date
See Here ---&gt; https://t.co/8KhpvFx8Dh

$MSCC $REGN $GRAM #stocksstock option expense as % of S&amp;P 500 EPS reaching 10 year high $CRM $ADSK $YHOO $FB $EXPE $REGN $EMC $ADBE $GOOGL https://t.co/cAndfYjuwoPAA Yield
See Here ---&gt; https://t.co/FWeFtzddfJ

$PAA $REGN $CHUY #investingSAlphaTrending: The Celgene-Agios Partnership Strategy https://t.co/CxDJsg6PgL $AGIO $AZN $GILD $JUNO $NVO $REGN $CELGThe Celgene-Agios Partnership Strategy https://t.co/LVXqXjpJa2 $AGIO $AZN $GILD $JUNO $NVO $REGN $CELG$IBB $XBI breaking down . . $CELG $GILD $BIIB $REGN way off today's highs.$REGN 1-hr  https://t.co/GIGjPTDJwj via https://t.co/11Wpw9y7t1Regeneron Pharmaceuticals $REGN Stock is the 'Chart of the Day' https://t.co/Oz04zzqLISRegeneron Pharmaceuticals $REGN Stock is the 'Chart of the Day' https://t.co/QtXb6NmT9D #StockAction$REGN Biotech company provides solid buying opportunity. Watch this video  https://t.co/HM7Fp4OKMi @XplosiveOptions https://t.co/Fw917KuqYgRT @DavidBautz: Commented on Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/518JooPvmr $ALXN $ENUM $GILD $REGN $‚Ä¶Pieris Pharmaceuticals: The Paradigm Shift That Antibodies Need https://t.co/RVCpEanG5L $PIRS, $ALXN, $ENUM, $GILD, $REGN, $SNYRT @DavidBautz: Commented on Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/518JooPvmr $ALXN $ENUM $GILD $REGN $‚Ä¶SFOR EOD Data
See Here ---&gt; https://t.co/YOfRXIGZHV

$SFOR $OME $REGN #tradeideas$REGN Biotech company provides solid buying opportunity. Watch this video  https://t.co/HM7Fp4OKMi @XplosiveOptions https://t.co/gFfiAvi7G9Vetr Inc. Downgrades Regeneron Pharmaceuticals Inc $REGN to Buy https://t.co/DTYTNDaLj9$XBI $ACAD $MDVN $NBIX $NVAX $ICPT $RARE $LGND $ALKS $SGEN $REGN https://t.co/hvSrgV2w8NVetr users have upgraded Regeneron Pharm... to a STRONG BUY Rating (5 stars), giving $REGN a target price of $478.65 https://t.co/Xy6N0XHB1RVetr Inc. Downgrades Regeneron Pharmaceuticals Inc $REGN to Buy https://t.co/6ETK20xljeVetr Inc. Downgrades Regeneron Pharmaceuticals Inc $REGN to Buy https://t.co/ejmsKTTtX2Commented on Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/518JooPvmr $ALXN $ENUM $GILD $REGN $SNY $PIRSRT SeekingAlpha: Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/XnI9dWqP6U $ALXN $ENUM $GILD $REGN $SNY $PIRSSeekingAlpha: Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/pGFtpN9Oqj $ALXN $ENUM $GILD $REGN $SNY $PIRSRT @SA_BioTech: Pieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/1KRWatsdjb $ALXN $ENUM $GILD $REGN $SNY $PIRSPieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/1KRWatsdjb $ALXN $ENUM $GILD $REGN $SNY $PIRSPieris Pharmaceuticals: The Blockbuster In Antibody Mimetics https://t.co/yTGcv6TKHH $ALXN $ENUM $GILD $REGN $SNY $PIRSRT @dhovekamp42: $PIRS Pieris Pharmaceuticals: The Paradigm Shift That #Antibodies Need https://t.co/KJBIuKcdlB $ALXN $ENUM $GILD $REGN $SN‚Ä¶RT @dhovekamp42: $PIRS Pieris Pharmaceuticals: The Paradigm Shift That #Antibodies Need https://t.co/KJBIuKcdlB $ALXN $ENUM $GILD $REGN $SN‚Ä¶RT @dhovekamp42: $PIRS Pieris Pharmaceuticals: The Paradigm Shift That #Antibodies Need https://t.co/KJBIuKcdlB $ALXN $ENUM $GILD $REGN $SN‚Ä¶$PIRS Pieris Pharmaceuticals: The Paradigm Shift That #Antibodies Need https://t.co/KJBIuKcdlB $ALXN $ENUM $GILD $REGN $SNY $PIRSOur CFO gives $REGN updates tomorrow @ 11am ET @Barclays US Biopharma Call Series https://t.co/jqzWwVHkc6Quotient Investors LLC Purchases 5,555 Shares of Regeneron Pharmaceuticals Inc $REGN https://t.co/iaypNMixRT$ACAD Imagine id DEJAVU https://t.co/6GuoiI5soT compare to $REGN in  5 years , 30 to 400 @hedgefundcloneRobert W. Baird Reiterates Buy Rating for Regeneron Pharmaceuticals Inc $REGN https://t.co/UCJHKapSLGRobert W. Baird Reiterates Buy Rating for Regeneron Pharmaceuticals Inc $REGN https://t.co/huX30A7o1qBetter Buy: #RegeneronPharmaceuticals, Inc. vs. Ophthotech. Read more: https://t.co/9GvRTLOlA2 $REGNBetter Buy: #RegeneronPharmaceuticals, Inc. vs. Ophthotech. Read more: https://t.co/89q13QROXy $REGNRegeneron Pharmaceuticals Inc $REGN Upgraded to ‚ÄúStrong-Buy‚Äù at Vetr Inc. https://t.co/Cc6eRKvAOqRegeneron Pharmaceuticals Inc $REGN Rating Increased to Strong-Buy at Vetr Inc. https://t.co/Hz78sPRlLLRegeneron Pharmaceuticals upgraded by Vetr Inc. to strong-buy. $478.65 PT. https://t.co/JjOL1nBjCo $REGN #REGNRegeneron Pharmaceuticals upgraded by Vetr Inc. to strong-buy. $478.65 PT. https://t.co/SsuwHz7NW3 $REGN #REGN$GILD is prolly waiting for 07-08 correction to go shopping,PE 7 or 5 will hardly matter, w $AAPL type cash. But $REGN shud raise some dough@pbmech $CELG atleast making some #hopium of its bloated MC; vs $REGN types doing zilch :)REGN News
See Here ---&gt; https://t.co/Fv4wb0wgVk

$REGN $FB $CELP #finance$REGN MACD crossed above Signal Line for 05/17 https://t.co/dJQnD0gQ23 #stockscreener https://t.co/ziPEftxDZ6MACD Bullish https://t.co/QkdwheMQMO $REGN $RDY $KEYS $NSIT $LOXO $ELOS $ADHD $HMY",2016-05-18,REGN,0
31,"RT @BColwell_ALT: Many Risks 4 The #Merus B.V. #IPO $MRUS https://t.co/NcpaK41Iak #venturecapital #vc $ipo $ipos #biotech #alternativeinves‚Ä¶Long $REGN$REGN New SEC Document(s) for Regeneron Pharmaceuticals, Inc.
From our Stock News Alerts App$REGN:

New Insider Transaction on REGN by EVP &amp; General Mgr Industrial O:

https://t.co/iIBnVmXLjU https://t.co/80lIWdxqkpRegeneron Pharmaceuticals's EVP %26 General Mgr Industrial O just cashed-in 9,460 options  https://t.co/puRqEIBtGG $REGNABEO 52Wk Low
See Here ---&gt; https://t.co/nDXbMQa6xy

$ABEO $OISHF $REGN #investing$REGN partnership w/ $NTLA could usher in a new wave of growth for this already growing beast...$REGN love the chart here as well....looks like it wants $420UTX Exchange
See Here ---&gt; https://t.co/MLTLbHiVLh

$UTX $REGN $LKQ #invest$REGN Regeneron Pharmaceuticals Inc  Kurtosis:-1.41 Skew:-0.29 Correlation Histogram #bigdata https://t.co/batufADxrX$REGN in 2 years it could have four blockbuster drugs on the market$REGN open a small position with $REGN at ave. $383/sh. 2 binary events are upcoming --&gt; sarilumab and Dupilumab = estimate $4-$5B in revRegeneron Pharmaceuticals Inc $REGN Cut to ‚ÄúBuy‚Äù at Vetr Inc. https://t.co/DX6xKRQ2hI$REGN bounce off 8EMA https://t.co/c6A8UEnEj4 via https://t.co/11Wpw9y7t1Vetr Inc. Upgrades Regeneron Pharmaceuticals Inc $REGN to Strong-Buy https://t.co/GX4dZR8ZIOVetr Inc. Upgrades Regeneron Pharmaceuticals Inc $REGN to Strong-Buy https://t.co/SZyGCwGzasVetr Inc. Upgrades Regeneron Pharmaceuticals Inc $REGN to Strong-Buy https://t.co/HIV1WBkaVwTime to leave the pink glasses. Here the truth drops to an another state of reality. $IBB $ALXN $REGNHere comes the Biotech bubble. $REGN $ALXN $IBBREGN Stock Forum
See Here ---&gt; https://t.co/CLG1hK804w

$REGN $XENT $ZEUS #investingIberiabank Corp Raises Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/jnpTkJgQmCIberiabank Corp Raises Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/1fGdtQAwULRobert W. Baird Reaffirms ‚ÄúBuy‚Äù Rating for Regeneron Pharmaceuticals Inc $REGN https://t.co/YpUSoTqfdRRobert W. Baird Reaffirms ‚ÄúBuy‚Äù Rating for Regeneron Pharmaceuticals Inc $REGN https://t.co/Ti1DtXYkRe@AndyBiotech @AndytweetM CSCC for sure.  Could be a few other winners in the data set as well $REGNRobert W. Baird Reaffirms ‚ÄúBuy‚Äù Rating for Regeneron Pharmaceuticals Inc $REGN https://t.co/p0MGcHvhAB$REGN Aggressive Phase 1 Combo Strategy For anti-PD1 In Competitive FieldJoel Isaacson &amp; Co. LLC Has $1,081,000 Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/cSh8hXJkoaPBFX Financials
See Here ---&gt; https://t.co/FhUAUFEvI2

$PBFX $REGN $AROC #tradeideasRT @AndyBiotech: #ASCO16 @tstamm7002 @andytweetM $REGN has already started a Ph2 trial in CSCC, presumably saw good activity there

https:/‚Ä¶#ASCO16 @tstamm7002 @andytweetM $REGN has already started a Ph2 trial in CSCC, presumably saw good activity there

https://t.co/Q1dgtCwNpRRT @AndyBiotech: #ASCO16 $REGN Anti-PD1 + radiation 

https://t.co/F7heDMjQpJWeekly S&amp;P500 #Stocks Trend $NVDA $WMB $MCK $SCHW $ETFC $REGN $LNC $KEY $LOW $RF $TYC $A $UNM $ADS $PRU $JPM  @ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Trend $NVDA $INCY $REGN $VOD $CHTR $QCOM $NXPI $CTSH $BMRN $ALXN $LLTC $TXN $NTES $CA  @ https://t.co/YdSIjFJqHfWeekly Nasdaq100 #Stocks Performance $NVDA $ENDP $NTES $INCY $STX $MYL $BMRN $REGN $VOD $CHTR $WDC $CA  more@ https://t.co/YdSIjFJqHfAIG Prev Close
See Here ---&gt; https://t.co/eJ4tCrYZAR

$AIG $MPC $REGN #stockRT @BColwell_ALT: Many Risks 4 The #Merus B.V. #IPO $MRUS https://t.co/NcpaK41Iak #venturecapital #vc $ipo $ipos #biotech #alternativeinves‚Ä¶Many Risks 4 The #Merus B.V. #IPO $MRUS https://t.co/NcpaK41Iak #venturecapital #vc $ipo $ipos #biotech #alternativeinvestments $regn $mackRT @AndyBiotech: #ASCO16 $REGN Anti-PD1 + radiation 

https://t.co/F7heDMjQpJRT @AndyBiotech: #ASCO16 $REGN Anti-PD1 + radiation 

https://t.co/F7heDMjQpJRT @biospace: Delving Into Pfizer $PFE's Acquisition Strategy and Its Impact on Regeneron $REGN https://t.co/AXN4jx99s6 https://t.co/V4JgmH‚Ä¶#ASCO16 $REGN Anti-PD1 + radiation 

https://t.co/F7heDMjQpJ$REGN testing this down trendline... Over is good but at a key pivot here. https://t.co/jVvW5ArsvZIchimoku Green https://t.co/NYnASjXbYr $FNMA $NVS $REGN $AGIO $LNCE $ZFGN $QSII $CEQP $EXTR $HMST $OSIS $FATE $UBIO $OHRP $HTGM $DSCI $SKYS",2016-05-19,REGN,1
32,"RT @sssvenky: With $IBB showing some strength, a decent move higher in $REGN. Mentioned a move over flag break during the weekend. https://‚Ä¶$REGNRT @paulwoll: $REGN nice look long setup tomorrow over red line... https://t.co/EdYvpvjKO6RT @paulwoll: $REGN nice look long setup tomorrow over red line... https://t.co/EdYvpvjKO6Baron Funds Comments on #RegeneronPharmaceuticals. Read more: https://t.co/kI5zlopqKQ $REGNRT @paulwoll: $REGN nice look long setup tomorrow over red line... https://t.co/EdYvpvjKO6$REGN nice look long setup tomorrow over red line... https://t.co/EdYvpvjKO6Nasdaq100 #Stocks Trend $INCY $TRIP $MU $INTU $AMAT $CSCO $TMUS $NXPI $MXIM $TXN $NVDA $LLTC $QCOM $REGN $NFLX  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $INCY $TRIP $MU $NFLX $WDC $VIAB $SWKS $NTAP $STX $REGN $MAT $INTU $ADSK  more@ https://t.co/YdSIjFJqHfScan results - Crossed Above 50 DMA today: $LXRX $WATT $EXPD $TSEM $DOW $JNS $RLYP $REGN $RHT $ISIL ... https://t.co/m3MWgOfbh0RT @sssvenky: With $IBB showing some strength, a decent move higher in $REGN. Mentioned a move over flag break during the weekend. https://‚Ä¶With $IBB showing some strength, a decent move higher in $REGN. Mentioned a move over flag break during the weekend. https://t.co/4AP5wJiXSnRT @pharmalot: Sanofi shifts top management &amp; top #diabetes exec will leave.. a 'purge' of the old guard.. https://t.co/Vg9zxq92US #pharma‚Ä¶RT @pharmalot: Sanofi shifts top management &amp; top #diabetes exec will leave.. a 'purge' of the old guard.. https://t.co/Vg9zxq92US #pharma‚Ä¶XNET Yield
See Here ---&gt; https://t.co/TRivQzFyzm

$XNET $GOOG $REGN #stocksS&amp;P500 #Stocks Trend $MON $TRIP $MU $RHT $BBY $DOW $REGN $DD $INTU $RL $GLW $AMAT $CRM $USD $INTC $CSCO $LLTC  @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $INCY $TRIP $MU $REGN $INTU $AMAT $INTC $CSCO $LLTC $TMUS $QCOM $NXPI $TXN $MXIM $ADI  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $INCY $TRIP $MU $VIAB $WDC $STX $SWKS $REGN $NFLX $ADSK $INTU $NTAP $MAT  more@ https://t.co/YdSIjFJqHfRT @pharmalot: Sanofi shifts top management &amp; top #diabetes exec will leave.. a 'purge' of the old guard.. https://t.co/Vg9zxq92US #pharma‚Ä¶RT @pharmalot: Sanofi shifts top management &amp; top #diabetes exec will leave.. a 'purge' of the old guard.. https://t.co/Vg9zxq92US #pharma‚Ä¶Sanofi shifts top management &amp; top #diabetes exec will leave.. a 'purge' of the old guard.. https://t.co/Vg9zxq92US #pharma $SNY $REGN $AMGNRT SeekingAlpha: Sanofi: High Quality Product Portfolio But Risks Remain https://t.co/kB5qmDoKnz $AMGN $REGN $MDVN $SNYSeekingAlpha: Sanofi: High Quality Product Portfolio But Risks Remain https://t.co/G2cqmaNjGP $AMGN $REGN $MDVN $SNYSanofi: High Quality Product Portfolio But Risks Remain https://t.co/c65yBAbm4C $AMGN $REGN $MDVN $SNYCall/Put Highest % volume changes:  Calls: $REGN, $SKX, $BMRN, $LLTC, $CCL.  Puts: $PAA, $CPB, $CSX, $RSX, $PKG.$REGN shook me out last week, but back on radar$REGN #Regeneron 395.34
for Mon May 23
VZVOLBO
Get Long BSTP 389.00
ATR tgt=395.00 MET
Today's O=386.46, H=396.99
but still below 144dma=454Nasdaq100 #Stocks Performance $INCY $TRIP $VIAB $STX $SWKS $WDC $NFLX $REGN $MU $AAPL $DISCA $NXPI $AVGO  more@ https://t.co/YdSIjFJqHf$REGN - Regeneron Pharmaceuticals' #REGN ""Hold"" Rating Reiterated at Wells Fargo https://t.co/wV6P9euvsrRegeneron Pharmaceuticals, Inc.  Reiterated Rating by Wells Fargo (Ranked 7th) to Hold $REGN #REGN https://t.co/6KTXk3W2QERegeneron Pharmaceuticals's hold rating reiterated at Wells Fargo. https://t.co/kX4IXxoYwc $REGN #REGNRegeneron Pharmaceuticals Inc $REGN Earns ‚ÄúHold‚Äù Rating from Wells Fargo https://t.co/2LchDeIpNuRegeneron Pharmaceuticals Inc $REGN Earns ‚ÄúHold‚Äù Rating from Wells Fargo https://t.co/NV8njtSsgwRegeneron Pharmaceuticals Inc $REGN Earns ‚ÄúHold‚Äù Rating from Wells Fargo https://t.co/WOSiyye8uvRegeneron Pharmaceuticals Inc $REGN Earns ‚ÄúHold‚Äù Rating from Wells Fargo https://t.co/851kPOeV3yRegeneron Pharmaceuticals's hold rating reiterated at Wells Fargo. https://t.co/WpXzt8CC3c $REGN #REGNRT @paulwoll: $REGN breaking over down trendline. today said to watch for this.. https://t.co/ptPzDcS7zoGS prefer exposure to stocks where see upside to estimates and/or pipeline optionality ‚Äì $AGN $AMGN $ABBV $BMY and $REGN$REGN breaking over down trendline. today said to watch for this.. https://t.co/ptPzDcS7zo$REGN: 1mRunaway+:1 [+3%,.2%offHi], 13:5Accel+, allTFs+; TLM:1.8; ILM:1.3, 1WkHi+, DyVol:270T:0.3x:0.3x, DyRng:3.2%:2.1x:1.2xRegeneron Receives a Hold from Wells Fargo $REGN https://t.co/pHGT7nJQZiREGN Message Board Posts
See Here ---&gt; https://t.co/Z4RvBqMdwn

$REGN $ENPH $LFUS #pennystocksPlew Daniel P. Van Sells 4,413 Shares of Regeneron Pharmaceuticals Inc $REGN Stock https://t.co/RcwPN7g9HMPlew Daniel P. Van Sells 4,413 Shares of Regeneron Pharmaceuticals Inc $REGN Stock https://t.co/DQ9bifIIRn",2016-05-23,REGN,1
33,"VA Stock Forum
See Here ---&gt; https://t.co/dKoxLMr0XR

$VA $HURN $REGN #stocksBearish Doji https://t.co/MLURCKnBwb $QUOT $BSJK $DXLG $CLS $REGN $CGIX $PBA $CARA $TKC $HAYN $RCII $SQNS $ZBRA $UAM $KTWO $BPTH $JMBA@jimcramer What's up with $REGN?Longest consecutive sequence of trades with increasing prices on 5/23 was 19 $REGN trades that started at 18:15:38.588The 10 Best #Healthcare Stocks to Buy in a Rocky Market $VRX $WBA $REGN https://t.co/gV2AIwuUxC @investorplaceI.e., $AGN touted an array of other ophthalmology programs, but mentioned Darpin only when asked. $NVS $REGN% off high
$CLVS 86,7%
$BLUE 78,6%
$HALO 61,6%
$RLYP 57,8%
$JUNO 41,8%
$REGN 34,5%
$ONCE 30,8%
$GILD 30,2%
$BIIB 25,3%
$AMGN 15,9%RT @portefeuillefun: Added 40 $REGN shares at $396.40, now 100 #zzporte shares, cost basis $387.00. @zzlangerhansRT @portefeuillefun: #zzporte top40. @zzlangerhans $AKBA $BLCM $BLUE $CLLS $ENTA $FPRX $GLPG $IONS $JUNO $MDVN $QURE $REGN. cash ‚âà $329k ht‚Ä¶#zzporte top40. @zzlangerhans $AKBA $BLCM $BLUE $CLLS $ENTA $FPRX $GLPG $IONS $JUNO $MDVN $QURE $REGN. cash ‚âà $329k https://t.co/1LMvX0Ma1fAdded 40 $REGN shares at $396.40, now 100 #zzporte shares, cost basis $387.00. @zzlangerhansREGN Day High
See Here ---&gt; https://t.co/vpwJZjDpab

$REGN $IPCI $ZTS #financeGreatest MACD increase within the $SPY $REGN $AGN $MCK $PRGO $SRCL https://t.co/uVyGkXPUhv https://t.co/on1jcFhHy2Eli Lilly $LLY and Regeneron $REGN: How to Find Your First Biopharma Job Out of College https://t.co/AIVtNCsJxn https://t.co/6JlDliKgG7I'm sure many more today... $IBB $GILD $AMGN $BIIB $REGN $CELG@jeff_whatever Yeah, but I missed that short. Shit!!  Wanted too long. Hoping for another push higher. $KITE. $REGN will start downturn..@BioStockAddict As I keep saying, #biospring :) $REGNRT @BioStockAddict: Keep an eye on $REGN: tripple bottom and now breaking out of that downtrend line. https://t.co/JEuAVhUaFNKeep an eye on $REGN: tripple bottom and now breaking out of that downtrend line. https://t.co/JEuAVhUaFN$REGN 400 https://t.co/pk96WC9D9a via https://t.co/11Wpw9y7t1RT @stockmonitorapp: Momentum is up on $REGN last 3 days, and price crossed above 50MA. More strength to come? https://t.co/ggVpQbQEcN‚Ä¶ htt‚Ä¶How I Made a Huge Profit on Regeneron -- And It was One of My Biggest Mistakes Ever $REGN https://t.co/6G9xLJW1nj https://t.co/IHQg4Td9NaMomentum is up on $REGN last 3 days, and price crossed above 50MA. More strength to come? https://t.co/ggVpQbQEcN‚Ä¶ https://t.co/iRxa0FjVMf$regn looking like it is trying to breakout.Texas Permanent School Fund Has $9,616,000 Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/PvfSfrVSw3Weekly Nasdaq100 #Stocks Trend $AMAT $MU $INCY $CSCO $TRIP $TMUS $INTU $NVDA $NXPI $QCOM $LLTC $TXN $MXIM $REGN @ https://t.co/YdSIjFJqHfRegeneron Pharmaceuticals Inc $REGN EVP Sells $1,702,403.01 in Stock https://t.co/swiE8oMSb9Regeneron Pharmaceuticals Inc $REGN EVP Sells $1,702,403.01 in Stock https://t.co/Uu5zY4pb2Dperformance update. @zzlangerhans #zzporte $ABBV $ALXN $AMGN $BIIB $BMY $CELG $FPRX $GILD $IBB $INO $REGN $VRX $XBI https://t.co/mKJWA9ohcTRegeneron Pharmaceuticals‚Äô $REGN ‚ÄúHold‚Äù Rating Reaffirmed at Wells Fargo https://t.co/WT3lAH7Y1kRT @sssvenky: With $IBB showing some strength, a decent move higher in $REGN. Mentioned a move over flag break during the weekend. https://‚Ä¶RT @paulwoll: $REGN nice look long setup tomorrow over red line... https://t.co/EdYvpvjKO6Stock Ideas For The Week Ahead ‚Äì $REGN $SA $DV $WYNN $MGM https://t.co/yuIIQAKKjI",2016-05-24,REGN,0
34,"@DShaywitz @dgmacarthur 
Sorry. Not saying @23andMe can't do it - if I had to choose 1, $regn discovery built over 25 years I pick that oneA Director at Regeneron (NASDAQ: REGN) is Selling Shares $REGN https://t.co/oPRfFNHXyG$REGN New SEC Document(s) for Regeneron Pharmaceuticals, Inc.
From our Stock News Alerts AppRegeneron Pharmaceuticals director just disposed of 3,000 shares  https://t.co/UQAeiZpW4M $REGNRT @ldbvua: @Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.‚Ä¶@Adaptimmune Therapeutics $ADAP

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/5l3FSjGjkn$REGN i believe buy ratings for this stock is like giving investors a hand grenade with a pulled fuse and running away :D$REGN acting sick. Better turn or this chart goes from here to zero.$REGN i think it will eventually break really bad like $VRX$REGN high p/e ratio and a very speculative stock. No idea who buys when insiders sell so much..New Century Investment Management Inc. Has $949,000 Stake in Regeneron Pharmaceuticals Inc $REGN https://t.co/UyEdeR2MKJFrank Sands Sells Visa, Baidu, Alibaba $MELI $PCLN $BABA $ALXN $REGN $BIDU $V $FTI https://t.co/45jXL91Dab@tgtxdough $REGN and $AMGN which are most exposed would see the most potential upside if the delay is confirmed.Mn Services Vermogensbeheer B.V. Invests $606,000 in Regeneron Pharmaceuticals Inc $REGN https://t.co/jhkpnAZDkMMn Services Vermogensbeheer B.V. Invests $606,000 in Regeneron Pharmaceuticals Inc $REGN https://t.co/RzuFPVsompSell-signal detected for 22 stocks: $RHT $CME $CSCO $INTU $JPM $SCHW $ADBE $KEY $JBL $PNC $CHRW $DD $AAPL $REGN $CI $WFM $MCHP $TXN $AGN ...RT @BioStockAddict: Keep an eye on $REGN: tripple bottom and now breaking out of that downtrend line. https://t.co/JEuAVhUaFNRT @RaginCajun: Stock Ideas For The Week Ahead ‚Äì $REGN $SA $DV $WYNN $MGM https://t.co/yuIIQAKKjIRT @RaginCajun: Stock Ideas For The Week Ahead ‚Äì $REGN $SA $DV $WYNN $MGM https://t.co/yuIIQAKKjICommented on StockTwits: $REGN $400 is a brick wall. Notice how it had no mojo today. Cross your fingers for higher. https://t.co/m5vgvqIFytRT @iviewmarkets: Greatest MACD increase within the $SPY $REGN $AGN $MCK $PRGO $SRCL https://t.co/uVyGkXPUhv https://t.co/on1jcFhHy2Commented on StockTwits: $REGN report: 5/18 BUY stamped $380s, but this on... https://t.co/QU3qxa6jYE",2016-05-25,REGN,0
35,"@ArmedGEMINI I think it's combination: 1) last yr extreme Val 2) LT $REGN comp 3) BB covering $INCY &amp; other losses along w bio-sell off180 Bullish https://t.co/vXytwc2xGl $SYKE $CECO $REGN $TMK $WLTW $EOI $INWK $AWH $SOL $EPHE $SNX $FTD $CASY $TASR $SJI $CHL $TSLX$REGN Regeneron Selected by Society for Science &amp; the Public a‚Ä¶ https://t.co/9ckCXWeK69$REGN Regeneron Named as Science Talent Search Sponsor‚Ä¶ https://t.co/AzdTtm8vxoRT @JohnCFierce: Good for $REGN. Sponsoring top science competition. Putting some of that big money to good work. by @matthewherper 
https:‚Ä¶#RSV market is rife with opportunity. How will new prophylactics from $REGN and $NVAX fare, impact $AZN's #Synagis? https://t.co/x1XLJoqWow#RegeneronPharmaceuticals Biotech firm Regeneron to take over science competition. Read more: https://t.co/8Ff80eUabq $REGN#RegeneronPharmaceuticals Biotech firm Regeneron to take over science competition. Read more: https://t.co/X5FQeO9vQE $REGNGood move, $REGN! https://t.co/3rcm1p4URj#zzporte top40. @zzlangerhans $AKBA $BLCM $BLUE $CLLS $ENTA $FPRX $GLPG $JUNO $MDVN $QURE $REGN $STML. cash ‚âà $414k https://t.co/yIcHFsGzvHGS Message Board Posts
See Here ---&gt; https://t.co/t7U6sTRkje

$GS $REGN $FOXA #investCEOs Vs. #HedgeFund Managers: Who Gets Paid Better? https://t.co/EcGPBVNdet @benzinga $EXPE $CBS $VIA $REGN $DIS $GGP $CMCSA $YHOO $HON $CRMRT @megtirrell: Scientists put a man on the moon, cured polio. But science has fallen off as top attracter of talent, $REGN's Yancopoulos s‚Ä¶$IONS guess this one wasn't the next $REGN either$REGN goes up on low volume.RT @cbtadvisors: It's the Bio Century! Regeneron $REGN to Sponsor Science Talent Search w $100M https://t.co/eLrBBLiyw2 @BioCentury https:/‚Ä¶$REGN to Sponsor Science Talent Search https://t.co/fSL2AgVWVT $INTC#RegeneronPharmaceuticals Regeneron Becomes New Sponsor for the Nation's Most Prestigious S... Read more: https://t.co/rt3y79M506 $REGN#RegeneronPharmaceuticals Regeneron Becomes New Sponsor for the Nation's Most Prestigious S... Read more: https://t.co/F7ZksW0SRY $REGN$REGN Selected by Society for Science https://t.co/X7Y1SOO9JO$REGN Selected by Society for Science https://t.co/FMVtdpBbd0 #biotechstocks #biotech #stocksCEOs Vs. Hedge Fund Managers: Who Gets Paid Better? $CMCSA $DIS $YHOO $HON $EXPE $CRM $REGN https://t.co/PlaDZw8msN https://t.co/vJ7JZGiizdBiotech Regeneron replaces Intel as sponsor of Science Talent Search https://t.co/dvi8Ox8f9Q $REGNRT @megtirrell: Announcement of $REGN as new Westinghouse prize sponsor at @AMNH w @neiltyson https://t.co/D8rvzVDPPNGo Lenny! #Biotech #Regeneron replaces #Intel as sponsor of Science Talent Search https://t.co/U9QUNZX8ne via @Reuters $REGN $INTCRT @megtirrell: ""It was an instant unanimous decision"" of $REGN BoD to sponsor Westinghouse, Len Schleifer says. Board's response: ""Go do i‚Ä¶RT @ronwinslow: Biotech $REGN is new corporate  sponsor of Science Talent Search, formerly ""The Westinghouse""  https://t.co/kSIjBvQ9RmCompetitions inspire and aggregate the best of us. $REGN investing heavily. ROI is clear for them. https://t.co/sjXXOpdeduRT @JohnCFierce: Good for $REGN. Sponsoring top science competition. Putting some of that big money to good work. by @matthewherper 
https:‚Ä¶#RegeneronPharmaceuticals This Biotech Is Replacing Intel as Sponsor of the Top U.S. Studen... Read more: https://t.co/kis5p3Q9Az $REGNRT @cbtadvisors: It's the Bio Century! Regeneron $REGN to Sponsor Science Talent Search w $100M https://t.co/eLrBBLiyw2 @BioCentury https:/‚Ä¶$REGN CEO: People ask: 'Who's $REGN; Now I hope they'll say 'they are the ones that sponsor the Science Talent Search'
#FutureOfSTS #biotech$REGN CEO: Approaching golden era in biological sciences w/ tools to create/store gobs of info; apply to #cancer, #Alzheimers
#FutureOfSTSRT @jonathanrockoff: Kudos to $REGN for investing in encouraging STEM in our kids, case of pharma doing not just good but great https://t.c‚Ä¶RT @megtirrell: $REGN won sponsorship of Westinghouse prize ""bc they're one of us,"" Society for Science &amp; the Public CEO says #FutureofSTSGreat stuff from @CNBC's @megtirrell about $REGN's sponsorship of the Science Talent Search. Check out her feed. #FutureofSTSRT @jonathanrockoff: Kudos to $REGN for investing in encouraging STEM in our kids, case of pharma doing not just good but great https://t.c‚Ä¶.@neiltyson: The nation is in science doldrums &amp; it needs $REGN investment to kick it you know where
#FutureOfSTS #science #pharma #biotech#RegeneronPharmaceuticals RPT-Biotech Regeneron replaces Intel as sponsor of Science Talent... Read more: https://t.co/CafytuEyHP $REGN#RegeneronPharmaceuticals Regeneron Replaces Intel as Science Talent Search Sponsor. Read more: https://t.co/CxJkqcw3dN $REGNRT @megtirrell: Scientists put a man on the moon, cured polio. But science has fallen off as top attracter of talent, $REGN's Yancopoulos s‚Ä¶RT @megtirrell: ""It was an instant unanimous decision"" of $REGN BoD to sponsor Westinghouse, Len Schleifer says. Board's response: ""Go do i‚Ä¶RT @megtirrell: $REGN won sponsorship of Westinghouse prize ""bc they're one of us,"" Society for Science &amp; the Public CEO says #FutureofSTSRT @jodigralnick: Behind the scenes: @cnbc @megtirrell interviews @neiltyson abt $REGN sponsoring Westinghouse prize https://t.co/l8QLOgdyxTRT @megtirrell: Announcement of $REGN as new Westinghouse prize sponsor at @AMNH w @neiltyson https://t.co/D8rvzVDPPNRT @megtirrell: Scientists put a man on the moon, cured polio. But science has fallen off as top attracter of talent, $REGN's Yancopoulos s‚Ä¶$REGN George Yancopoulos: We provide right example of using #science and #innovation to do good
#FutureOfSTS #pharma #biotechRT @megtirrell: Scientists put a man on the moon, cured polio. But science has fallen off as top attracter of talent, $REGN's Yancopoulos s‚Ä¶Kudos to $REGN for investing in encouraging STEM in our kids, case of pharma doing not just good but great https://t.co/G3k5ydrf5mScientists put a man on the moon, cured polio. But science has fallen off as top attracter of talent, $REGN's Yancopoulos says #FutureofSTS""It was an instant unanimous decision"" of $REGN BoD to sponsor Westinghouse, Len Schleifer says. Board's response: ""Go do it. It's perfect.""RT @bioILLOGICAL: #biotech is the new #tech

$REGN was selected as the new named sponsor of the Science Talent Search https://t.co/wW9WItbS‚Ä¶RT @bioILLOGICAL: #biotech is the new #tech

$REGN was selected as the new named sponsor of the Science Talent Search https://t.co/wW9WItbS‚Ä¶#biotech is the new #tech

$REGN was selected as the new named sponsor of the Science Talent Search https://t.co/wW9WItbSdm via @WSJRT @jodigralnick: Behind the scenes: @cnbc @megtirrell interviews @neiltyson abt $REGN sponsoring Westinghouse prize https://t.co/l8QLOgdyxTRT @jodigralnick: Behind the scenes: @cnbc @megtirrell interviews @neiltyson abt $REGN sponsoring Westinghouse prize https://t.co/l8QLOgdyxTRT @megtirrell: Announcement of $REGN as new Westinghouse prize sponsor at @AMNH w @neiltyson https://t.co/D8rvzVDPPN$REGN won sponsorship of Westinghouse prize ""bc they're one of us,"" Society for Science &amp; the Public CEO says #FutureofSTS$REGN to sponsor Science Talent Search high-school competition, doubling funding to $100mn over 10 yrs: https://t.co/gHk0J6kPew @ronwinslowRT @jodigralnick: Behind the scenes: @cnbc @megtirrell interviews @neiltyson abt $REGN sponsoring Westinghouse prize https://t.co/l8QLOgdyxTBehind the scenes: @cnbc @megtirrell interviews @neiltyson abt $REGN sponsoring Westinghouse prize https://t.co/l8QLOgdyxTRT @megtirrell: Announcement of $REGN as new Westinghouse prize sponsor at @AMNH w @neiltyson https://t.co/D8rvzVDPPNAnnouncement of $REGN as new Westinghouse prize sponsor at @AMNH w @neiltyson https://t.co/D8rvzVDPPNIt's the Bio Century! Regeneron $REGN to Sponsor Science Talent Search w $100M https://t.co/eLrBBLiyw2 @BioCentury https://t.co/JD2EpPXEbSCool video included in $REGN‚Äôs Science Talent Search PR. Kudos to them on sponsoring a great thing. https://t.co/sjOBCpowbt$REGN Regeneron Selected by Society for Science &amp; the Public as New Sponsor of the Science Talent Search
From our Stock News Alerts AppRT @JohnCFierce: Good for $REGN. Sponsoring top science competition. Putting some of that big money to good work. by @matthewherper 
https:‚Ä¶Outstanding news! The greatest #STEM fair in the world lives on thanks to $REGN - thanks!
https://t.co/xFCSEKYEgfRT @JohnCFierce: Good for $REGN. Sponsoring top science competition. Putting some of that big money to good work. by @matthewherper 
https:‚Ä¶$INCY triggered 5/11; $BMRN 5/17; $JAZZ 5/18; $SHPG 5/19; $REGN 5/23; $AMGN would trigger potential breakout at 155.84#RegeneronPharmaceuticals Regeneron Named as Science Talent Search Sponsor. Read more: https://t.co/vDTO1fTujT $REGNRT @JohnCFierce: Good for $REGN. Sponsoring top science competition. Putting some of that big money to good work. by @matthewherper 
https:‚Ä¶RT @ronwinslow: Biotech $REGN is new corporate  sponsor of Science Talent Search, formerly ""The Westinghouse""  https://t.co/kSIjBvQ9RmGood for $REGN. Sponsoring top science competition. Putting some of that big money to good work. by @matthewherper 
https://t.co/UcxvQQN9L4megtirrell: New sponsor of Westinghouse prize? $REGN: https://t.co/YNC6dGlN9HRT @megtirrell: New sponsor of Westinghouse prize? $REGN: https://t.co/qGiIKajUolNew sponsor of Westinghouse prize? $REGN: https://t.co/qGiIKajUolBiotech $REGN is new corporate  sponsor of Science Talent Search, formerly ""The Westinghouse""  https://t.co/kSIjBvQ9Rm$REGN Statement of Changes in Beneficial Ownership (4)‚Ä¶ https://t.co/tdzkWyh4HaREGN Filings
See Here ---&gt; https://t.co/3eSm75JwPA

$REGN $MDT $HQCL #finance#RegeneronPharmaceuticals to Sponsor Science Talent Search. Read more: https://t.co/wEJHdIIpTc $REGNAfter Intel's exit, Regeneron commits $100m over 10 years to sponsor #Science Talent Search. https://t.co/2hMgHyYEOg $REGN #biotech #STEM#RegeneronPharmaceuticals Biotech Regeneron replaces Intel as sponsor of Science Talent Sea... Read more: https://t.co/dwF6hcx3QR $REGN#RegeneronPharmaceuticals Biotech Regeneron replaces Intel as sponsor of Science Talent Sea... Read more: https://t.co/BAeEhWaeW5 $REGN#RegeneronPharmaceuticals : Named as Science Talent Search Sponsor. Read more: https://t.co/GtfdrE3mWn $REGN#RegeneronPharmaceuticals Biotech Regeneron replaces Intel as sponsor of Science Talent Sea... Read more: https://t.co/Sb63mGh3ix $REGNInsider Selling: Regeneron Pharmaceuticals Inc $REGN Director Sells 1,000 Shares of Stock https://t.co/H6Ufn9vPfCInsider Selling: Regeneron Pharmaceuticals Inc $REGN Director Sells 1,000 Shares of Stock https://t.co/Dgde4Z8IWS",2016-05-26,REGN,1
36,"RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶REGN Summary
See Here ---&gt; https://t.co/Qy0mfKZ8Ba

$REGN $GBCI $AGIO #stockRT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶Investment Analysts‚Äô Weekly Ratings Changes for Regeneron Pharmaceuticals $REGN https://t.co/a5NlOTWV0HInvestment Analysts‚Äô Weekly Ratings Changes for Regeneron Pharmaceuticals $REGN https://t.co/igfeW9UdMQRT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD $INCY $REGNDCO Current Price
See Here ---&gt; https://t.co/kzbJykA2Lk

$DCO $REGN $PF #tradeideasRT @MktOutperform: Amazon is the 5th best performing stock in the S&amp;P 500 over the past 10 years. #1-4: $PCLN, $REGN, $NFLX, and $MA. https‚Ä¶$REGN:US Regeneron Presents Positive Interim Data From Phase 2 Study Of Evinacumab #REGENERON PHARMACEUT  https://t.co/kp2XJ5002P #NASDAQ$REGN the bull pattern is confirmed &amp; a BUY signal is issued @ https://t.co/u0JXvIHf7y. Buy Level: 398.9300   Target: 414.8872RT @MktOutperform: Amazon is the 5th best performing stock in the S&amp;P 500 over the past 10 years. #1-4: $PCLN, $REGN, $NFLX, and $MA. https‚Ä¶MERC % Change
See Here ---&gt; https://t.co/Ho7bMJItqI

$MERC $ENOC $REGN #stocksRT @MktOutperform: Amazon is the 5th best performing stock in the S&amp;P 500 over the past 10 years. #1-4: $PCLN, $REGN, $NFLX, and $MA. https‚Ä¶Amazon is the 5th best performing stock in the S&amp;P 500 over the past 10 years. #1-4: $PCLN, $REGN, $NFLX, and $MA. https://t.co/rXYXGIhREPRT @paulwoll: Keep eye on $REGN looks to be coiling here....$REGN Regeneron Presents Positive Interim Data from Phase 2 Pr‚Ä¶ https://t.co/eVZO77XKZ0Nasdaq100 #Stocks Trend $VRTX $BIIB $MU $DLTR $DISH $AMGN $EBAY $CELG $FISV $ULTA $VIAB $WDC $AMZN $NXPI $REGN  @ https://t.co/YdSIjFJqHf$REGN https://t.co/JNxH9o5yEJRegeneron Pharmaceuticals Inc $REGN Receives Consensus Rating of ‚ÄúHold‚Äù from Brokerages https://t.co/f0l0p3LXR2Keep eye on $REGN looks to be coiling here....CSCO Company Info
See Here ---&gt; https://t.co/0mN8sbQnGe

$CSCO $REGN $SFE #investingRegeneron Pharmaceuticals (REGN) is About to Regenerate $REGN #RegeneronPharmaceuticals https://t.co/CFHkx2X3Rc$REGN announces interim data for¬†evinacumab https://t.co/AhsboUqOrO#RegeneronPharmaceuticals Regeneron Presents Favorable Interim Data From Stage 2 Proof-Of-C... Read more: https://t.co/GmGBLKfKGC $REGN#RegeneronPharmaceuticals BRIEF-Regeneron presents positive data from phase 2 study of Evin... Read more: https://t.co/PqxSJ3u2jJ $REGN#RegeneronPharmaceuticals Regeneron Presents Positive Interim Data from Phase 2 Proof-of-Co... Read more: https://t.co/8RNIrfbTYJ $REGN#RegeneronPharmaceuticals Regeneron Presents Positive Interim Data From Phase 2 Proof-Of-Co... Read more: https://t.co/NWZT83Cxid $REGN#RegeneronPharmaceuticals Regeneron Presents Positive Interim Data From Phase 2 Study Of Ev... Read more: https://t.co/fjDNGVI78c $REGN#RegeneronPharmaceuticals Regeneron Presents Positive Interim Data From Phase 2 Study Of Ev... Read more: https://t.co/U0KAeRCLPA $REGNDo not sell out on $CELG and $REGN after this little upmove. Only few growth names available at decent/attractive valuations.$REGN Regeneron Presents Favorable Interim Data From Stage 2 Proof-Of-Concept Trial Of Evinacumab‚Ä¶ https://t.co/jhYGQOMJPC ‚Üí via @AlertTrade$REGN Regeneron Presents Favorable Interim Data From Stage 2 Proof-Of-Concept Trial Of Evinacumab - https://t.co/XrJ0pi2PJ6Apex Capital Management Has $4,273,000 Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/JaWfuU6sEpApex Capital Management Has $4,273,000 Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/AilgqGEK1R$REGN Presents Positive Phase 2 Proof-of-Concept Study of Evinacumab in Patients with HoFH
https://t.co/y6ykXOI0l3$REGN I have the feeling there is also insider selling today...Third consecutive insider selling at $REGN with 6 days spacing in between sales.$REGN Presents Positive Interim Data https://t.co/ovslApxF3E@El_Mono1958 Now to get $REGN off its assInterim data encouraging for Regeneron's evinacumab in patients with inherited ultra-high cholesterol https://t.co/4KKshtaVbk $REGN $MRKInterim data encouraging for Regeneron's evinacumab in patients with inherited ultra-high cholesterol https://t.co/99ngPNPzKD $REGN $MRKInterim data encouraging for Regeneron's evinacumab in patients with inherited ultra-high cholesterol https://t.co/U7QwbWFhNr $REGN $MRK$REGN Presents Positive Interim Data https://t.co/xcaX8hnM2I #biotechstocks #biotech #stocksRT @WrigleyTom: $REGN
Presents Positive Interim Data From Ph 2 Proof-Of-Concept Study Of Evinacumab In Patients w/Homozygous Familial Hyper‚Ä¶$REGN Regeneron Presents Positive Interim Data from Phase 2 Proof-of-Concept Study of Evinacumab in Patients 
From our Stock News Alerts AppRT @WrigleyTom: $REGN
Presents Positive Interim Data From Ph 2 Proof-Of-Concept Study Of Evinacumab In Patients w/Homozygous Familial Hyper‚Ä¶$REGN
Presents Positive Interim Data From Ph 2 Proof-Of-Concept Study Of Evinacumab In Patients w/Homozygous Familial Hypercholesterolemia1,120 Shares in Regeneron Pharmaceuticals Inc $REGN Acquired by Parametrica Management Ltd https://t.co/f8HP5rREMZ1,120 Shares in Regeneron Pharmaceuticals Inc $REGN Acquired by Parametrica Management Ltd https://t.co/WQ17ZW8useIf $REGN-gives up here I will cut it.New eczema treatments could be available soon $REGN https://t.co/0mlGuqHxe2 via @WSJ",2016-05-31,REGN,1
37,"#RegeneronPharmaceuticals Regeneron Reports Interim Data on Cholesterol Lowering Drug. Read more: https://t.co/2W1yeWpgvA $REGNOver Ichimoku https://t.co/mnY2SqLVtI $UN $OLLI $BLDP $AVEO $XRM $DNOW $UMPQ $XRS $PVH $NR $HUM $BSV $BNS $CZR $REGN $BCE $SGMSRT @MatrizBiotech: Pre-Marke, ideas para observar:$VRTX, $REGN, $TEVA, $BMRN....y m√°s en nuestro newslleter diario gratuito con info  para‚Ä¶S&amp;P500 #Stocks Trend $WFM $TAP $MU $MNK $WDC $AET $CNC $REGN $JCI $ALXN $DHI $DG $MNST $MCK $TMO $TDC $VRTX $C @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $WFM $MU $WDC $DISH $ULTA $REGN $ALXN $MNST $MXIM $VRTX $MDLZ $CMCSA $VIAB $ESRX $DLTR  @ https://t.co/YdSIjG11yNNasdaq100 #Stocks Performance $ENDP $WFM $CHTR $MU $MYL $COST $WDC $STX $MAR $DISH $FOXA $ULTA $REGN $ALXN  more@ https://t.co/YdSIjFJqHfREGN Day High
See Here ---&gt; https://t.co/QSpXIMomAJ

$REGN $HPE $GWPH #stockmarketNext-generation eczema drugs on pace for 2017 launch https://t.co/nSmqryKS5k $PFE $SNY $REGNMSGN 52Wk High
See Here ---&gt; https://t.co/nKyp2WzTAC

$MSGN $PNY $REGN #stocks$BABA $AMZN $SRPT $BMRN $REGN https://t.co/BoBvtoso0bRT @MktOutperform: Amazon is the 5th best performing stock in the S&amp;P 500 over the past 10 years. #1-4: $PCLN, $REGN, $NFLX, and $MA. https‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶$BABA $AMZN $SRPT $BMRN $REGN market recap 6/1 https://t.co/NbmRIfSkYAS&amp;P500 #Stocks Trend $WFM $MNK $TAP $WDC $MU $REGN $ALXN $AET $MNST $CNC $DHI $TMO $TDC $WAT $DG $VRTX $CMCSA  @ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $WFM $WDC $MU $DISH $REGN $ALXN $ULTA $MNST $VRTX $MXIM $CMCSA $ESRX $DLTR $CERN $CTXS  @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $ENDP $WFM $CHTR $MYL $COST $WDC $MU $STX $DISH $REGN $INCY $FOXA $ALXN $MAR  more@ https://t.co/YdSIjFJqHf$REGN Sold $410 calls at $3.60 from $2.10 avg entry earlier. Decent gains there. $IBB &amp; $XBI still bullish imo$IBB $XBI $REGN $AGIO $KITE https://t.co/a8ywMRd1h4Regeneron Pharmaceuticals hits a 1 month high https://t.co/ljMX9dmC2H $REGN #RegeneronPharmaceuticals https://t.co/Y6DgNapQFH$REGN comfortably above 400, a volume pocket above https://t.co/OCDHEyJwrq via https://t.co/11Wpw9y7t1Indices flatlining today . but certain BIOS . in boom mode $LABU. $REGN $IBB107.4% earnings üå±growthüå± in 3 years.. What‚Äôs your opinion? Regeneron Pharmaceuticals $REGN https://t.co/4wKd7cV0co https://t.co/Ch8P1CaFRZRT @MktOutperform: Amazon is the 5th best performing stock in the S&amp;P 500 over the past 10 years. #1-4: $PCLN, $REGN, $NFLX, and $MA. https‚Ä¶$REGN #Regeneron 407.24
Wed June 1
VZVOLBO:
Get Long BSTP 401.66
ATR tgt=406.14 MET
today's O=398.75, H=408.35
Predicted Px works w/ VZVOLBORT @VictorZubarev: $REGN #Regeneron 407.52
Wed June 1
Predicted Px Range:
H=402.44, L=396.97
actual H=408.35, L=395.14
always on the list
@‚Ä¶$REGN #Regeneron 407.52
Wed June 1
Predicted Px Range:
H=402.44, L=396.97
actual H=408.35, L=395.14
always on the list
@vxx46Not sure what to do with $REGN? Explore our #fundamental pros and cons.  https://t.co/5ue7vzjlWZRT @DozenStocks: S&amp;P500 #Stocks Performance $ENDP $KORS $WFM $MPC $MYL $COG $TSO $COST $MNK $HBI $AGN $VLO $REGN $WDC $THC  more@ https://t‚Ä¶S&amp;P500 #Stocks Trend $WFM $VRTX $TDC $ESRX $CNC $PFE $DG $MDLZ $CERN $AMZN $HPQ $CMCSA $BIIB $HSY $DLTR $REGN  @ https://t.co/RPeaHBHYi0S&amp;P500 #Stocks Performance $ENDP $KORS $WFM $MPC $MYL $COG $TSO $COST $MNK $HBI $AGN $VLO $REGN $WDC $THC  more@ https://t.co/RPeaHBHYi0Nasdaq100 #Stocks Trend $WFM $DISH $VRTX $ULTA $ESRX $MDLZ $CERN $AMZN $CMCSA $BIIB $DLTR $REGN $MXIM $CA $FISV @ https://t.co/YdSIjFJqHfNasdaq100 #Stocks Performance $ENDP $WFM $MYL $CHTR $COST $REGN $WDC $FOXA $ALXN $DISH $VRTX $ULTA $CTXS  more@ https://t.co/YdSIjFJqHf$REGN $VLO Unlikely suspects feeling good on a gloomy market day. Go figure... We remain very interested in $VLO ...REGN - Stock Investment Research, IBD Stock Charts https://t.co/KPXyLUcGb6 #IBDCharts via @IBDinvestors  $REGN$REGN Don't Buy Buffet Picks@El_Mono1958 $REGN Got a tgt $428.50 on my pos,from yesterday$REGN and $VMW from mention yesterday moving well as is $IBBPopular: $JDST, $P, $ZEN, $F, $REGN, $BOX, $EGHT, $TRIL, $HMSY, $CRC, $LNCE, $GM, $TERP, $BYD, $FLKSRT @MktOutperform: Amazon is the 5th best performing stock in the S&amp;P 500 over the past 10 years. #1-4: $PCLN, $REGN, $NFLX, and $MA. https‚Ä¶RT @afortunetraders: $regn looks great but options pricing too high so am sitting out$regn looks great but options pricing too high so am sitting outMy focus remains on #biotech as mentioned during the weekend. Looking for a pullback to enter. $REGN is a screaming buy at these levels.Pre-Marke, ideas para observar:$VRTX, $REGN, $TEVA, $BMRN....y m√°s en nuestro newslleter diario gratuito con info  para  el inversorRT SeekingAlpha: Investor Education - Cramer's Mad Money (5/31/16) https://t.co/z1oQ6cN3dA $REGNRT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶Investor Education - Cramer's Mad Money (5/31/16) https://t.co/81Hj9pk4pR $REGNInvestor Education - Cramer's Mad Money (5/31/16) https://t.co/um0CQjWnQQ $REGNRT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @MktOutperform: Amazon is the 5th best performing stock in the S&amp;P 500 over the past 10 years. #1-4: $PCLN, $REGN, $NFLX, and $MA. https‚Ä¶MFC Quotes
See Here ---&gt; https://t.co/7jQtM8OvDi

$MFC $REGN $VAR #stocks$regn looks similar to $biib, they both may be turning back in favor like alot of the biosRT @MktOutperform: Amazon is the 5th best performing stock in the S&amp;P 500 over the past 10 years. #1-4: $PCLN, $REGN, $NFLX, and $MA. https‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶RT @MktOutperform: Amazon is the 5th best performing stock in the S&amp;P 500 over the past 10 years. #1-4: $PCLN, $REGN, $NFLX, and $MA. https‚Ä¶Elder Green https://t.co/83mRXXHCRM $DRH $OMC $ENIC $GTE $EDR $GNRT $CBYL $NWS $SWC $QGEN $PTCT $SBRA $THC $GLBL $ICON $REGN $ERIIRT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶CTWS News
See Here ---&gt; https://t.co/7R0CAbrvj1

$CTWS $REGN $WAFD #stocksRT @MktOutperform: Amazon is the 5th best performing stock in the S&amp;P 500 over the past 10 years. #1-4: $PCLN, $REGN, $NFLX, and $MA. https‚Ä¶RT @StockTwits: Such an interesting visual. The biotech stocks with the most phase 2 trials right now: https://t.co/JBDT87OyDo

$CELG $GILD‚Ä¶",2016-06-01,REGN,1
38,"Call/Put Highest % volume changes:  Calls: $GME, $MUR, $TWX, $HPE, $CHS.  Puts: $JD, $URI, $MMM, $OXY, $REGN.performance update. @zzlangerhans #zzporte $ABBV $ALXN $AMGN $BIIB $CELG $FPRX $GILD $IBB $INO $MDVN $REGN $VRX $XBI https://t.co/wnL9Sfqd3p$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/J753ayJve8Brian Lockhart of Peak Capital Mgmt. talked $RTN $ED $ETP $PAA $REGN $GG &amp; $NEM during ""Hold It or Fold It"" in today's #MoneyLifeMarketCall$PFE is looking for a dosing advantage-via $HALO - to make up for lost time in the PCSK9 race- they won't be quiet if they see promise $REGN$REGN some resistance above, but it &gt; 410 it can run  https://t.co/aTlGEub4Xm via https://t.co/11Wpw9y7t1$XBI https://t.co/jsvSPloY1b breaking Biotechs, I like $GILD $REGN in this spaceNasdaq100 #Stocks Trend $BMRN $DISH $ALXN $ESRX $AMGN $MNST $WFM $ULTA $WDC $VRTX $BIIB $DLTR $FISV $LRCX $REGN @ https://t.co/YdSIjFJqHfVirginia Retirement System Invests $6,575,000 in Regeneron Pharmaceuticals Inc $REGN https://t.co/o9fwzbAJeY$REGN 403.42 [update]
taking its time building rt side
thru diag &amp; riding 50sma
watching lat 408.35
eventual 420/429 https://t.co/hFV56M4ImzRegeneron Pharmaceuticals Inc $REGN Position Increased by Nisa Investment Advisors L.L.C. https://t.co/RshoXDQhtMBiotech Stocks: Don‚Äôt Expect a ‚ÄòMiraculous Recovery‚Äô https://t.co/UxjxbX15fm via @barronsonline $XBI $IBB $GILD $BIIB $REGNRegeneron Pharmaceuticals Inc $REGN Upgraded at Zacks Investment Research https://t.co/SaZOusUVZH$REGN - Regeneron Pharmaceuticals Inc #REGN Upgraded at Zacks Investment Research https://t.co/6bzFLnVUrb$REGN - Regeneron Pharmaceuticals Inc #REGN Upgraded at Zacks Investment Research https://t.co/AbsF0qeB4DThe Medicines Company hits enrollment target in mid-stage study of RNAi therapeutic for t... https://t.co/d3mmxtHzOD $MDCO $ALNY $AMGN $REGNRT @MarketCurrents: The Medicines Company hits enrollment target in mid-stage study of RNAi therap... https://t.co/KiBeshijNU #premarket $M‚Ä¶The Medicines Company hits enrollment target in mid-stage study of RNAi therap... https://t.co/DUOX2std4Y #premarket $MDCO $ALNY $AMGN $REGNThe Medicines Company hits enrollment target in mid-stage study of RNAi therap... https://t.co/icoPFVy9bR #premarket $MDCO $ALNY $AMGN $REGNThe Medicines Company hits enrollment target in mid-stage study of RNAi therap... https://t.co/KiBeshijNU #premarket $MDCO $ALNY $AMGN $REGNWeekly S&amp;P500 #Stocks Trend $DLTR $MU $HPQ $DG $WDC $MNK $VIAB $WFM $CNC $VRTX $ADS $TDC $TAP $REGN $ALXN  @ https://t.co/RPeaHBHYi0Weekly Nasdaq100 #Stocks Trend $DLTR $MU $ULTA $WDC $VIAB $DISH $WFM $VRTX $REGN $ALXN $MXIM $CMCSA $ESRX $MDLZ @ https://t.co/YdSIjFJqHfRegeneron Pharmaceuticals upgraded by Zacks Investment Research to hold. https://t.co/p59PNdigr9 $REGN #REGNRegeneron Pharmaceuticals upgraded by Zacks Investment Research to hold. https://t.co/qZeSDuhNFE $REGN #REGNCabot Wealth Management Inc. Decreases Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/z1ds4zhI81Cabot Wealth Management Inc. Decreases Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/HXeihCWS7URegeneron: Coming Into Its Own - Barron's $REGN $SNY https://t.co/tbcis3of9JRT @AndyBiotech: Biotech and Pharma companies with most Medicare Part B exposure (via GS)

$REGN $AMGN $SGEN $BXLT $BIIB https://t.co/68nii‚Ä¶REGN Ask Size
See Here ---&gt; https://t.co/Q6tV5fyve4

$REGN $UTX $IYR #tradeideas$REGN, bull flag breakout, hit top of BB today. Has more room higher but some short term unwinding needed. https://t.co/GpA1kmX72n$REGN top ten OTM 6/17 CALLS by most LAST CHANGE [EOD:6/1]. DWNLD Options Analytics: https://t.co/IikqKCXxqi #stocks https://t.co/SoGc8tgrgLTCS Investor Opinions
See Here ---&gt; https://t.co/b5eGh0y5Xu

$TCS $GPRO $REGN #investRegeneron Pharmaceuticals's outperform rating reiterated at Leerink Swann. $530.00 PT. https://t.co/pEKSTHkPHN $REGN #REGNRegeneron Pharmaceuticals's outperform rating reiterated at Leerink Swann. $530.00 PT. https://t.co/Lch8OVmkUZ $REGN #REGNDVA Summary
See Here ---&gt; https://t.co/7OOfovTV62

$DVA $REGN $MCIG #investing",2016-06-02,REGN,0
39,"SIRG Investor Opinions
See Here ---&gt; https://t.co/7sh3Fo80m9

$SIRG $BRWC $REGN #investing#RegeneronPharmaceuticals Regeneron and Sanofi's Dermatitis Drug Meets Goals in Late-Stage ... Read more: https://t.co/4OWql0xE5r $REGNRT @JNapodano: Please see my article on $PIRS #asthma drug PRS-060 and how recent data from $REGN / $SNY validate the strategy &gt; https://t.‚Ä¶RT @MarketCurrents: Regeneron and Sanofi's dupilumab successful in late-stage atopic dermatitis study https://t.co/ylqroNWiPY $REGN $SNY$REGN's dupilumab successful in late-stage atopic dermatitis study https://t.co/1AbJHq0uIR by @SeekingAlphaGreenday - $ARGS $AERI $CDNL $HUSA $INO $KORS $NUGT $REGN $RLYP $SNY üòäRT @JNapodano: Please see my article on $PIRS #asthma drug PRS-060 and how recent data from $REGN / $SNY validate the strategy &gt; https://t.‚Ä¶RT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNYThe BioTech mutual fund I run is having a crazy three weeks!

#Investing
#Stocks
$GILD
$INSY
$KITE
$JUNO
$REGN
$AGN https://t.co/2NcgxRGFcIRT @fwpharma: Sanofi, Regeneron's experimental drug dupilumab hits main goals of Phase III atopic dermatitis study https://t.co/uMiCHKBYoZ‚Ä¶Regeneron and Sanofi's dupilumab successful in late-stage atopic dermatitis study https://t.co/qU979obolK $REGN $SNYRegeneron and Sanofi's dupilumab successful in late-stage atopic dermatitis study https://t.co/1jDR53Q016 $REGN $SNYRegeneron and Sanofi's dupilumab successful in late-stage atopic dermatitis study https://t.co/ylqroNWiPY $REGN $SNYIf you did buy these #biotech, not bad taking some profit off the table. $CELG $REGN $GILD $ALXN https://t.co/maN1PtuKjkAll of the following are excellent put ratio spread candidates, tweet us if u want specifics. $BIIB $ALXN $REGN $CMG $TSLA $AMZN $AGN $NTESRT @fwpharma: Sanofi, Regeneron's experimental drug dupilumab hits main goals of Phase III atopic dermatitis study https://t.co/uMiCHKBYoZ‚Ä¶RT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNYAIR Stock Forum
See Here ---&gt; https://t.co/iY0VyH9HLW

$AIR $REGN $CMC #tradeideasRT @portefeuillefun: #zzporte top40. @zzlangerhans $AKBA $BLCM $BLUE $CLLS $ENTA $FPRX $ITCI $JUNO $MDVN $QURE $REGN $STML. cash ‚âà $443k ht‚Ä¶#zzporte top40. @zzlangerhans $AKBA $BLCM $BLUE $CLLS $ENTA $FPRX $ITCI $JUNO $MDVN $QURE $REGN $STML. cash ‚âà $443k https://t.co/F2ClmIYacw$REGN trying hammer above 400 https://t.co/75gGk34a6JRegeneron Pharmaceuticals Inc $REGN Position Raised by Commonwealth Equity Services Inc https://t.co/370HE50mMp$REGN - Regeneron Pharmaceuticals Inc #REGN Rating Reiterated by Cowen and Company https://t.co/cCzKpnGfXyRegeneron Pharmaceuticals, Inc.  Reiterated Rating by Cowen &amp; Co (Ranked 53rd) to Hold $REGN #REGN https://t.co/6KTXk3W2QERegeneron Pharmaceuticals's hold rating reiterated at Cowen and Company. https://t.co/OXQx0D8j80 $REGN #REGNRT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNYRT @JNapodano: Please see my article on $PIRS #asthma drug PRS-060 and how recent data from $REGN / $SNY validate the strategy &gt; https://t.‚Ä¶Regeneron Pharmaceuticals's hold rating reiterated at Cowen and Company. https://t.co/nZH8F5iUdY $REGN #REGNRT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNYPlease see my article on $PIRS #asthma drug PRS-060 and how recent data from $REGN / $SNY validate the strategy &gt; https://t.co/WXzLksUrJLTop #sentiment for #SP1500 #stocks at midday: $BMY $MRK $JNJ $AGN $REGN (2016/06/06) #stocktrading #predictiveanalytics #bigdataTop sentiment for SP1500 stocks at midday: $BMY $MRK $JNJ $AGN $REGN (2016/06/06) #sentiment #stock #alexandriaRT @JNapodano: $PIRS - Target Validation Enhances Potential For Pieris‚Äô Inhaled Asthma Drug &gt;&gt; https://t.co/WXzLksUrJL // $REGN $SNYRT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNYRT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNYRT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNYRegeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/2XB44kRL1Q by JohnCBiotech $REGN $SNY story from FierceBi‚Ä¶RT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNYRT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNY$ACUR $RLYP $INO $REGN $ARGS all looking good... For my labsRT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNY$REGN Just turned green. Let's see if $MON can do that now.RT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNYRegeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNYRT @go2sleepjj: Should've exited $EBIO sooner, $REGN ugh, $MON wtf?! $RLYP...is $RLYP....argggh...we'll get them next time! üòÇShould've exited $EBIO sooner, $REGN ugh, $MON wtf?! $RLYP...is $RLYP....argggh...we'll get them next time! üòÇ$REGN:US Sanofi and Regeneron report positive skin disease trial #REGENERON PHARMACEUT  https://t.co/VlYoXRXA5e #SP500RT @tgtxdough: WF $REGN https://t.co/dC6TrzWB9QRegeneron Pharmaceuticals‚Äô $REGN Outperform Rating Reiterated at Leerink Swann https://t.co/mL8cXazdhYRegeneron Pharmaceuticals‚Äô $REGN Outperform Rating Reiterated at Leerink Swann https://t.co/L6kGjIQvSRRT @fwpharma: Sanofi, Regeneron's experimental drug dupilumab hits main goals of Phase III atopic dermatitis study https://t.co/uMiCHKBYoZ‚Ä¶$REGN: Regeneron Pharma and Sanofi (SNY) report Phase 3 data for Dupilumab met primary and key secondary endpoints https://t.co/rEbgqoNC14RT @JNapodano: $PIRS - Target Validation Enhances Potential For Pieris‚Äô Inhaled Asthma Drug &gt;&gt; https://t.co/WXzLksUrJL // $REGN $SNYRT @JNapodano: $PIRS - Target Validation Enhances Potential For Pieris‚Äô Inhaled Asthma Drug &gt;&gt; https://t.co/WXzLksUrJL // $REGN $SNY$PIRS - Target Validation Enhances Potential For Pieris‚Äô Inhaled Asthma Drug &gt;&gt; https://t.co/WXzLksUrJL // $REGN $SNYRT @fwpharma: Sanofi, Regeneron's experimental drug dupilumab hits main goals of Phase III atopic dermatitis study https://t.co/uMiCHKBYoZ‚Ä¶REED Tick
See Here ---&gt; https://t.co/WzWkAJf7tZ

$REED $REGN $CAG #nasdaqRT @fwpharma: Sanofi, Regeneron's experimental drug dupilumab hits main goals of Phase III atopic dermatitis study https://t.co/uMiCHKBYoZ‚Ä¶WF $REGN https://t.co/dC6TrzWB9QRT @fwpharma: Sanofi, Regeneron's experimental drug dupilumab hits main goals of Phase III atopic dermatitis study https://t.co/uMiCHKBYoZ‚Ä¶BlackRock Fund Advisors Has $796,096,000 Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/Gg99SwdOiVRT @fwpharma: Sanofi, Regeneron's experimental drug dupilumab hits main goals of Phase III atopic dermatitis study https://t.co/uMiCHKBYoZ‚Ä¶Regeneron Pharmaceuticals Inc $REGN Stock Rating Upgraded by Zacks Investment Research https://t.co/UijtM2PilURegeneron Pharmaceuticals Inc $REGN Stock Rating Upgraded by Zacks Investment Research https://t.co/65VSIt6oTRRegeneron Pharmaceuticals Inc $REGN Stock Rating Upgraded by Zacks Investment Research https://t.co/jLwK2kKPdERT @fwpharma: Sanofi, Regeneron's experimental drug dupilumab hits main goals of Phase III atopic dermatitis study https://t.co/uMiCHKBYoZ‚Ä¶Sanofi, Regeneron's experimental drug dupilumab hits main goals of Phase III atopic dermatitis study https://t.co/uMiCHKBYoZ $SNY $REGNRegeneron Pharmaceuticals Inc $REGN Position Maintained by Sentry Investment Management LLC https://t.co/vABrSOInM1$REGN: Regeneron Pharma and Sanofi (SNY) reports Phase 3 data for Dupilumab met primary and key secondary endpoints https://t.co/rEbgqoNC14RT @ScripMandy: @bradloncar That's why there are 37 PD-1/L1 inhibitors in devt, per @BioMedTracker database: $REGN, $INCY etc. want their o‚Ä¶$REGN Regeneron and Sanofi Announce that Dupilumab Used with Topical Corticosteroids (TCS) was Superior to Tr
From our Stock News Alerts App@bradloncar That's why there are 37 PD-1/L1 inhibitors in devt, per @BioMedTracker database: $REGN, $INCY etc. want their own for combos.RT @AndysCycles: $IBB biotech index components. $ENDP $VRTX $MYL $BIIB $ALXN $AMGN $ILMN $REGN $CELG $BMRN $INCY $JAZZ $GILD $MDVN https://‚Ä¶$IBB biotech index components. $ENDP $VRTX $MYL $BIIB $ALXN $AMGN $ILMN $REGN $CELG $BMRN $INCY $JAZZ $GILD $MDVN https://t.co/EdsQv7PvjxGet to know the main five #Biotech stocks in the US $GILD $AMGN $CELG $BIIB $REGN https://t.co/2ufHFlwWMh https://t.co/BTfEluIMZX",2016-06-06,REGN,0
40,"Enter Ichimoku https://t.co/lUKbqU3c1R $REGN $FLIR $HAR $HEWJ $ELTK $OMED $MIFI $NATI $UTHR $GNRT $ARAY $CTIX $ENVA $YRCW $YUME $GCAP $PNFPRegeneron Pharmaceuticals Inc $REGN Stock Price Down 1.8% https://t.co/QWNNiEJBk6Regeneron Pharmaceuticals Inc $REGN Stock Price Down 1.8% https://t.co/vIf6CXvjsoRT @AndysCycles: $IBB #Biotech top components sorted by 1month chg. $MDVN $INCY $VRTX $ILMN $BMRN $REGN $BIIB $CELG $AMGN $MYL $GILD https:‚Ä¶Regeneron Pharmaceuticals Inc $REGN Receives ‚ÄúHold‚Äù Rating from Piper Jaffray https://t.co/4vAPEyuoNDRegeneron Pharmaceuticals Inc $REGN Receives ‚ÄúHold‚Äù Rating from Piper Jaffray https://t.co/T9Zvgt9z2A3 Drugs Stocks Dragging The Industry Down $REGN https://t.co/bPKW9e4btkRegeneron Pharmaceuticals, Inc.  Reiterated Rating by Piper Jaffray (Ranked 59th) to Hold $REGN #REGN https://t.co/6KTXk3W2QE$VRX https://t.co/KYNGRKZWtC its going to Zero. Keep an eye $IBB, $ALXN, $BIIB, $REGN major components tripping the $IBB today.Vetr users have downgraded Regeneron Pharmace... to a BUY Rating (3.5 stars), giving $REGN a target price of $429.64 https://t.co/Xy6N0XHB1RRT @JNapodano: Please see my article on $PIRS #asthma drug PRS-060 and how recent data from $REGN / $SNY validate the strategy &gt; https://t.‚Ä¶Regeneron Pharmaceuticals Inc $REGN Lifted to Hold at Zacks Investment Research https://t.co/XoRZP0JMIyRegeneron Pharmaceuticals Inc $REGN Lifted to Hold at Zacks Investment Research https://t.co/oIl41gAPSwRegeneron Pharmaceuticals Inc $REGN Lifted to Hold at Zacks Investment Research https://t.co/eP4PzLi5K5Regeneron Pharmaceuticals Inc $REGN Lifted to Hold at Zacks Investment Research https://t.co/eZnlIKU8UlRT @JNapodano: $PIRS - Target Validation Enhances Potential For Pieris‚Äô Inhaled Asthma Drug &gt;&gt; https://t.co/WXzLksUrJL // $REGN $SNYBreakthrough-designation drug dupilumab for #eczema #atopic dermatitis has another positive clinical study https://t.co/o97gYKv5I0 $REGNINFO: $REGN SENTIMENT indicator (as seen by investors in News &amp; Social Media)  shows very positive perception. https://t.co/Zj9O1CG8M7RT @fwpharma: Sanofi, Regeneron's experimental drug dupilumab hits main goals of Phase III atopic dermatitis study https://t.co/uMiCHKBYoZ‚Ä¶@redacre Sort of yes and no. The top five securities are given an 8% weight every time it rebalances. $BIIB $REGN $AMGN $GILD, and $CELG.UBSH Stock Message Board
See Here ---&gt; https://t.co/i8mIrBj3So

$UBSH $BHI $REGN #stocksDupilumab Used with Topical Corticosteroids (TCS) was Superior to Treatment with TCS Alone $REGN , $SNY https://t.co/O1SWdXXsmlRegeneron Pharmaceuticals Inc $REGN Receives Outperform Rating from Leerink Swann https://t.co/nIdgTp0v4m$REGN #Regeneron and #Sanofi 's #dupilumab successful in late-stage atopic dermatitis study https://t.co/ysp5mSvtVx#RegeneronPharmaceuticals Regeneron, Sanofi Report Positive Dupilumab Phase III Data. Read more: https://t.co/9K5maDMhM7 $REGN#RegeneronPharmaceuticals Regeneron, Sanofi Report Positive Dupilumab Phase III Data. Read more: https://t.co/0fwQPf1d9H $REGNRT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNYRT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNYRegeneron Pharmaceuticals Inc $REGN Lowered to ‚ÄúBuy‚Äù at Vetr Inc. https://t.co/flQAGxMYYBREGN Company Info
See Here ---&gt; https://t.co/nrHC9f7o1v

$REGN $ENR $ELGX #shareRegeneron Pharmaceuticals Inc $REGN Lowered to Buy at Vetr Inc. https://t.co/GmNMh5nFJZRegeneron Pharmaceuticals downgraded by Vetr Inc. to buy. $429.64 PT. https://t.co/4dLlzIC1G6 $REGN #REGNRT @FierceBiotech: Regeneron, Sanofi take another big step toward quick dupilumab OK - https://t.co/ejzaYuBPDR by @JohnCBiotech $REGN $SNYRT @JNapodano: $PIRS - Target Validation Enhances Potential For Pieris‚Äô Inhaled Asthma Drug &gt;&gt; https://t.co/WXzLksUrJL // $REGN $SNY#RegeneronPharmaceuticals Sanofi and Regeneron hit goals with Phase III dupilumab study for... Read more: https://t.co/VVs1X4Oh7D $REGN#RegeneronPharmaceuticals Sanofi and Regeneron hit goals with Phase III dupilumab study for... Read more: https://t.co/IcOHKBgf32 $REGN",2016-06-07,REGN,0
41,"RT @regeneron: $REGN chairman Roy Vagelos accepting the Lifetime Achievement Award @American_Heart Congrats Roy! https://t.co/3lm4ZQAIJ2$REGN chairman Roy Vagelos accepting the Lifetime Achievement Award @American_Heart Congrats Roy! https://t.co/3lm4ZQAIJ2REGN EOD Data
See Here ---&gt; https://t.co/SvDxm57zGM

$REGN $RH $EQT #invest$REGN how I set this up....NO trigger no trade!!  https://t.co/9e66zz9PsNBelow Ichimoku https://t.co/v7aInmbQ0K $IMS $OXM $REGN $HW $GLBL $XRS $SSNC $SMG $QURE $HRTX $MOMO $ELLI $SSNI $CACB $ZSL $HCI $RTKRT @Fibonacciqueen: $REGN it's decision time HERE...look at the symmetry with the prior declines!!! https://t.co/GItKvDlbuART @Fibonacciqueen: $REGN it's decision time HERE...look at the symmetry with the prior declines!!! https://t.co/GItKvDlbuA$REGN Hammer candlestick / holding symmetry support https://t.co/2fakfa3L9WRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶Thanks Carolyn for Fib charts on $REGN in recent weeks! https://t.co/O0sOOAKuhh$REGN it's decision time HERE...look at the symmetry with the prior declines!!! https://t.co/GItKvDlbuAUSB Last Price
See Here ---&gt; https://t.co/NLW2NjSRnj

$USB $REGN $SIPC #stockmarketRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @regeneron: June is #NationalSafetyMonth. At $REGN, we offer courses for our colleagues to become certified in CPR &amp; First Aid https://t‚Ä¶Biotech Stocks: Much Ado About Nothing at ASCO? $CELG $GILD $REGN $AMGN https://t.co/ujBtmgfS5qRegeneron Pharmaceuticals Inc $REGN Position Lowered by TIAA CREF Investment Management LLC https://t.co/XeLmklsY9dRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @AmericanBanking: $REGN - Regeneron Pharmaceuticals Inc #REGN Given Sell Rating at Chardan Capital https://t.co/KfZZDNrDYV$REGN - Regeneron Pharmaceuticals Inc #REGN Given Sell Rating at Chardan Capital https://t.co/KfZZDNrDYVRegeneron Pharmaceuticals Inc $REGN Position Lowered by TIAA CREF Investment Management LLC https://t.co/yR3XgXXg1FCatabasis' lipid drug flunks mid-stage study in patients with high cholesterol $CATB  
$AMGN $REGN $MRK $ESPR  https://t.co/15AeXZOUTDJune is #NationalSafetyMonth. At $REGN, we offer courses for our colleagues to become certified in CPR &amp; First Aid https://t.co/gOGV41KHNJ@tgtxdough @AndyBiotech Event rate in $REGN CVOT trial WAS LOWER (than estimate) from day one (2012)....way surprised now?BAML $AMGN Repatha CVOT data delayed to 1H17; expects results from imaging study in 2H16 $SNY $REGN $MRK $ESPRJune 8 Biotech Update $AMGN $MDCO $REGN $SRPT https://t.co/627LqSuXG7@MarkYusko  innovative DISRUPTIVE stocks 
$AAPL $TSLA $UA  $NFLX  $CRM 
$AMZN $CELG  $WDAY $FB $SBUX 
$REGN $CMG $HAIN $JUNO $GOOGL $MBLY$AMGN likely to report data from its PCSK9 cardiovascular outcomes trial FOURIER in the 2H16 #cholesterol $SNY $REGN #praluent #repathaIs $600 Around the Corner For Regeneron $REGN?
https://t.co/cFTkDMHsGGSFTW Investor long-term stock recommendation: $REGN Regeneron Pharmaceuticals, Inc. (SS: 70) https://t.co/ajLDr7suctRT @AndyBiotech: $AMGN Repatha CVOT has now accrued ~85% of requisite events and will continue to accrue remaining events over the summer.‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶Franklin Resources Inc. Has $240,516,000 Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/ypeNgqfN64Regeneron Pharmaceuticals Inc $REGN Rating Reiterated by Piper Jaffray https://t.co/QHFZ1mqsK6Regeneron Pharmaceuticals Inc $REGN Stock Rating Lowered by Vetr Inc. https://t.co/XyIfhLAe62Regeneron Pharmaceuticals Inc $REGN Stock Rating Lowered by Vetr Inc. https://t.co/yL1rB91squRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @AndyBiotech: $AMGN Repatha CVOT has now accrued ~85% of requisite events and will continue to accrue remaining events over the summer.‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶Reminder that $REGN spent $67.5M to get to all these PCSK9 scripts early

https://t.co/eUIAAxG7GqChardan Capital Reaffirms ‚ÄúSell‚Äù Rating for Regeneron Pharmaceuticals Inc $REGN https://t.co/NX1QfcceXFChardan Capital Reaffirms ‚ÄúSell‚Äù Rating for Regeneron Pharmaceuticals Inc $REGN https://t.co/9FeTu0m2UART @AndyBiotech: $AMGN Repatha CVOT has now accrued ~85% of requisite events and will continue to accrue remaining events over the summer.‚Ä¶RT @AndyBiotech: $AMGN Repatha CVOT has now accrued ~85% of requisite events and will continue to accrue remaining events over the summer.‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶Regeneron Pharmaceuticals's sell rating reiterated at Chardan Capital. $325.00 PT. https://t.co/5DN0qC6QhW $REGN #REGN$AMGN Repatha CVOT has now accrued ~85% of requisite events and will continue to accrue remaining events over the summer.
$REGN $SNY $PFEQuick summary for #ASCO16 heavyweights $AMGN $CELG $GILD $REGN

Biotech Stocks: Much Ado About Nothing at ASCO? https://t.co/QoBhNa3tB1RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶Regeneron Pharmaceuticals Inc $REGN Stake Maintained by Peapack Gladstone Financial Corp https://t.co/13QiRsNtZIRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶Chardan Capital Reiterates a Sell Rating on Regeneron $REGN https://t.co/yracg1pV0eRegeneron Pharmaceuticals Inc $REGN Stock Rating Reaffirmed by Wells Fargo https://t.co/Eew86ESRXbRegeneron Pharmaceuticals's hold rating reiterated at Wells Fargo. https://t.co/fDdfjouezi $REGN #REGNRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶$REGN watch for possible bounce at 50DMA tomorrow https://t.co/dZ7tqQl4ig via https://t.co/11Wpw9PIRBRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶RT @seeitmarket: 5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $‚Ä¶5 Large Cap Biotech Stocks With Long-Term Upside (from Apr. 5) - https://t.co/T46RnBtL3B  by @OphirGottlieb  $CELG $GILD $AMGN $BIIB $REGNRT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶RT @AndyBiotech: $AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiob‚Ä¶$AMGN #PCSK9 Repatha CVOT top-line data pushed back to 1Q17 and full data expected at #ACC17.

$REGN $SNY $PFE CC @cardiobrief",2016-06-08,REGN,0
42,"REGN update $REGN https://t.co/gf1LW59Eiz$REGN chart: REGN update. https://t.co/nY8FDgRiIN$REGN  so far there is NO buy trigger on this 30-minute chart...no entry yet... https://t.co/sjXPBCo7OtRT @Escells: REGENERON PHARMACEUTICALS, INC. (NASDAQ: $REGN ) target price of $489.94 https://t.co/iciUXmsN0c $IBB #biotech$REGN ... Short Sell in #Biotech - #regeneron https://t.co/My6cOViYGUbubble is bursting $BIIB $IBB $REGN $ALXN$REGN Eylea Trails in DME Drug Cost-Effectiveness Study: JAMA OphthalmologyRT @Escells: REGENERON PHARMACEUTICALS, INC. (NASDAQ: $REGN ) target price of $489.94 https://t.co/iciUXmsN0c $IBB #biotechRT @Escells: REGENERON PHARMACEUTICALS, INC. (NASDAQ: $REGN ) target price of $489.94 https://t.co/iciUXmsN0c $IBB #biotechRT @Escells: REGENERON PHARMACEUTICALS, INC. (NASDAQ: $REGN ) target price of $489.94 https://t.co/iciUXmsN0c $IBB #biotechREGENERON PHARMACEUTICALS, INC. (NASDAQ: $REGN ) target price of $489.94 https://t.co/iciUXmsN0c $IBB #biotechPrudential Financial Inc. Sells 191,540 Shares of Regeneron Pharmaceuticals Inc $REGN https://t.co/R7JUN73jh0$REGN 1-hr nice first hour candle https://t.co/FdrZhG4REA via https://t.co/11Wpw9y7t1Regeneron Pharmaceuticals Inc $REGN Stock Price Down 1.8% https://t.co/ul9rFCQbBFRegeneron Pharmaceuticals Inc $REGN Stock Price Down 1.8% https://t.co/aEahQRBriEPiper Jaffray Reaffirms Hold Rating for Regeneron Pharmaceuticals Inc $REGN https://t.co/II3B4t7BBj$REGN - SELL Signal at 388.97 on Jun 08, 16 By https://t.co/6PpjiKmc9G Trading Robot #Stockstowatch #Stockmarket #trading #trade #investingDW Day High
See Here ---&gt; https://t.co/Wd5RqCVVQE

$DW $ISBG $REGN #financeRegeneron Pharmaceuticals Inc $REGN Downgraded by Chardan Capital to Sell https://t.co/KOxw3TbP6RRegeneron Pharmaceuticals Inc $REGN Downgraded by Chardan Capital to Sell https://t.co/o8h2LfKwtgMomentum is down on $REGN last 3 days, and price crossed below 50MA. More weakness to come? https://t.co/ezNtrFrydY‚Ä¶ https://t.co/o7KfszSnSc$REGN possible bounce off 380, if not gap close below to 369.46  https://t.co/31G0QZjukN via https://t.co/11Wpw9y7t1REGN Day High
See Here ---&gt; https://t.co/U1fWWZhAw2

$REGN $FNHC $SHLM #nasdaqRegeneron Pharmaceuticals‚Äô $REGN ‚ÄúHold‚Äù Rating Reaffirmed at Wells Fargo https://t.co/6D8iWq0Y7fRegeneron Pharmaceuticals‚Äô $REGN ‚ÄúHold‚Äù Rating Reaffirmed at Wells Fargo https://t.co/IH8Sln45DZRT @Fibonacciqueen: $REGN it's decision time HERE...look at the symmetry with the prior declines!!! https://t.co/GItKvDlbuAGVA Stock Message Board
See Here ---&gt; https://t.co/K7zjBwZO4d

$GVA $CCLP $REGN #nasdaqRT @AndyBiotech: $AMGN Repatha CVOT has now accrued ~85% of requisite events and will continue to accrue remaining events over the summer.‚Ä¶COST Summary
See Here ---&gt; https://t.co/arby06Vy4T

$COST $REGN $IPGP #stockmarketRT @Fibonacciqueen: $REGN how I set this up....NO trigger no trade!!  https://t.co/9e66zz9PsN$REGN - SELL Signal at 388.97 on Jun 08, 16 By https://t.co/6PpjiK4AL6 Trading Robot #Stockstowatch #Stockmarket #trading #trade #investingRT @regeneron: $REGN chairman Roy Vagelos accepting the Lifetime Achievement Award @American_Heart Congrats Roy! https://t.co/3lm4ZQAIJ2",2016-06-09,REGN,0
43,"Here are 5 stocks worth buying in June https://t.co/4OXHrw30R3 $MCD $NVAX $IBM $REGN $EOG$AZN $REGN $BGNE:

Has Cancer Research Become Cancerous? Same Cancer Strategy ‚Ä¶:

https://t.co/ecSehvycCkChardan Capital Lowers Regeneron Pharmaceuticals Inc $REGN to Sell https://t.co/YyQFQS0KomRegeneron Pharmaceuticals‚Äô $REGN Hold Rating Reiterated at Wells Fargo https://t.co/vOyZZbkx9JRegeneron Pharmaceuticals‚Äô $REGN Hold Rating Reiterated at Wells Fargo https://t.co/Bpc2mynAjhRegeneron Pharmaceuticals‚Äô $REGN Hold Rating Reiterated at Wells Fargo https://t.co/dRtXSp7ZTuChardan Capital Lowers Regeneron Pharmaceuticals Inc $REGN to Sell https://t.co/AQ02PRsrDFChardan Capital Lowers Regeneron Pharmaceuticals Inc $REGN to Sell https://t.co/aB8RhZaZdZREGN 52Wk High
See Here ---&gt; https://t.co/u3tWODBh7I

$REGN $MTW $CVGI #stockmarketNikko Asset Management Americas Inc. Acquires Shares of 600 Regeneron Pharmaceuticals Inc $REGN https://t.co/nWPDSuPb8SCan Pfizer's Outperformance Continue? https://t.co/4Tu6bjvzLe $AGN $ANAC $AZN $GILD $IBB $MDVN $REGN $PFEShufro Rose &amp; Co. LLC Buys New Position in Regeneron Pharmaceuticals Inc $REGN https://t.co/VWCv089FlyRT @CashRocket: Some biopharma M&amp;A candidates: $AERI $CRIS $ITCI $MDCO $NBRV $OCUL $REGN $SGEN $SPPI https://t.co/k87oKr6ZnOJNJ Johnson &amp; Johnson Shares
https://t.co/FEw1WG8Lst

$JNJ $REGN $MU $ASTID  #invest #financeCan Pfizer's Outperformance Continue? https://t.co/1y03ffxU9j $AGN $ANAC $AZN $GILD $IBB $MDVN $REGN $PFECan Pfizer's Outperformance Continue? https://t.co/5B5BuvHTEe $AGN $ANAC $AZN $GILD $IBB $MDVN $REGN $PFECan Pfizer's Outperformance Continue? https://t.co/GhE0Tba8nL $AGN $ANAC $AZN $GILD $IBB $MDVN $REGN $PFECan Pfizer's Outperformance Continue? https://t.co/VlyVyYE5CE $AGN $ANAC $AZN $GILD $IBB $MDVN $REGN $PFEC M Bidwell &amp; Associates Ltd. Invests $3,612,000 in Regeneron Pharmaceuticals Inc $REGN https://t.co/5ggCBt6eCjRegeneron Pharmaceuticals Inc $REGN Stake Boosted by M&amp;T Bank Corp https://t.co/r73kUXlYCORegeneron Pharmaceuticals Inc $REGN Lifted to Strong-Buy at Vetr Inc. https://t.co/NK0HAHxx0BRT @MarketSwingPlay: $SPY $REGN $FAS  In order to make sure your trading account pop, you need to detect subtle pops or drops by MSP ALGO h‚Ä¶$SPY $REGN $FAS  In order to make sure your trading account pop, you need to detect subtle pops or drops by MSP ALGO https://t.co/n2Bebc2CCU",2016-06-13,REGN,0
44,"It's hard to believe that only 26 yrs ago, $REGN published our first paper in @sciencemagazine. Check it out: https://t.co/hI1volglU13 Biotech Stocks to Buy If the Market Crashes -- $CELG $GILD $REGN #STOCKS  The Motley Fool https://t.co/7SQRjQ23NC$REGN Company REGENERON PHARMACEUTICALS INC just submited new SEC filing https://t.co/KjMzFPRRBwOpenOutcrier: RECAP 6/14 -Neg Comments:
$REGN - Chardan
$TMO - Cleveland
$PKI - Cleveland
$WAT - Cleveland
$WYNN - ITG
$COF - EvercoreRECAP 6/14 -Neg Comments:
$REGN - Chardan
$TMO - Cleveland
$PKI - Cleveland
$WAT - Cleveland
$WYNN - ITG
$COF - EvercoreApproached some solid\u2026 $REGN https://t.co/8wLNtLn7nkKeep an eye on $SPPI $LXRX $VRX $GILD and $REGN over next few months.  #FDA news coming.$REGN bounce here or stare at the abyss  https://t.co/IddqW1vj5o via https://t.co/11Wpw9y7t1$REGN-Chardan sees risk of injunction for Praluent in IP suit w/ Amgen. I'll be shocked if inj. granted-would mean no other PCSK9 inh on mktRegeneron Pharmaceuticals Inc $REGN Shares Sold by Teachers Advisors Inc. https://t.co/IdowAKwZdJChardan - 9 Reasons Praluent Could Be Forced From the US Market $regn $sny
https://t.co/Bg0t3CnQEdOpenOutcrier: $REGN Hearing Chardan with cautious commentsRegeneron Pharmaceuticals hits a 1 month low https://t.co/ljMX9dmC2H $REGN #RegeneronPharmaceuticals https://t.co/8RjyfGcoueRT @OpenOutcrier: $REGN Hearing Chardan with cautious comments$REGN Hearing Chardan with cautious commentsZiarco Lacks Sparkle In Atopic Dermatitis https://t.co/61uKZe4CWT $VRX $SNY $REGN $PFE $ANACEsperion Therapeutics: Why IMPROVE-IT Hasn't Cast A Shadow Over ETC-1002 https://t.co/ky4MVpcfXW $AMGN $MRK $REGN $SNY $ESPRRegeneron Pharmaceuticals Inc $REGN Upgraded by Vetr Inc. to Strong-Buy https://t.co/LfTFY1TKqTRegeneron Pharmaceuticals Inc $REGN Upgraded by Vetr Inc. to Strong-Buy https://t.co/HaGbiKyJH3Regeneron Pharmaceuticals Inc $REGN Downgraded by Chardan Capital to Sell https://t.co/X0BeizK785$IBB monthly $GILD $CELG $BIIB $REGN $CELG $ALXN $AGN https://t.co/HwAS0vZjv3XOP Direxion Daily FTSE China Bear 3x Shares Chart
https://t.co/EzQ6fXALlI

$XOP $REGN $ERF $WMT  #share #financeREGN Regeneron Pharmaceuticals, Inc. News
https://t.co/eTZDDGRTfX

$REGN $SVXY $FNMA $HD  #nasdaq #tradeideasRT @MFIndustryFocus: Here are 5 stocks worth buying in June https://t.co/4OXHrw30R3 $MCD $NVAX $IBM $REGN $EOGRT @JFDI: Charts Of Interest - $IBB $ALXN $ILMN $JAZZ $REGN  $BIIB https://t.co/tEw4yl1SrtCharts Of Interest - $IBB $ALXN $ILMN $JAZZ $REGN  $BIIB https://t.co/tEw4yl1Srt",2016-06-14,REGN,1
45,"#RegeneronPharmaceuticals REGENERON PHARMACEUTICALS INC : Submission of Matters to a Vote o... Read more: https://t.co/VkgFj4XToG $REGN#RegeneronPharmaceuticals REGENERON PHARMACEUTICALS INC : Submission of Matters to a Vote o... Read more: https://t.co/R882SyyavS $REGN$REGN New SEC Document(s) for Regeneron Pharmaceuticals, Inc.
From our Stock News Alerts AppSubmission   of Matters to a Vote of Security  https://t.co/FCR2i71FWk $REGNOXFD Bid
See Here ---&gt; https://t.co/3k4BphVDCT

$OXFD $GBSN $REGN #tradeideas$ADAP @Adaptimmune Therapeutics

$MDT $BSX $TMO $EW $DXCM $IDXX $NVTA $AMGN $SNY $LLY $BAYRY $GILD $BIIB $CELG $REGN https://t.co/n0u1iP7r2xRT @regeneron: It's hard to believe that only 26 yrs ago, $REGN published our first paper in @sciencemagazine. Check it out: https://t.co/h‚Ä¶Below PC https://t.co/PuGbnWjp9t $PSA $PMCB $REGN $RCII $MLM $GAHC $PHG $VXUS $FSC $CONN $ANTH $SAEX $UTHR $MORE $NTG $TLLP $SCZ",2016-06-15,REGN,0
